ANIRBANMAITRAANIRBAN MAITRA9915MAITRA, ANIRBANProfessorprns:coAuthorOfcoauthor ofFaculty Rankprns:fullNamefull nameprns:hasAuthorListauthor listprns:hasFacultyRankhas faculty rankprns:hasNetworkhas networkprns:hasPublicationVenuepublished inprns:informationResourceReferenceinformation resource referenceprns:isPrimaryPositionis primary positionprns:maxWeightmaximum weightprns:medlineTAjournal title abbreviationprns:meshDescriptorUIMeSH DescriptorUIprns:meshSemanticGroupNameMeSH semantic group nameprns:minWeightminimum weightprns:numberOfAuthorsnumber of authorsprns:numberOfConnectionsnumber of connectionsprns:numberOfPublicationsnumber of publicationsprns:personIdPerson IDprns:personInPrimaryPositionperson in primary positionprns:positionInDepartmentposition in departmentprns:positionInDivisionposition in divisionprns:predicateNodepredicate nodeprns:publicationDatepublication dateprns:similarTosimilar toprns:sortOrdersort orderprns:uniquenessWeightuniqueness weightprns:yearyearAcademic ArticleArticleDocumentbibo:pmidPubMed IdentifierAddressvivo:address1address line 1vivo:addressCitycityvivo:addressPostalCodepostal codevivo:addressStatestate or provincevivo:authorInAuthorshipselected publicationsvivo:authorRankauthor rank in publicationAuthorshipDepartmentDivisionvivo:hasResearchArearesearch areasvivo:hrJobTitleHR job titleInformation Resourcevivo:linkedAuthorlinked authorvivo:linkedInformationResourcelinked information resourcevivo:mailingAddressmailing addressvivo:personInPositionpositionsPositionvivo:positionInOrganizationposition in organizationvivo:preferredTitlepreferred titlerdf:predicatepredicaterdf:typetyperdfs:labellabelConceptAgentfoaf:firstNamefirst namefoaf:lastNamelast nameOrganizationPerson6565 MD Anderson BlvdHouston77030TXAuthorship 1670784Authorship 1671952Authorship 1680493Authorship 1682811Authorship 1687443Authorship 1687522Authorship 1691374Authorship 1703662Authorship 1708301Authorship 1708753Authorship 17148516Authorship 1716122Authorship 1719382Authorship 1724653Authorship 1725772Authorship 1727556Authorship 1736284Authorship 1745477Authorship 1749748Authorship 1752935Authorship 1758378Authorship 17706322Authorship 17744110Authorship 17814213Authorship 1781455Authorship 1781966Authorship 17881810Authorship 1789702Authorship 17913312Authorship 1794014Authorship 1800967Authorship 18035611Authorship 18039110Authorship 1805246Authorship 18059625Authorship 18092613Authorship 18143011Authorship 18251213Authorship 18298511Authorship 1832927Authorship 18329411Authorship 1839821Authorship 1844746Authorship 1848806Authorship 18522824Authorship 1874607Authorship 18799111Authorship 18799223Authorship 1884048Authorship 18862613Authorship 1888969Authorship 18948314Authorship 19108812Authorship 1911848Authorship 19130316Authorship 19149525Authorship 19200397Authorship 1921619Authorship 1923537Authorship 1930746Authorship 19357311Authorship 1938852Authorship 1941181Authorship 19491522Authorship 19514219Authorship 19524799516976Yashima K, Milchgrub S, Gollahon LS, Maitra A, Saboorian MH, Shay JW, Gazdar AFClinical cancer research : an official journal of the American Association for Cancer ResearchTelomerase enzyme activity and RNA expression during the multistage pathogenesis of breast carcinoma. Clin Cancer Res. 1998 Jan; 4(1):229-34.Clin Cancer Res1998-01-01T00:00:001998Telomerase enzyme activity and RNA expression during the multistage pathogenesis of breast carcinoma.9596280Yashima K, Maitra A, Timmons CF, Rogers BB, Pinar H, Shay JW, Gazdar AFHuman pathologyExpression of the RNA component of telomerase in Wilms tumor and nephrogenic rest recapitulates renal embryogenesis. Hum Pathol. 1998 May; 29(5):536-42.Hum Pathol1998-05-01T00:00:001998Expression of the RNA component of telomerase in Wilms tumor and nephrogenic rest recapitulates renal embryogenesis.10547393Park IW, Wistuba II, Maitra A, Milchgrub S, Virmani AK, Minna JD, Gazdar AFJournal of the National Cancer InstituteMultiple clonal abnormalities in the bronchial epithelium of patients with lung cancer. J Natl Cancer Inst. 1999 Nov 03; 91(21):1863-8.J Natl Cancer Inst1999-11-03T00:00:001999Multiple clonal abnormalities in the bronchial epithelium of patients with lung cancer.10667421Maitra A, Tavassoli FA, Albores-Saavedra J, Behrens C, Wistuba II, Bryant D, Weinberg AG, Rogers BB, Saboorian MH, Gazdar AFHuman pathologyMolecular abnormalities associated with secretory carcinomas of the breast. Hum Pathol. 1999 Dec; 30(12):1435-40.Hum Pathol1999-12-01T00:00:001999Molecular abnormalities associated with secretory carcinomas of the breast.10829951Verma AK, Vohra A, Maitra A, Banerjee M, Singh R, Mittal SK, Bharadwaj V, Batra V, Bhatia A, Aggarwal PIndian journal of pediatricsEpidemiology of chronic suppurative otitis media and deafness in a rural area and developing an intervention strategy. Indian J Pediatr. 1995 Nov-Dec; 62(6):725-9.Indian J Pediatr1995-11-01T00:00:001995Epidemiology of chronic suppurative otitis media and deafness in a rural area and developing an intervention strategy.10843288Krueger JE, Maitra A, Albores-Saavedra JThe American journal of surgical pathologyInherited medullary microcarcinoma of the thyroid: a study of 11 cases. Am J Surg Pathol. 2000 Jun; 24(6):853-8.Am J Surg Pathol2000-06-01T00:00:002000Inherited medullary microcarcinoma of the thyroid: a study of 11 cases.10914700Wistuba II, Berry J, Behrens C, Maitra A, Shivapurkar N, Milchgrub S, Mackay B, Minna JD, Gazdar AFClinical cancer research : an official journal of the American Association for Cancer ResearchMolecular changes in the bronchial epithelium of patients with small cell lung cancer. Clin Cancer Res. 2000 Jul; 6(7):2604-10.Clin Cancer Res2000-07-01T00:00:002000Molecular changes in the bronchial epithelium of patients with small cell lung cancer.11392884Maitra A, McKenna RW, Weinberg AG, Schneider NR, Kroft SHAmerican journal of clinical pathologyPrecursor B-cell lymphoblastic lymphoma. A study of nine cases lacking blood and bone marrow involvement and review of the literature. Am J Clin Pathol. 2001 Jun; 115(6):868-75.Am J Clin Pathol2001-06-01T00:00:002001Precursor B-cell lymphoblastic lymphoma. A study of nine cases lacking blood and bone marrow involvement and review of the literature.12057912Wistuba II, Ashfaq R, Maitra A, Alvarez H, Riquelme E, Gazdar AFThe American journal of pathologyFragile histidine triad gene abnormalities in the pathogenesis of gallbladder carcinoma. Am J Pathol. 2002 Jun; 160(6):2073-9.Am J Pathol2002-06-01T00:00:002002Fragile histidine triad gene abnormalities in the pathogenesis of gallbladder carcinoma.12163387Toyooka KO, Toyooka S, Maitra A, Feng Q, Kiviat NC, Smith A, Minna JD, Ashfaq R, Gazdar AFThe American journal of pathologyEstablishment and validation of real-time polymerase chain reaction method for CDH1 promoter methylation. Am J Pathol. 2002 Aug; 161(2):629-34.Am J Pathol2002-08-01T00:00:002002Establishment and validation of real-time polymerase chain reaction method for CDH1 promoter methylation.12177780Wistuba II, Maitra A, Carrasco R, Tang M, Troncoso P, Minna JD, Gazdar AFBritish journal of cancerHigh resolution chromosome 3p, 8p, 9q and 22q allelotyping analysis in the pathogenesis of gallbladder carcinoma. Br J Cancer. 2002 Aug 12; 87(4):432-40.Br J Cancer2002-08-12T00:00:002002High resolution chromosome 3p, 8p, 9q and 22q allelotyping analysis in the pathogenesis of gallbladder carcinoma.12651607Iacobuzio-Donahue CA, Maitra A, Olsen M, Lowe AW, van Heek NT, Rosty C, Walter K, Sato N, Parker A, Ashfaq R, Jaffee E, Ryu B, Jones J, Eshleman JR, Yeo CJ, Cameron JL, Kern SE, Hruban RH, Brown PO, Goggins MThe American journal of pathologyExploration of global gene expression patterns in pancreatic adenocarcinoma using cDNA microarrays. Am J Pathol. 2003 Apr; 162(4):1151-62.Am J Pathol2003-04-01T00:00:002003Exploration of global gene expression patterns in pancreatic adenocarcinoma using cDNA microarrays.12819026Hansel DE, Rahman A, Hidalgo M, Thuluvath PJ, Lillemoe KD, Schulick R, Ku JL, Park JG, Miyazaki K, Ashfaq R, Wistuba II, Varma R, Hawthorne L, Geradts J, Argani P, Maitra AThe American journal of pathologyIdentification of novel cellular targets in biliary tract cancers using global gene expression technology. Am J Pathol. 2003 07; 163(1):217-29.Am J Pathol2003-07-01T00:00:002003Identification of novel cellular targets in biliary tract cancers using global gene expression technology.14520411Berman DM, Karhadkar SS, Maitra A, Montes De Oca R, Gerstenblith MR, Briggs K, Parker AR, Shimada Y, Eshleman JR, Watkins DN, Beachy PANatureWidespread requirement for Hedgehog ligand stimulation in growth of digestive tract tumours. Nature. 2003 Oct 23; 425(6960):846-51.Nature2003-09-14T00:00:002003Widespread requirement for Hedgehog ligand stimulation in growth of digestive tract tumours.14612490Hansel DE, Rahman A, Wehner S, Herzog V, Yeo CJ, Maitra ACancer researchIncreased expression and processing of the Alzheimer amyloid precursor protein in pancreatic cancer may influence cellular proliferation. Cancer Res. 2003 Nov 01; 63(21):7032-7.Cancer Res2003-11-01T00:00:002003Increased expression and processing of the Alzheimer amyloid precursor protein in pancreatic cancer may influence cellular proliferation.15017593Swierczynski SL, Maitra A, Abraham SC, Iacobuzio-Donahue CA, Ashfaq R, Cameron JL, Schulick RD, Yeo CJ, Rahman A, Hinkle DA, Hruban RH, Argani PHuman pathologyAnalysis of novel tumor markers in pancreatic and biliary carcinomas using tissue microarrays. Hum Pathol. 2004 Mar; 35(3):357-66.Hum Pathol2004-03-01T00:00:002004Analysis of novel tumor markers in pancreatic and biliary carcinomas using tissue microarrays.15833824Jimeno A, Rubio-Viqueira B, Amador ML, Oppenheimer D, Bouraoud N, Kulesza P, Sebastiani V, Maitra A, Hidalgo MCancer researchEpidermal growth factor receptor dynamics influences response to epidermal growth factor receptor targeted agents. Cancer Res. 2005 Apr 15; 65(8):3003-10.Cancer Res2005-04-15T00:00:002005Epidermal growth factor receptor dynamics influences response to epidermal growth factor receptor targeted agents.15908786Hustinx SR, Fukushima N, Zahurak ML, Riall TS, Maitra A, Brosens L, Cameron JL, Yeo CJ, Offerhaus GJ, Hruban RH, Goggins MCancer biology & therapyExpression and prognostic significance of 14-3-3sigma and ERM family protein expression in periampullary neoplasms. Cancer Biol Ther. 2005 May; 4(5):596-601.Cancer Biol Ther2005-05-13T00:00:002005Expression and prognostic significance of 14-3-3sigma and ERM family protein expression in periampullary neoplasms.16084606Chen YC, Davidson B, Cheng CC, Maitra A, Giuntoli RL, Hruban RH, Wang TL, Shih IeMBiochimica et biophysica actaIdentification and characterization of membralin, a novel tumor-associated gene, in ovarian carcinoma. Biochim Biophys Acta. 2005 Aug 15; 1730(2):96-102.Biochim Biophys Acta2005-08-15T00:00:002005Identification and characterization of membralin, a novel tumor-associated gene, in ovarian carcinoma.16224217Powell EL, Leoni LM, Canto MI, Forastiere AA, Iocobuzio-Donahue CA, Wang JS, Maitra A, Montgomery EThe American journal of surgical pathologyConcordant loss of MTAP and p16/CDKN2A expression in gastroesophageal carcinogenesis: evidence of homozygous deletion in esophageal noninvasive precursor lesions and therapeutic implications. Am J Surg Pathol. 2005 Nov; 29(11):1497-504.Am J Surg Pathol2005-11-01T00:00:002005Concordant loss of MTAP and p16/CDKN2A expression in gastroesophageal carcinogenesis: evidence of homozygous deletion in esophageal noninvasive precursor lesions and therapeutic implications.16488438Sui G, Bonde P, Dhara S, Broor A, Wang J, Marti G, Feldmann G, Duncan M, Montgomery E, Maitra A, Harmon JWThe Journal of surgical researchEpidermal growth factor receptor and hedgehog signaling pathways are active in esophageal cancer cells from rat reflux model. J Surg Res. 2006 Jul; 134(1):1-9.J Surg Res2006-02-20T00:00:002006Epidermal growth factor receptor and hedgehog signaling pathways are active in esophageal cancer cells from rat reflux model.16557277Hansel DE, Meeker AK, Hicks J, De Marzo AM, Lillemoe KD, Schulick R, Hruban RH, Maitra A, Argani PModern pathology : an official journal of the United States and Canadian Academy of Pathology, IncTelomere length variation in biliary tract metaplasia, dysplasia, and carcinoma. Mod Pathol. 2006 Jun; 19(6):772-9.Mod Pathol2006-06-01T00:00:002006Telomere length variation in biliary tract metaplasia, dysplasia, and carcinoma.16899615Rubio-Viqueira B, Jimeno A, Cusatis G, Zhang X, Iacobuzio-Donahue C, Karikari C, Shi C, Danenberg K, Danenberg PV, Kuramochi H, Tanaka K, Singh S, Salimi-Moosavi H, Bouraoud N, Amador ML, Altiok S, Kulesza P, Yeo C, Messersmith W, Eshleman J, Hruban RH, Maitra A, Hidalgo MClinical cancer research : an official journal of the American Association for Cancer ResearchAn in vivo platform for translational drug development in pancreatic cancer. Clin Cancer Res. 2006 Aug 01; 12(15):4652-61.Clin Cancer Res2006-08-01T00:00:002006An in vivo platform for translational drug development in pancreatic cancer.17262812Wu F, Dassopoulos T, Cope L, Maitra A, Brant SR, Harris ML, Bayless TM, Parmigiani G, Chakravarti SInflammatory bowel diseasesGenome-wide gene expression differences in Crohn's disease and ulcerative colitis from endoscopic pinch biopsies: insights into distinctive pathogenesis. Inflamm Bowel Dis. 2007 Jul; 13(7):807-21.Inflamm Bowel Dis2007-07-01T00:00:002007Genome-wide gene expression differences in Crohn's disease and ulcerative colitis from endoscopic pinch biopsies: insights into distinctive pathogenesis.17332349Feldmann G, Dhara S, Fendrich V, Bedja D, Beaty R, Mullendore M, Karikari C, Alvarez H, Iacobuzio-Donahue C, Jimeno A, Gabrielson KL, Matsui W, Maitra ACancer researchBlockade of hedgehog signaling inhibits pancreatic cancer invasion and metastases: a new paradigm for combination therapy in solid cancers. Cancer Res. 2007 Mar 01; 67(5):2187-96.Cancer Res2007-03-01T00:00:002007Blockade of hedgehog signaling inhibits pancreatic cancer invasion and metastases: a new paradigm for combination therapy in solid cancers.17363501Jimeno A, Rubio-Viqueira B, Amador ML, Grunwald V, Maitra A, Iacobuzio-Donahue C, Hidalgo MMolecular cancer therapeuticsDual mitogen-activated protein kinase and epidermal growth factor receptor inhibition in biliary and pancreatic cancer. Mol Cancer Ther. 2007 Mar; 6(3):1079-88.Mol Cancer Ther2007-03-01T00:00:002007Dual mitogen-activated protein kinase and epidermal growth factor receptor inhibition in biliary and pancreatic cancer.17404500Salaria SN, Illei P, Sharma R, Walter KM, Klein AP, Eshleman JR, Maitra A, Schulick R, Winter J, Ouellette MM, Goggins M, Hruban RCancer biology & therapyPalladin is overexpressed in the non-neoplastic stroma of infiltrating ductal adenocarcinomas of the pancreas, but is only rarely overexpressed in neoplastic cells. Cancer Biol Ther. 2007 Mar; 6(3):324-8.Cancer Biol Ther2007-03-24T00:00:002007Palladin is overexpressed in the non-neoplastic stroma of infiltrating ductal adenocarcinomas of the pancreas, but is only rarely overexpressed in neoplastic cells.17714470Lee KM, Cao D, Itami A, Pour PM, Hruban RH, Maitra A, Ouellette MMHistopathologyClass III beta-tubulin, a marker of resistance to paclitaxel, is overexpressed in pancreatic ductal adenocarcinoma and intraepithelial neoplasia. Histopathology. 2007 Oct; 51(4):539-46.Histopathology2007-08-21T00:00:002007Class III beta-tubulin, a marker of resistance to paclitaxel, is overexpressed in pancreatic ductal adenocarcinoma and intraepithelial neoplasia.17912030Lucito R, Suresh S, Walter K, Pandey A, Lakshmi B, Krasnitz A, Sebat J, Wigler M, Klein AP, Brune K, Palmisano E, Maitra A, Goggins M, Hruban RHCancer biology & therapyCopy-number variants in patients with a strong family history of pancreatic cancer. Cancer Biol Ther. 2007 Oct; 6(10):1592-9.Cancer Biol Ther2007-07-12T00:00:002007Copy-number variants in patients with a strong family history of pancreatic cancer.17996793Hruban RH, Maitra A, Kern SE, Goggins MGastroenterology clinics of North AmericaPrecursors to pancreatic cancer. Gastroenterol Clin North Am. 2007 Dec; 36(4):831-49, vi.Gastroenterol Clin North Am2007-12-01T00:00:002007Precursors to pancreatic cancer.18413752Jimeno A, Tan AC, Coffa J, Rajeshkumar NV, Kulesza P, Rubio-Viqueira B, Wheelhouse J, Diosdado B, Messersmith WA, Iacobuzio-Donahue C, Maitra A, Varella-Garcia M, Hirsch FR, Meijer GA, Hidalgo MCancer researchCoordinated epidermal growth factor receptor pathway gene overexpression predicts epidermal growth factor receptor inhibitor sensitivity in pancreatic cancer. Cancer Res. 2008 Apr 15; 68(8):2841-9.Cancer Res2008-04-15T00:00:002008Coordinated epidermal growth factor receptor pathway gene overexpression predicts epidermal growth factor receptor inhibitor sensitivity in pancreatic cancer.18691948Alvarez H, Rojas PL, Yong KT, Ding H, Xu G, Prasad PN, Wang J, Canto M, Eshleman JR, Montgomery EA, Maitra ANanomedicine : nanotechnology, biology, and medicineMesothelin is a specific biomarker of invasive cancer in the Barrett-associated adenocarcinoma progression model: translational implications for diagnosis and therapy. Nanomedicine. 2008 Dec; 4(4):295-301.Nanomedicine2008-08-08T00:00:002008Mesothelin is a specific biomarker of invasive cancer in the Barrett-associated adenocarcinoma progression model: translational implications for diagnosis and therapy.18787394Alvarez H, Koorstra JB, Hong SM, Boonstra JJ, Dinjens WN, Foratiere AA, Wu TT, Montgomery E, Eshleman JR, Maitra ACancer biology & therapyEstablishment and characterization of a bona fide Barrett esophagus-associated adenocarcinoma cell line. Cancer Biol Ther. 2008 Nov; 7(11):1753-5.Cancer Biol Ther2008-11-04T00:00:002008Establishment and characterization of a bona fide Barrett esophagus-associated adenocarcinoma cell line.18843278Hristov AC, Cope L, Reyes MD, Singh M, Iacobuzio-Donahue C, Maitra A, Resar LMModern pathology : an official journal of the United States and Canadian Academy of Pathology, IncHMGA2 protein expression correlates with lymph node metastasis and increased tumor grade in pancreatic ductal adenocarcinoma. Mod Pathol. 2009 Jan; 22(1):43-9.Mod Pathol2008-08-29T00:00:002008HMGA2 protein expression correlates with lymph node metastasis and increased tumor grade in pancreatic ductal adenocarcinoma.19028870Habbe N, Shi G, Meguid RA, Fendrich V, Esni F, Chen H, Feldmann G, Stoffers DA, Konieczny SF, Leach SD, Maitra AProceedings of the National Academy of Sciences of the United States of AmericaSpontaneous induction of murine pancreatic intraepithelial neoplasia (mPanIN) by acinar cell targeting of oncogenic Kras in adult mice. Proc Natl Acad Sci U S A. 2008 Dec 02; 105(48):18913-8.Proc Natl Acad Sci U S A2008-11-21T00:00:002008Spontaneous induction of murine pancreatic intraepithelial neoplasia (mPanIN) by acinar cell targeting of oncogenic Kras in adult mice.19260743Ottenhof NA, Milne AN, Morsink FH, Drillenburg P, Ten Kate FJ, Maitra A, Offerhaus GJArchives of pathology & laboratory medicinePancreatic intraepithelial neoplasia and pancreatic tumorigenesis: of mice and men. Arch Pathol Lab Med. 2009 Mar; 133(3):375-81.Arch Pathol Lab Med2009-03-01T00:00:002009Pancreatic intraepithelial neoplasia and pancreatic tumorigenesis: of mice and men.19815696Shi C, Chandrasekaran A, Thuluvath PJ, Karikari C, Argani P, Goggins M, Maitra A, Eshleman JRThe Journal of molecular diagnostics : JMDUltrasensitive detection of KRAS2 mutations in bile and serum from patients with biliary tract carcinoma using LigAmp technology. J Mol Diagn. 2009 Nov; 11(6):583-9.J Mol Diagn2009-10-08T00:00:002009Ultrasensitive detection of KRAS2 mutations in bile and serum from patients with biliary tract carcinoma using LigAmp technology.19820691Hristov AC, Cope L, Di Cello F, Reyes MD, Singh M, Hillion JA, Belton A, Joseph B, Schuldenfrei A, Iacobuzio-Donahue CA, Maitra A, Resar LMModern pathology : an official journal of the United States and Canadian Academy of Pathology, IncHMGA1 correlates with advanced tumor grade and decreased survival in pancreatic ductal adenocarcinoma. Mod Pathol. 2010 Jan; 23(1):98-104.Mod Pathol2009-10-09T00:00:002009HMGA1 correlates with advanced tumor grade and decreased survival in pancreatic ductal adenocarcinoma.19923581Hidalgo M, Maitra AThe New England journal of medicineThe hedgehog pathway and pancreatic cancer. N Engl J Med. 2009 Nov 19; 361(21):2094-6.N Engl J Med2009-11-19T00:00:002009The hedgehog pathway and pancreatic cancer.20713615Shi C, Siegelman SS, Kawamoto S, Wolfgang CL, Schulick RD, Maitra A, Hruban RHRadiologyPancreatic duct stenosis secondary to small endocrine neoplasms: a manifestation of serotonin production? Radiology. 2010 Oct; 257(1):107-14.Radiology2010-08-16T00:00:002010Pancreatic duct stenosis secondary to small endocrine neoplasms: a manifestation of serotonin production?20818175Hector A, Montgomery EA, Karikari C, Canto M, Dunbar KB, Wang JS, Feldmann G, Hong SM, Haffner MC, Meeker AK, Holland SJ, Yu J, Heckrodt TJ, Zhang J, Ding P, Goff D, Singh R, Roa JC, Marimuthu A, Riggins GJ, Eshleman JR, Nelkin BD, Pandey A, Maitra ACancer biology & therapyThe Axl receptor tyrosine kinase is an adverse prognostic factor and a therapeutic target in esophageal adenocarcinoma. Cancer Biol Ther. 2010 Nov 15; 10(10):1009-18.Cancer Biol Ther2010-11-15T00:00:002010The Axl receptor tyrosine kinase is an adverse prognostic factor and a therapeutic target in esophageal adenocarcinoma.21622730Pramanik D, Campbell NR, Karikari C, Chivukula R, Kent OA, Mendell JT, Maitra AMolecular cancer therapeuticsRestitution of tumor suppressor microRNAs using a systemic nanovector inhibits pancreatic cancer growth in mice. Mol Cancer Ther. 2011 Aug; 10(8):1470-80.Mol Cancer Ther2011-05-27T00:00:002011Restitution of tumor suppressor microRNAs using a systemic nanovector inhibits pancreatic cancer growth in mice.21700832Fishel ML, Jiang Y, Rajeshkumar NV, Scandura G, Sinn AL, He Y, Shen C, Jones DR, Pollok KE, Ivan M, Maitra A, Kelley MRMolecular cancer therapeuticsImpact of APE1/Ref-1 redox inhibition on pancreatic tumor growth. Mol Cancer Ther. 2011 Sep; 10(9):1698-708.Mol Cancer Ther2011-06-23T00:00:002011Impact of APE1/Ref-1 redox inhibition on pancreatic tumor growth.21719641Heaphy CM, de Wilde RF, Jiao Y, Klein AP, Edil BH, Shi C, Bettegowda C, Rodriguez FJ, Eberhart CG, Hebbar S, Offerhaus GJ, McLendon R, Rasheed BA, He Y, Yan H, Bigner DD, Oba-Shinjo SM, Marie SK, Riggins GJ, Kinzler KW, Vogelstein B, Hruban RH, Maitra A, Papadopoulos N, Meeker AKScience (New York, N.Y.)Altered telomeres in tumors with ATRX and DAXX mutations. Science. 2011 Jul 22; 333(6041):425.Science2011-06-30T00:00:002011Altered telomeres in tumors with ATRX and DAXX mutations.21888887Heaphy CM, Subhawong AP, Hong SM, Goggins MG, Montgomery EA, Gabrielson E, Netto GJ, Epstein JI, Lotan TL, Westra WH, Shih IeM, Iacobuzio-Donahue CA, Maitra A, Li QK, Eberhart CG, Taube JM, Rakheja D, Kurman RJ, Wu TC, Roden RB, Argani P, De Marzo AM, Terracciano L, Torbenson M, Meeker AKThe American journal of pathologyPrevalence of the alternative lengthening of telomeres telomere maintenance mechanism in human cancer subtypes. Am J Pathol. 2011 Oct; 179(4):1608-15.Am J Pathol2011-09-01T00:00:002011Prevalence of the alternative lengthening of telomeres telomere maintenance mechanism in human cancer subtypes.22167000Matthaei H, Norris AL, Tsiatis AC, Olino K, Hong SM, dal Molin M, Goggins MG, Canto M, Horton KM, Jackson KD, Capelli P, Zamboni G, Bortesi L, Furukawa T, Egawa S, Ishida M, Ottomo S, Unno M, Motoi F, Wolfgang CL, Edil BH, Cameron JL, Eshleman JR, Schulick RD, Maitra A, Hruban RHAnnals of surgeryClinicopathological characteristics and molecular analyses of multifocal intraductal papillary mucinous neoplasms of the pancreas. Ann Surg. 2012 Feb; 255(2):326-33.Ann Surg2012-02-01T00:00:002012Clinicopathological characteristics and molecular analyses of multifocal intraductal papillary mucinous neoplasms of the pancreas.22233809Shain AH, Giacomini CP, Matsukuma K, Karikari CA, Bashyam MD, Hidalgo M, Maitra A, Pollack JRProceedings of the National Academy of Sciences of the United States of AmericaConvergent structural alterations define SWItch/Sucrose NonFermentable (SWI/SNF) chromatin remodeler as a central tumor suppressive complex in pancreatic cancer. Proc Natl Acad Sci U S A. 2012 Jan 31; 109(5):E252-9.Proc Natl Acad Sci U S A2012-01-10T00:00:002012Convergent structural alterations define SWItch/Sucrose NonFermentable (SWI/SNF) chromatin remodeler as a central tumor suppressive complex in pancreatic cancer.22251937Yachida S, Vakiani E, White CM, Zhong Y, Saunders T, Morgan R, de Wilde RF, Maitra A, Hicks J, Demarzo AM, Shi C, Sharma R, Laheru D, Edil BH, Wolfgang CL, Schulick RD, Hruban RH, Tang LH, Klimstra DS, Iacobuzio-Donahue CAThe American journal of surgical pathologySmall cell and large cell neuroendocrine carcinomas of the pancreas are genetically similar and distinct from well-differentiated pancreatic neuroendocrine tumors. Am J Surg Pathol. 2012 Feb; 36(2):173-84.Am J Surg Pathol2012-02-01T00:00:002012Small cell and large cell neuroendocrine carcinomas of the pancreas are genetically similar and distinct from well-differentiated pancreatic neuroendocrine tumors.22302717Leidner RS, Ravi L, Leahy P, Chen Y, Bednarchik B, Streppel M, Canto M, Wang JS, Maitra A, Willis J, Markowitz SD, Barnholtz-Sloan J, Adams MD, Chak A, Guda KGenes, chromosomes & cancerThe microRNAs, MiR-31 and MiR-375, as candidate markers in Barrett's esophageal carcinogenesis. Genes Chromosomes Cancer. 2012 May; 51(5):473-9.Genes Chromosomes Cancer2012-02-03T00:00:002012The microRNAs, MiR-31 and MiR-375, as candidate markers in Barrett's esophageal carcinogenesis.22752426Mizuma M, Rasheed ZA, Yabuuchi S, Omura N, Campbell NR, de Wilde RF, De Oliveira E, Zhang Q, Puig O, Matsui W, Hidalgo M, Maitra A, Rajeshkumar NVMolecular cancer therapeuticsThe gamma secretase inhibitor MRK-003 attenuates pancreatic cancer growth in preclinical models. Mol Cancer Ther. 2012 Sep; 11(9):1999-2009.Mol Cancer Ther2012-07-02T00:00:002012The gamma secretase inhibitor MRK-003 attenuates pancreatic cancer growth in preclinical models.22753594Cui Y, Brosnan JA, Blackford AL, Sur S, Hruban RH, Kinzler KW, Vogelstein B, Maitra A, Diaz LA, Iacobuzio-Donahue CA, Eshleman JRClinical cancer research : an official journal of the American Association for Cancer ResearchGenetically defined subsets of human pancreatic cancer show unique in vitro chemosensitivity. Clin Cancer Res. 2012 Dec 01; 18(23):6519-30.Clin Cancer Res2012-07-02T00:00:002012Genetically defined subsets of human pancreatic cancer show unique in vitro chemosensitivity.23238009Maitra A, Leach SDCancer cellDisputed paternity: the uncertain ancestry of pancreatic ductal neoplasia. Cancer Cell. 2012 Dec 11; 22(6):701-3.Cancer Cell2012-12-11T00:00:002012Disputed paternity: the uncertain ancestry of pancreatic ductal neoplasia.23340293Kamiyama H, Rauenzahn S, Shim JS, Karikari CA, Feldmann G, Hua L, Kamiyama M, Schuler FW, Lin MT, Beaty RM, Karanam B, Liang H, Mullendore ME, Mo G, Hidalgo M, Jaffee E, Hruban RH, Jinnah HA, Roden RB, Jimeno A, Liu JO, Maitra A, Eshleman JRClinical cancer research : an official journal of the American Association for Cancer ResearchPersonalized chemotherapy profiling using cancer cell lines from selectable mice. Clin Cancer Res. 2013 Mar 01; 19(5):1139-46.Clin Cancer Res2013-01-22T00:00:002013Personalized chemotherapy profiling using cancer cell lines from selectable mice.23846778Molin MD, Matthaei H, Wu J, Blackford A, Debeljak M, Rezaee N, Wolfgang CL, Butturini G, Salvia R, Bassi C, Goggins MG, Kinzler KW, Vogelstein B, Eshleman JR, Hruban RH, Maitra AAnnals of surgical oncologyClinicopathological correlates of activating GNAS mutations in intraductal papillary mucinous neoplasm (IPMN) of the pancreas. Ann Surg Oncol. 2013 Nov; 20(12):3802-8.Ann Surg Oncol2013-07-12T00:00:002013Clinicopathological correlates of activating GNAS mutations in intraductal papillary mucinous neoplasm (IPMN) of the pancreas.23918603Zhang G, He P, Tan H, Budhu A, Gaedcke J, Ghadimi BM, Ried T, Yfantis HG, Lee DH, Maitra A, Hanna N, Alexander HR, Hussain SPClinical cancer research : an official journal of the American Association for Cancer ResearchIntegration of metabolomics and transcriptomics revealed a fatty acid network exerting growth inhibitory effects in human pancreatic cancer. Clin Cancer Res. 2013 Sep 15; 19(18):4983-93.Clin Cancer Res2013-08-05T00:00:002013Integration of metabolomics and transcriptomics revealed a fatty acid network exerting growth inhibitory effects in human pancreatic cancer.24638272Pekala KR, Ma X, Kropp PA, Petersen CP, Hudgens CW, Chung CH, Shi C, Merchant NB, Maitra A, Means AL, Gannon MALaboratory investigation; a journal of technical methods and pathologyLoss of HNF6 expression correlates with human pancreatic cancer progression. Lab Invest. 2014 May; 94(5):517-27.Lab Invest2014-03-17T00:00:002014Loss of HNF6 expression correlates with human pancreatic cancer progression.Clinical Cancer PreventionGastroenterology Hepatology & NutritionGI Medical OncologyRadiation OncologySurgical OncologyMD AndersonJASON BFLEMINGJASON B FLEMING8742FLEMING, JASON BProfessor23.09460.004815271562research areas3.843450.0267323196coauthor of876.09297.295260similar to11684selected publicationsROBERT AWOLFFROBERT A WOLFF8726WOLFF, ROBERT AProfessorEUGENE JONKOAYEUGENE JON KOAY9552KOAY, EUGENE JONAssistant ProfessorKEPINGXIEKEPING XIE8634XIE, KEPINGProfessorMATTHEW HAROLDKATZMATTHEW HAROLD KATZ9338KATZ, MATTHEW HAROLDAssociate ProfessorSONALGUPTASONAL GUPTA9905GUPTA, SONALAssistant ProfessorFLORENCIAMCALLISTERFLORENCIA MCALLISTER9947MCALLISTER, FLORENCIAAssistant ProfessorAuthorship 2157461Authorship 2163221Authorship 2163282Authorship 2167651Authorship 2174361Authorship 2175395Authorship 2178661Authorship 2178943Authorship 2181252Authorship 2181441Authorship 2183241Authorship 2187621Authorship 2187781Authorship 2188217Authorship 2188491Authorship 2193171Authorship 2193432Authorship 2194332Authorship 2194902Authorship 2198272Authorship 2200678Authorship 2203571Authorship 22051214Authorship 2208563Authorship 2208653Authorship 2209948Authorship 2209977Authorship 2210622Authorship 2210912Authorship 2210968Authorship 2211041Authorship 2211125Authorship 2212263Authorship 2212434Authorship 2212869Authorship 2213259Authorship 2214196Authorship 2214331Authorship 2216563Authorship 2220703Authorship 2221687Authorship 2222018Authorship 2222421Authorship 2223404Authorship 2225535Authorship 2226058Authorship 2226267Authorship 22280713Authorship 22287815Authorship 2229207Authorship 2235743Authorship 22364015Authorship 22368010Authorship 2242497Authorship 2244237Authorship 2247145Authorship 2248279Authorship 2252568Authorship 2256572Authorship 2257893Authorship 2258406Authorship 2260094Authorship 2265358Authorship 2267356Authorship 2267468Authorship 22677617Authorship 22739810Authorship 22786711Authorship 22787413Authorship 2279255Authorship 2280595Authorship 22812816Authorship 22851114Authorship 2291013Authorship 2291256Authorship 22924617Authorship 2293085Authorship 22958212Authorship 22989024Authorship 2299694Authorship 22997110Authorship 2301194Authorship 23012316Authorship 2302537Authorship 2306336Authorship 2307083Authorship 2309179Authorship 2314188Authorship 23175914Authorship 23179215Authorship 2318214Authorship 23194011Authorship 23215414Authorship 2326475Authorship 23315513Authorship 23340311Authorship 23364813Authorship 2342215Authorship 2343793Authorship 23500510Authorship 23501612Authorship 2350186Authorship 23514711Authorship 2353221410091748Maitra A, Yashima K, Rathi A, Timmons CF, Rogers BB, Shay JW, Gazdar AFCancerThe RNA component of telomerase as a marker of biologic potential and clinical outcome in childhood neuroblastic tumors. Cancer. 1999 Feb 01; 85(3):741-9.Cancer1999-02-01T00:00:001999The RNA component of telomerase as a marker of biologic potential and clinical outcome in childhood neuroblastic tumors.10202940Maitra A, Wistuba II, Virmani AK, Sakaguchi M, Park I, Stucky A, Milchgrub S, Gibbons D, Minna JD, Gazdar AFNature medicineEnrichment of epithelial cells for molecular studies. Nat Med. 1999 Apr; 5(4):459-63.Nat Med1999-04-01T00:00:001999Enrichment of epithelial cells for molecular studies.10227597Lindberg GM, Maitra A, Gokaslan ST, Saboorian MH, Albores-Saavedra JCancerLow grade fibromyxoid sarcoma: fine-needle aspiration cytology with histologic, cytogenetic, immunohistochemical, and ultrastructural correlation. Cancer. 1999 Apr 25; 87(2):75-82.Cancer1999-04-25T00:00:001999Low grade fibromyxoid sarcoma: fine-needle aspiration cytology with histologic, cytogenetic, immunohistochemical, and ultrastructural correlation.10374782Maitra A, Amirkhan RH, Saboorian MH, Frawley WH, Ashfaq RHuman pathologySurvival in small cell lung carcinoma is independent of Bcl-2 expression. Hum Pathol. 1999 Jun; 30(6):712-7.Hum Pathol1999-06-01T00:00:001999Survival in small cell lung carcinoma is independent of Bcl-2 expression.10441628Maitra A, Salahuddin S, Timmons CF, Gazdar AFPediatric and developmental pathology : the official journal of the Society for Pediatric Pathology and the Paediatric Pathology SocietyAllelotyping nephrogenic rests: putative precursor lesions of Wilms tumors. Pediatr Dev Pathol. 1999 Sep-Oct; 2(5):488-9.Pediatr Dev Pathol1999-09-01T00:00:001999Allelotyping nephrogenic rests: putative precursor lesions of Wilms tumors.10446964Shivapurkar N, Sood S, Wistuba II, Virmani AK, Maitra A, Milchgrub S, Minna JD, Gazdar AFCancer researchMultiple regions of chromosome 4 demonstrating allelic losses in breast carcinomas. Cancer Res. 1999 Aug 01; 59(15):3576-80.Cancer Res1999-08-01T00:00:001999Multiple regions of chromosome 4 demonstrating allelic losses in breast carcinomas.11000339Maitra A, Weinberg AG, Schneider N, Patterson KPediatric and developmental pathology : the official journal of the Society for Pediatric Pathology and the Paediatric Pathology SocietyDetection of t(11;22)(q24;q12) translocation and EWS-FLI-1 fusion transcript in a case of solid pseudopapillary tumor of the pancreas. Pediatr Dev Pathol. 2000 Nov-Dec; 3(6):603-5.Pediatr Dev Pathol2000-11-01T00:00:002000Detection of t(11;22)(q24;q12) translocation and EWS-FLI-1 fusion transcript in a case of solid pseudopapillary tumor of the pancreas.11241269Maitra A, Rathi A, Gazdar AF, Sagalowsky A, Ashfaq RCancerExpression of the RNA component of human telemorase (hTR) in ThinPrep preparations from bladder washings. Cancer. 2001 Feb 25; 93(1):73-9.Cancer2001-02-25T00:00:002001Expression of the RNA component of human telemorase (hTR) in ThinPrep preparations from bladder washings.11325823Z?chbauer-M?ller S, Fong KM, Maitra A, Lam S, Geradts J, Ashfaq R, Virmani AK, Milchgrub S, Gazdar AF, Minna JDCancer research5' CpG island methylation of the FHIT gene is correlated with loss of gene expression in lung and breast cancer. Cancer Res. 2001 May 01; 61(9):3581-5.Cancer Res2001-05-01T00:00:0020015' CpG island methylation of the FHIT gene is correlated with loss of gene expression in lung and breast cancer.11325854Wistuba II, Tang M, Maitra A, Alvarez H, Troncoso P, Pimentel F, Gazdar AFCancer researchGenome-wide allelotyping analysis reveals multiple sites of allelic loss in gallbladder carcinoma. Cancer Res. 2001 May 01; 61(9):3795-800.Cancer Res2001-05-01T00:00:002001Genome-wide allelotyping analysis reveals multiple sites of allelic loss in gallbladder carcinoma.11345832Maitra A, Murakata LA, Albores-Saavedra JAmerican journal of clinical pathologyImmunoreactivity for hepatocyte paraffin 1 antibody in hepatoid adenocarcinomas of the gastrointestinal tract. Am J Clin Pathol. 2001 May; 115(5):689-94.Am J Clin Pathol2001-05-01T00:00:002001Immunoreactivity for hepatocyte paraffin 1 antibody in hepatoid adenocarcinomas of the gastrointestinal tract.11438460Maitra A, Wistuba II, Washington C, Virmani AK, Ashfaq R, Milchgrub S, Gazdar AF, Minna JDThe American journal of pathologyHigh-resolution chromosome 3p allelotyping of breast carcinomas and precursor lesions demonstrates frequent loss of heterozygosity and a discontinuous pattern of allele loss. Am J Pathol. 2001 Jul; 159(1):119-30.Am J Pathol2001-07-01T00:00:002001High-resolution chromosome 3p allelotyping of breast carcinomas and precursor lesions demonstrates frequent loss of heterozygosity and a discontinuous pattern of allele loss.11473466Maitra A, Timmons CF, Siddiqui MT, Saboorian MHArchives of pathology & laboratory medicineFine-needle aspiration biopsy features in a case of giant cell fibroblastoma of the chest wall. Arch Pathol Lab Med. 2001 Aug; 125(8):1091-4.Arch Pathol Lab Med2001-08-01T00:00:002001Fine-needle aspiration biopsy features in a case of giant cell fibroblastoma of the chest wall.11570918Maitra A, Baskin LB, Lee ELArchives of pathology & laboratory medicineMalignancies arising in oncocytic schneiderian papillomas: a report of 2 cases and review of the literature. Arch Pathol Lab Med. 2001 Oct; 125(10):1365-7.Arch Pathol Lab Med2001-10-01T00:00:002001Malignancies arising in oncocytic schneiderian papillomas: a report of 2 cases and review of the literature.11691816Xu XL, Wu LC, Du F, Davis A, Peyton M, Tomizawa Y, Maitra A, Tomlinson G, Gazdar AF, Weissman BE, Bowcock AM, Baer R, Minna JDCancer researchInactivation of human SRBC, located within the 11p15.5-p15.4 tumor suppressor region, in breast and lung cancers. Cancer Res. 2001 Nov 01; 61(21):7943-9.Cancer Res2001-11-01T00:00:002001Inactivation of human SRBC, located within the 11p15.5-p15.4 tumor suppressor region, in breast and lung cancers.11899240Maitra A, Wistuba II, Gazdar AFCurrent molecular medicineMicrodissection and the study of cancer pathways. Curr Mol Med. 2001 Mar; 1(1):153-62.Curr Mol Med2001-03-01T00:00:002001Microdissection and the study of cancer pathways.11943709Iacobuzio-Donahue CA, Maitra A, Shen-Ong GL, van Heek T, Ashfaq R, Meyer R, Walter K, Berg K, Hollingsworth MA, Cameron JL, Yeo CJ, Kern SE, Goggins M, Hruban RHThe American journal of pathologyDiscovery of novel tumor markers of pancreatic cancer using global gene expression technology. Am J Pathol. 2002 Apr; 160(4):1239-49.Am J Pathol2002-04-01T00:00:002002Discovery of novel tumor markers of pancreatic cancer using global gene expression technology.12692194Parwani AV, Geradts J, Caspers E, Offerhaus GJ, Yeo CJ, Cameron JL, Klimstra DS, Maitra A, Hruban RH, Argani PModern pathology : an official journal of the United States and Canadian Academy of Pathology, IncImmunohistochemical and genetic analysis of non-small cell and small cell gallbladder carcinoma and their precursor lesions. Mod Pathol. 2003 Apr; 16(4):299-308.Mod Pathol2003-04-01T00:00:002003Immunohistochemical and genetic analysis of non-small cell and small cell gallbladder carcinoma and their precursor lesions.12794524Ye D, Maitra A, Timmons CF, Leavey PJ, Ashfaq R, Ilaria RLJournal of pediatric hematology/oncologyThe epidermal growth factor receptor HER2 is not a major therapeutic target in Ewing sarcoma. J Pediatr Hematol Oncol. 2003 Jun; 25(6):459-66.J Pediatr Hematol Oncol2003-06-01T00:00:002003The epidermal growth factor receptor HER2 is not a major therapeutic target in Ewing sarcoma.12842085Miyamoto Y, Maitra A, Ghosh B, Zechner U, Argani P, Iacobuzio-Donahue CA, Sriuranpong V, Iso T, Meszoely IM, Wolfe MS, Hruban RH, Ball DW, Schmid RM, Leach SDCancer cellNotch mediates TGF alpha-induced changes in epithelial differentiation during pancreatic tumorigenesis. Cancer Cell. 2003 Jun; 3(6):565-76.Cancer Cell2003-06-01T00:00:002003Notch mediates TGF alpha-induced changes in epithelial differentiation during pancreatic tumorigenesis.12874021Sato N, Maitra A, Fukushima N, van Heek NT, Matsubayashi H, Iacobuzio-Donahue CA, Rosty C, Goggins MCancer researchFrequent hypomethylation of multiple genes overexpressed in pancreatic ductal adenocarcinoma. Cancer Res. 2003 Jul 15; 63(14):4158-66.Cancer Res2003-07-15T00:00:002003Frequent hypomethylation of multiple genes overexpressed in pancreatic ductal adenocarcinoma.13679454Maitra A, Adsay NV, Argani P, Iacobuzio-Donahue C, De Marzo A, Cameron JL, Yeo CJ, Hruban RHModern pathology : an official journal of the United States and Canadian Academy of Pathology, IncMulticomponent analysis of the pancreatic adenocarcinoma progression model using a pancreatic intraepithelial neoplasia tissue microarray. Mod Pathol. 2003 Sep; 16(9):902-12.Mod Pathol2003-09-01T00:00:002003Multicomponent analysis of the pancreatic adenocarcinoma progression model using a pancreatic intraepithelial neoplasia tissue microarray.14501508House MG, Herman JG, Guo MZ, Hooker CM, Schulick RD, Lillemoe KD, Cameron JL, Hruban RH, Maitra A, Yeo CJAnnals of surgeryAberrant hypermethylation of tumor suppressor genes in pancreatic endocrine neoplasms. Ann Surg. 2003 Sep; 238(3):423-31; discussion 431-2.Ann Surg2003-09-01T00:00:002003Aberrant hypermethylation of tumor suppressor genes in pancreatic endocrine neoplasms.14608893Rahman A, Maitra A, Ashfaq R, Yeo CJ, Cameron JL, Hansel DEAmerican journal of clinical pathologyLoss of p27 nuclear expression in a prognostically favorable subset of well-differentiated pancreatic endocrine neoplasms. Am J Clin Pathol. 2003 Nov; 120(5):685-90.Am J Clin Pathol2003-11-01T00:00:002003Loss of p27 nuclear expression in a prognostically favorable subset of well-differentiated pancreatic endocrine neoplasms.14656942Yeh CN, Maitra A, Lee KF, Jan YY, Chen MFCarcinogenesisThioacetamide-induced intestinal-type cholangiocarcinoma in rat: an animal model recapitulating the multi-stage progression of human cholangiocarcinoma. Carcinogenesis. 2004 Apr; 25(4):631-6.Carcinogenesis2003-12-04T00:00:002003Thioacetamide-induced intestinal-type cholangiocarcinoma in rat: an animal model recapitulating the multi-stage progression of human cholangiocarcinoma.14668721House MG, Herman JG, Guo MZ, Hooker CM, Schulick RD, Cameron JL, Hruban RH, Maitra A, Yeo CJSurgeryPrognostic value of hMLH1 methylation and microsatellite instability in pancreatic endocrine neoplasms. Surgery. 2003 Dec; 134(6):902-8; discussion 909.Surgery2003-12-01T00:00:002003Prognostic value of hMLH1 methylation and microsatellite instability in pancreatic endocrine neoplasms.14676124Maitra A, Hansel DE, Argani P, Ashfaq R, Rahman A, Naji A, Deng S, Geradts J, Hawthorne L, House MG, Yeo CJClinical cancer research : an official journal of the American Association for Cancer ResearchGlobal expression analysis of well-differentiated pancreatic endocrine neoplasms using oligonucleotide microarrays. Clin Cancer Res. 2003 Dec 01; 9(16 Pt 1):5988-95.Clin Cancer Res2003-12-01T00:00:002003Global expression analysis of well-differentiated pancreatic endocrine neoplasms using oligonucleotide microarrays.14695172Iacobuzio-Donahue CA, Ashfaq R, Maitra A, Adsay NV, Shen-Ong GL, Berg K, Hollingsworth MA, Cameron JL, Yeo CJ, Kern SE, Goggins M, Hruban RHCancer researchHighly expressed genes in pancreatic ductal adenocarcinomas: a comprehensive characterization and comparison of the transcription profiles obtained from three major technologies. Cancer Res. 2003 Dec 15; 63(24):8614-22.Cancer Res2003-12-15T00:00:002003Highly expressed genes in pancreatic ductal adenocarcinomas: a comprehensive characterization and comparison of the transcription profiles obtained from three major technologies.14706336Hingorani SR, Petricoin EF, Maitra A, Rajapakse V, King C, Jacobetz MA, Ross S, Conrads TP, Veenstra TD, Hitt BA, Kawaguchi Y, Johann D, Liotta LA, Crawford HC, Putt ME, Jacks T, Wright CV, Hruban RH, Lowy AM, Tuveson DACancer cellPreinvasive and invasive ductal pancreatic cancer and its early detection in the mouse. Cancer Cell. 2003 Dec; 4(6):437-50.Cancer Cell2003-12-01T00:00:002003Preinvasive and invasive ductal pancreatic cancer and its early detection in the mouse.14982844Sato N, Fukushima N, Maitra A, Iacobuzio-Donahue CA, van Heek NT, Cameron JL, Yeo CJ, Hruban RH, Goggins MThe American journal of pathologyGene expression profiling identifies genes associated with invasive intraductal papillary mucinous neoplasms of the pancreas. Am J Pathol. 2004 Mar; 164(3):903-14.Am J Pathol2004-03-01T00:00:002004Gene expression profiling identifies genes associated with invasive intraductal papillary mucinous neoplasms of the pancreas.15006928Koopmann J, Fedarko NS, Jain A, Maitra A, Iacobuzio-Donahue C, Rahman A, Hruban RH, Yeo CJ, Goggins MCancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive OncologyEvaluation of osteopontin as biomarker for pancreatic adenocarcinoma. Cancer Epidemiol Biomarkers Prev. 2004 Mar; 13(3):487-91.Cancer Epidemiol Biomarkers Prev2004-03-01T00:00:002004Evaluation of osteopontin as biomarker for pancreatic adenocarcinoma.15084967Takaori K, Hruban RH, Maitra A, Tanigawa NPancreasPancreatic intraepithelial neoplasia. Pancreas. 2004 Apr; 28(3):257-62.Pancreas2004-04-01T00:00:002004Pancreatic intraepithelial neoplasia.15104297Hansel DE, Wilentz RE, Yeo CJ, Schulick RD, Montgomery E, Maitra AThe American journal of surgical pathologyExpression of neuropilin-1 in high-grade dysplasia, invasive cancer, and metastases of the human gastrointestinal tract. Am J Surg Pathol. 2004 Mar; 28(3):347-56.Am J Surg Pathol2004-03-01T00:00:002004Expression of neuropilin-1 in high-grade dysplasia, invasive cancer, and metastases of the human gastrointestinal tract.15123581Maitra A, Cohen Y, Gillespie SE, Mambo E, Fukushima N, Hoque MO, Shah N, Goggins M, Califano J, Sidransky D, Chakravarti AGenome researchThe Human MitoChip: a high-throughput sequencing microarray for mitochondrial mutation detection. Genome Res. 2004 May; 14(5):812-9.Genome Res2004-05-01T00:00:002004The Human MitoChip: a high-throughput sequencing microarray for mitochondrial mutation detection.15180731Maitra A, Thuluvath PJThe American journal of gastroenterologyGP73 and liver disease: a (Golgi) complex enigma. Am J Gastroenterol. 2004 Jun; 99(6):1096-8.Am J Gastroenterol2004-06-01T00:00:002004GP73 and liver disease: a (Golgi) complex enigma.15181454Goldenberg D, Rosenbaum E, Argani P, Wistuba II, Sidransky D, Thuluvath PJ, Hidalgo M, Califano J, Maitra AModern pathology : an official journal of the United States and Canadian Academy of Pathology, IncThe V599E BRAF mutation is uncommon in biliary tract cancers. Mod Pathol. 2004 Nov; 17(11):1386-91.Mod Pathol2004-11-01T00:00:002004The V599E BRAF mutation is uncommon in biliary tract cancers.15252303Hruban RH, Takaori K, Klimstra DS, Adsay NV, Albores-Saavedra J, Biankin AV, Biankin SA, Compton C, Fukushima N, Furukawa T, Goggins M, Kato Y, Kl?ppel G, Longnecker DS, L?ttges J, Maitra A, Offerhaus GJ, Shimizu M, Yonezawa SThe American journal of surgical pathologyAn illustrated consensus on the classification of pancreatic intraepithelial neoplasia and intraductal papillary mucinous neoplasms. Am J Surg Pathol. 2004 Aug; 28(8):977-87.Am J Surg Pathol2004-08-01T00:00:002004An illustrated consensus on the classification of pancreatic intraepithelial neoplasia and intraductal papillary mucinous neoplasms.15448000Henke RT, Haddad BR, Kim SE, Rone JD, Mani A, Jessup JM, Wellstein A, Maitra A, Riegel ATClinical cancer research : an official journal of the American Association for Cancer ResearchOverexpression of the nuclear receptor coactivator AIB1 (SRC-3) during progression of pancreatic adenocarcinoma. Clin Cancer Res. 2004 Sep 15; 10(18 Pt 1):6134-42.Clin Cancer Res2004-09-15T00:00:002004Overexpression of the nuclear receptor coactivator AIB1 (SRC-3) during progression of pancreatic adenocarcinoma.15467436Cao D, Hustinx SR, Sui G, Bala P, Sato N, Martin S, Maitra A, Murphy KM, Cameron JL, Yeo CJ, Kern SE, Goggins M, Pandey A, Hruban RHCancer biology & therapyIdentification of novel highly expressed genes in pancreatic ductal adenocarcinomas through a bioinformatics analysis of expressed sequence tags. Cancer Biol Ther. 2004 Nov; 3(11):1081-9; discussion 1090-1.Cancer Biol Ther2004-11-12T00:00:002004Identification of novel highly expressed genes in pancreatic ductal adenocarcinomas through a bioinformatics analysis of expressed sequence tags.15473694Gr?nborg M, Bunkenborg J, Kristiansen TZ, Jensen ON, Yeo CJ, Hruban RH, Maitra A, Goggins MG, Pandey AJournal of proteome researchComprehensive proteomic analysis of human pancreatic juice. J Proteome Res. 2004 Sep-Oct; 3(5):1042-55.J Proteome Res2004-09-01T00:00:002004Comprehensive proteomic analysis of human pancreatic juice.15542896Hruban RH, Wilentz RE, Maitra AMethods in molecular medicineIdentification and analysis of precursors to invasive pancreatic cancer. Methods Mol Med. 2005; 103:1-13.Methods Mol Med2005-01-01T00:00:002005Identification and analysis of precursors to invasive pancreatic cancer.15604284Amador ML, Oppenheimer D, Perea S, Maitra A, Cusatis G, Cusati G, Iacobuzio-Donahue C, Baker SD, Ashfaq R, Takimoto C, Forastiere A, Hidalgo MCancer researchAn epidermal growth factor receptor intron 1 polymorphism mediates response to epidermal growth factor receptor inhibitors. Cancer Res. 2004 Dec 15; 64(24):9139-43.Cancer Res2004-12-15T00:00:002004An epidermal growth factor receptor intron 1 polymorphism mediates response to epidermal growth factor receptor inhibitors.15662124Hustinx SR, Hruban RH, Leoni LM, Iacobuzio-Donahue C, Cameron JL, Yeo CJ, Brown PN, Argani P, Ashfaq R, Fukushima N, Goggins M, Kern SE, Maitra ACancer biology & therapyHomozygous deletion of the MTAP gene in invasive adenocarcinoma of the pancreas and in periampullary cancer: a potential new target for therapy. Cancer Biol Ther. 2005 Jan; 4(1):83-6.Cancer Biol Ther2005-01-15T00:00:002005Homozygous deletion of the MTAP gene in invasive adenocarcinoma of the pancreas and in periampullary cancer: a potential new target for therapy.15729073Duxbury MS, Matros E, Clancy T, Bailey G, Doff M, Zinner MJ, Ashley SW, Maitra A, Redston M, Whang EEAnnals of surgeryCEACAM6 is a novel biomarker in pancreatic adenocarcinoma and PanIN lesions. Ann Surg. 2005 Mar; 241(3):491-6.Ann Surg2005-03-01T00:00:002005CEACAM6 is a novel biomarker in pancreatic adenocarcinoma and PanIN lesions.15762277Hansel DE, Ashfaq R, Rahman A, Wanzer D, Yeo CJ, Wilentz RE, Maitra AAmerican journal of clinical pathologyA subset of pancreatic adenocarcinomas demonstrates coamplification of topoisomerase IIalpha and HER2/neu: use of immunolabeling and multicolor FISH for potential patient screening andtreatment. Am J Clin Pathol. 2005 Jan; 123(1):28-35.Am J Clin Pathol2005-01-01T00:00:002005A subset of pancreatic adenocarcinomas demonstrates coamplification of topoisomerase IIalpha and HER2/neu: use of immunolabeling and multicolor FISH for potential patient screening andtreatment.15858150Jakupciak JP, Wang W, Markowitz ME, Ally D, Coble M, Srivastava S, Maitra A, Barker PE, Sidransky D, O'Connell CDThe Journal of molecular diagnostics : JMDMitochondrial DNA as a cancer biomarker. J Mol Diagn. 2005 May; 7(2):258-67.J Mol Diagn2005-05-01T00:00:002005Mitochondrial DNA as a cancer biomarker.16368504House MG, Cameron JL, Lillemoe KD, Schulick RD, Choti MA, Hansel DE, Hruban RH, Maitra A, Yeo CJJournal of gastrointestinal surgery : official journal of the Society for Surgery of the Alimentary TractDifferences in survival for patients with resectable versus unresectable metastases from pancreatic islet cell cancer. J Gastrointest Surg. 2006 Jan; 10(1):138-45.J Gastrointest Surg2006-01-01T00:00:002006Differences in survival for patients with resectable versus unresectable metastases from pancreatic islet cell cancer.16397221Hruban RH, Adsay NV, Albores-Saavedra J, Anver MR, Biankin AV, Boivin GP, Furth EE, Furukawa T, Klein A, Klimstra DS, Kloppel G, Lauwers GY, Longnecker DS, Luttges J, Maitra A, Offerhaus GJ, P?rez-Gallego L, Redston M, Tuveson DACancer researchPathology of genetically engineered mouse models of pancreatic exocrine cancer: consensus report and recommendations. Cancer Res. 2006 Jan 01; 66(1):95-106.Cancer Res2006-01-01T00:00:002006Pathology of genetically engineered mouse models of pancreatic exocrine cancer: consensus report and recommendations.16492916Cunningham SC, Kamangar F, Kim MP, Hammoud S, Haque R, Iacobuzio-Donahue CA, Maitra A, Ashfaq R, Hustinx S, Heitmiller RE, Choti MA, Lillemoe KD, Cameron JL, Yeo CJ, Schulick RD, Montgomery ECancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive OncologyClaudin-4, mitogen-activated protein kinase kinase 4, and stratifin are markers of gastric adenocarcinoma precursor lesions. Cancer Epidemiol Biomarkers Prev. 2006 Feb; 15(2):281-7.Cancer Epidemiol Biomarkers Prev2006-02-01T00:00:002006Claudin-4, mitogen-activated protein kinase kinase 4, and stratifin are markers of gastric adenocarcinoma precursor lesions.16778826Cao D, Antonescu C, Wong G, Winter J, Maitra A, Adsay NV, Klimstra DS, Hruban RHModern pathology : an official journal of the United States and Canadian Academy of Pathology, IncPositive immunohistochemical staining of KIT in solid-pseudopapillary neoplasms of the pancreas is not associated with KIT/PDGFRA mutations. Mod Pathol. 2006 Sep; 19(9):1157-63.Mod Pathol2006-06-16T00:00:002006Positive immunohistochemical staining of KIT in solid-pseudopapillary neoplasms of the pancreas is not associated with KIT/PDGFRA mutations.17094435Amoh Y, Nagakura C, Maitra A, Moossa AR, Katsuoka K, Hoffman RM, Bouvet MAnticancer researchDual-color imaging of nascent angiogenesis and its inhibition in liver metastases of pancreatic cancer. Anticancer Res. 2006 Sep-Oct; 26(5A):3237-42.Anticancer Res2006-09-01T00:00:002006Dual-color imaging of nascent angiogenesis and its inhibition in liver metastases of pancreatic cancer.17166268Sui G, Zhou S, Wang J, Canto M, Lee EE, Eshleman JR, Montgomery EA, Sidransky D, Califano JA, Maitra AMolecular cancerMitochondrial DNA mutations in preneoplastic lesions of the gastrointestinal tract: a biomarker for the early detection of cancer. Mol Cancer. 2006 Dec 13; 5:73.Mol Cancer2006-12-13T00:00:002006Mitochondrial DNA mutations in preneoplastic lesions of the gastrointestinal tract: a biomarker for the early detection of cancer.17172427Jimeno A, Amador ML, Kulesza P, Wang X, Rubio-Viqueira B, Zhang X, Chan A, Wheelhouse J, Kuramochi H, Tanaka K, Danenberg K, Messersmith WA, Almuete V, Hruban RH, Maitra A, Yeo CJ, Hidalgo MMolecular cancer therapeuticsAssessment of celecoxib pharmacodynamics in pancreatic cancer. Mol Cancer Ther. 2006 Dec; 5(12):3240-7.Mol Cancer Ther2006-12-01T00:00:002006Assessment of celecoxib pharmacodynamics in pancreatic cancer.17308050Rubio-Viqueira B, Mezzadra H, Nielsen ME, Jimeno A, Zhang X, Iacobuzio-Donahue C, Maitra A, Hidalgo M, Altiok SMolecular cancer therapeuticsOptimizing the development of targeted agents in pancreatic cancer: tumor fine-needle aspiration biopsy as a platform for novel prospective ex vivo drug sensitivity assays. Mol Cancer Ther. 2007 Feb; 6(2):515-23.Mol Cancer Ther2007-02-01T00:00:002007Optimizing the development of targeted agents in pancreatic cancer: tumor fine-needle aspiration biopsy as a platform for novel prospective ex vivo drug sensitivity assays.17552555Qian J, Yong KT, Roy I, Ohulchanskyy TY, Bergey EJ, Lee HH, Tramposch KM, He S, Maitra A, Prasad PNThe journal of physical chemistry. BImaging pancreatic cancer using surface-functionalized quantum dots. J Phys Chem B. 2007 Jun 28; 111(25):6969-72.J Phys Chem B2007-06-07T00:00:002007Imaging pancreatic cancer using surface-functionalized quantum dots.17914115Fendrich V, Waldmann J, Esni F, Ramaswamy A, Mullendore M, Buchholz M, Maitra A, Feldmann GEndocrine-related cancerSnail and Sonic Hedgehog activation in neuroendocrine tumors of the ileum. Endocr Relat Cancer. 2007 Sep; 14(3):865-74.Endocr Relat Cancer2007-09-01T00:00:002007Snail and Sonic Hedgehog activation in neuroendocrine tumors of the ileum.18043034Daniels JA, Lederman HM, Maitra A, Montgomery EAThe American journal of surgical pathologyGastrointestinal tract pathology in patients with common variable immunodeficiency (CVID): a clinicopathologic study and review. Am J Surg Pathol. 2007 Dec; 31(12):1800-12.Am J Surg Pathol2007-12-01T00:00:002007Gastrointestinal tract pathology in patients with common variable immunodeficiency (CVID): a clinicopathologic study and review.18094415Mithani SK, Smith IM, Zhou S, Gray A, Koch WM, Maitra A, Califano JAClinical cancer research : an official journal of the American Association for Cancer ResearchMitochondrial resequencing arrays detect tumor-specific mutations in salivary rinses of patients with head and neck cancer. Clin Cancer Res. 2007 Dec 15; 13(24):7335-40.Clin Cancer Res2007-12-15T00:00:002007Mitochondrial resequencing arrays detect tumor-specific mutations in salivary rinses of patients with head and neck cancer.18175224Lam-Himlin DM, Daniels JA, Gayyed MF, Dong J, Maitra A, Pan D, Montgomery EA, Anders RAInternational journal of gastrointestinal cancerThe hippo pathway in human upper gastrointestinal dysplasia and carcinoma: a novel oncogenic pathway. Int J Gastrointest Cancer. 2006; 37(4):103-9.Int J Gastrointest Cancer2006-01-01T00:00:002006The hippo pathway in human upper gastrointestinal dysplasia and carcinoma: a novel oncogenic pathway.18382097Koorstra JB, Hustinx SR, Offerhaus GJ, Maitra APancreatology : official journal of the International Association of Pancreatology (IAP) ... [et al.]Pancreatic carcinogenesis. Pancreatology. 2008; 8(2):110-25.Pancreatology2008-04-01T00:00:002008Pancreatic carcinogenesis.18515092Fendrich V, Esni F, Garay MV, Feldmann G, Habbe N, Jensen JN, Dor Y, Stoffers D, Jensen J, Leach SD, Maitra AGastroenterologyHedgehog signaling is required for effective regeneration of exocrine pancreas. Gastroenterology. 2008 Aug; 135(2):621-31.Gastroenterology2008-04-16T00:00:002008Hedgehog signaling is required for effective regeneration of exocrine pancreas.18515410Feldmann G, Habbe N, Dhara S, Bisht S, Alvarez H, Fendrich V, Beaty R, Mullendore M, Karikari C, Bardeesy N, Ouellette MM, Yu W, Maitra AGutHedgehog inhibition prolongs survival in a genetically engineered mouse model of pancreatic cancer. Gut. 2008 Oct; 57(10):1420-30.Gut2008-05-30T00:00:002008Hedgehog inhibition prolongs survival in a genetically engineered mouse model of pancreatic cancer.19174553Jimeno A, Feldmann G, Su?rez-Gauthier A, Rasheed Z, Solomon A, Zou GM, Rubio-Viqueira B, Garc?a-Garc?a E, L?pez-R?os F, Matsui W, Maitra A, Hidalgo MMolecular cancer therapeuticsA direct pancreatic cancer xenograft model as a platform for cancer stem cell therapeutic development. Mol Cancer Ther. 2009 Feb; 8(2):310-4.Mol Cancer Ther2009-01-27T00:00:002009A direct pancreatic cancer xenograft model as a platform for cancer stem cell therapeutic development.19206569Kumar R, Roy I, Ohulchanskyy TY, Goswami LN, Bonoiu AC, Bergey EJ, Tramposch KM, Maitra A, Prasad PNACS nanoCovalently dye-linked, surface-controlled, and bioconjugated organically modified silica nanoparticles as targeted probes for optical imaging. ACS Nano. 2008 Mar; 2(3):449-56.ACS Nano2008-03-01T00:00:002008Covalently dye-linked, surface-controlled, and bioconjugated organically modified silica nanoparticles as targeted probes for optical imaging.19243145Yong KT, Ding H, Roy I, Law WC, Bergey EJ, Maitra A, Prasad PNACS nanoImaging pancreatic cancer using bioconjugated InP quantum dots. ACS Nano. 2009 Mar 24; 3(3):502-10.ACS Nano2009-03-24T00:00:002009Imaging pancreatic cancer using bioconjugated InP quantum dots.19252414Koorstra JB, Karikari CA, Feldmann G, Bisht S, Rojas PL, Offerhaus GJ, Alvarez H, Maitra ACancer biology & therapyThe Axl receptor tyrosine kinase confers an adverse prognostic influence in pancreatic cancer and represents a new therapeutic target. Cancer Biol Ther. 2009 Apr; 8(7):618-26.Cancer Biol Ther2009-04-22T00:00:002009The Axl receptor tyrosine kinase confers an adverse prognostic influence in pancreatic cancer and represents a new therapeutic target.19296468Selaru FM, Olaru AV, Kan T, David S, Cheng Y, Mori Y, Yang J, Paun B, Jin Z, Agarwal R, Hamilton JP, Abraham J, Georgiades C, Alvarez H, Vivekanandan P, Yu W, Maitra A, Torbenson M, Thuluvath PJ, Gores GJ, LaRusso NF, Hruban R, Meltzer SJHepatology (Baltimore, Md.)MicroRNA-21 is overexpressed in human cholangiocarcinoma and regulates programmed cell death 4 and tissue inhibitor of metalloproteinase 3. Hepatology. 2009 May; 49(5):1595-601.Hepatology2009-05-01T00:00:002009MicroRNA-21 is overexpressed in human cholangiocarcinoma and regulates programmed cell death 4 and tissue inhibitor of metalloproteinase 3.19395878Scudiere JR, Maitra A, Montgomery EAAdvances in anatomic pathologySelected topics in the evaluation of pediatric gastrointestinal mucosal biopsies. Adv Anat Pathol. 2009 May; 16(3):154-60.Adv Anat Pathol2009-05-01T00:00:002009Selected topics in the evaluation of pediatric gastrointestinal mucosal biopsies.19652585Wu JM, Alvarez H, Garc?a P, Rojas PL, Wong G, Maitra A, Antonescu C, Montgomery EAThe American Journal of dermatopathologyMelanoma hyperpigmentation is strongly associated with KIT alterations. Am J Dermatopathol. 2009 Oct; 31(7):619-25.Am J Dermatopathol2009-10-01T00:00:002009Melanoma hyperpigmentation is strongly associated with KIT alterations.20037478Kent OA, Mullendore M, Wentzel EA, L?pez-Romero P, Tan AC, Alvarez H, West K, Ochs MF, Hidalgo M, Arking DE, Maitra A, Mendell JTCancer biology & therapyA resource for analysis of microRNA expression and function in pancreatic ductal adenocarcinoma cells. Cancer Biol Ther. 2009 Nov; 8(21):2013-24.Cancer Biol Ther2009-11-01T00:00:002009A resource for analysis of microRNA expression and function in pancreatic ductal adenocarcinoma cells.20164446Rasheed ZA, Yang J, Wang Q, Kowalski J, Freed I, Murter C, Hong SM, Koorstra JB, Rajeshkumar NV, He X, Goggins M, Iacobuzio-Donahue C, Berman DM, Laheru D, Jimeno A, Hidalgo M, Maitra A, Matsui WJournal of the National Cancer InstitutePrognostic significance of tumorigenic cells with mesenchymal features in pancreatic adenocarcinoma. J Natl Cancer Inst. 2010 Mar 03; 102(5):340-51.J Natl Cancer Inst2010-02-17T00:00:002010Prognostic significance of tumorigenic cells with mesenchymal features in pancreatic adenocarcinoma.20231822Kamiyama H, Kamiyama M, Hong SM, Karikari CA, Lin MT, Borges MW, Griffith M, Young A, Norris-Kirby A, Lubek C, Mizuma M, Feldmann G, Shi C, Liang H, Goggins MG, Maitra A, Hruban RH, Eshleman JRLaboratory investigation; a journal of technical methods and pathologyIn vivo and in vitro propagation of intraductal papillary mucinous neoplasms. Lab Invest. 2010 May; 90(5):665-73.Lab Invest2010-03-15T00:00:002010In vivo and in vitro propagation of intraductal papillary mucinous neoplasms.20647339Bisht S, Mizuma M, Feldmann G, Ottenhof NA, Hong SM, Pramanik D, Chenna V, Karikari C, Sharma R, Goggins MG, Rudek MA, Ravi R, Maitra A, Maitra AMolecular cancer therapeuticsSystemic administration of polymeric nanoparticle-encapsulated curcumin (NanoCurc) blocks tumor growth and metastases in preclinical models of pancreatic cancer. Mol Cancer Ther. 2010 Aug; 9(8):2255-64.Mol Cancer Ther2010-07-20T00:00:002010Systemic administration of polymeric nanoparticle-encapsulated curcumin (NanoCurc) blocks tumor growth and metastases in preclinical models of pancreatic cancer.20959520Liby KT, Royce DB, Risingsong R, Williams CR, Maitra A, Hruban RH, Sporn MBCancer prevention research (Philadelphia, Pa.)Synthetic triterpenoids prolong survival in a transgenic mouse model of pancreatic cancer. Cancer Prev Res (Phila). 2010 Nov; 3(11):1427-34.Cancer Prev Res (Phila)2010-10-19T00:00:002010Synthetic triterpenoids prolong survival in a transgenic mouse model of pancreatic cancer.21041407Cai J, Zhang N, Zheng Y, de Wilde RF, Maitra A, Pan DGenes & developmentThe Hippo signaling pathway restricts the oncogenic potential of an intestinal regeneration program. Genes Dev. 2010 Nov 01; 24(21):2383-8.Genes Dev2010-11-01T00:00:002010The Hippo signaling pathway restricts the oncogenic potential of an intestinal regeneration program.21154121Bisht S, Brossart P, Maitra A, Feldmann GCurrent opinion in investigational drugs (London, England : 2000)Agents targeting the Hedgehog pathway for pancreatic cancer treatment. Curr Opin Investig Drugs. 2010 Dec; 11(12):1387-98.Curr Opin Investig Drugs2010-12-01T00:00:002010Agents targeting the Hedgehog pathway for pancreatic cancer treatment.21248225Wang Q, Chaerkady R, Wu J, Hwang HJ, Papadopoulos N, Kopelovich L, Maitra A, Matthaei H, Eshleman JR, Hruban RH, Kinzler KW, Pandey A, Vogelstein BProceedings of the National Academy of Sciences of the United States of AmericaMutant proteins as cancer-specific biomarkers. Proc Natl Acad Sci U S A. 2011 Feb 08; 108(6):2444-9.Proc Natl Acad Sci U S A2011-01-19T00:00:002011Mutant proteins as cancer-specific biomarkers.21252315Jiao Y, Shi C, Edil BH, de Wilde RF, Klimstra DS, Maitra A, Schulick RD, Tang LH, Wolfgang CL, Choti MA, Velculescu VE, Diaz LA, Vogelstein B, Kinzler KW, Hruban RH, Papadopoulos NScience (New York, N.Y.)DAXX/ATRX, MEN1, and mTOR pathway genes are frequently altered in pancreatic neuroendocrine tumors. Science. 2011 Mar 04; 331(6021):1199-203.Science2011-01-20T00:00:002011DAXX/ATRX, MEN1, and mTOR pathway genes are frequently altered in pancreatic neuroendocrine tumors.21383670Matthaei H, Schulick RD, Hruban RH, Maitra ANature reviews. Gastroenterology & hepatologyCystic precursors to invasive pancreatic cancer. Nat Rev Gastroenterol Hepatol. 2011 Mar; 8(3):141-50.Nat Rev Gastroenterol Hepatol2011-03-01T00:00:002011Cystic precursors to invasive pancreatic cancer.21389100Rajeshkumar NV, De Oliveira E, Ottenhof N, Watters J, Brooks D, Demuth T, Shumway SD, Mizuarai S, Hirai H, Maitra A, Hidalgo MClinical cancer research : an official journal of the American Association for Cancer ResearchMK-1775, a potent Wee1 inhibitor, synergizes with gemcitabine to achieve tumor regressions, selectively in p53-deficient pancreatic cancer xenografts. Clin Cancer Res. 2011 May 01; 17(9):2799-806.Clin Cancer Res2011-03-09T00:00:002011MK-1775, a potent Wee1 inhibitor, synergizes with gemcitabine to achieve tumor regressions, selectively in p53-deficient pancreatic cancer xenografts.21483804Alvarez H, Opalinska J, Zhou L, Sohal D, Fazzari MJ, Yu Y, Montagna C, Montgomery EA, Canto M, Dunbar KB, Wang J, Roa JC, Mo Y, Bhagat T, Ramesh KH, Cannizzaro L, Mollenhauer J, Thompson RF, Suzuki M, Meltzer SJ, Meltzer S, Melnick A, Greally JM, Maitra A, Verma APLoS geneticsWidespread hypomethylation occurs early and synergizes with gene amplification during esophageal carcinogenesis. PLoS Genet. 2011 Mar; 7(3):e1001356.PLoS Genet2011-03-31T00:00:002011Widespread hypomethylation occurs early and synergizes with gene amplification during esophageal carcinogenesis.21742805Garrido-Laguna I, Uson M, Rajeshkumar NV, Tan AC, de Oliveira E, Karikari C, Villaroel MC, Salomon A, Taylor G, Sharma R, Hruban RH, Maitra A, Laheru D, Rubio-Viqueira B, Jimeno A, Hidalgo MClinical cancer research : an official journal of the American Association for Cancer ResearchTumor engraftment in nude mice and enrichment in stroma- related gene pathways predict poor survival and resistance to gemcitabine in patients with pancreatic cancer. Clin Cancer Res. 2011 Sep 01; 17(17):5793-800.Clin Cancer Res2011-07-08T00:00:002011Tumor engraftment in nude mice and enrichment in stroma- related gene pathways predict poor survival and resistance to gemcitabine in patients with pancreatic cancer.21768779Feldmann G, Mishra A, Bisht S, Karikari C, Garrido-Laguna I, Rasheed Z, Ottenhof NA, Dadon T, Alvarez H, Fendrich V, Rajeshkumar NV, Matsui W, Brossart P, Hidalgo M, Bannerji R, Maitra A, Nelkin BDCancer biology & therapyCyclin-dependent kinase inhibitor Dinaciclib (SCH727965) inhibits pancreatic cancer growth and progression in murine xenograft models. Cancer Biol Ther. 2011 Oct 01; 12(7):598-609.Cancer Biol Ther2011-10-01T00:00:002011Cyclin-dependent kinase inhibitor Dinaciclib (SCH727965) inhibits pancreatic cancer growth and progression in murine xenograft models.21775669Wu J, Matthaei H, Maitra A, Dal Molin M, Wood LD, Eshleman JR, Goggins M, Canto MI, Schulick RD, Edil BH, Wolfgang CL, Klein AP, Diaz LA, Allen PJ, Schmidt CM, Kinzler KW, Papadopoulos N, Hruban RH, Vogelstein BScience translational medicineRecurrent GNAS mutations define an unexpected pathway for pancreatic cyst development. Sci Transl Med. 2011 Jul 20; 3(92):92ra66.Sci Transl Med2011-07-20T00:00:002011Recurrent GNAS mutations define an unexpected pathway for pancreatic cyst development.21940037Dal Molin M, Hong SM, Hebbar S, Sharma R, Scrimieri F, de Wilde RF, Mayo SC, Goggins M, Wolfgang CL, Schulick RD, Lin MT, Eshleman JR, Hruban RH, Maitra A, Matthaei HHuman pathologyLoss of expression of the SWI/SNF chromatin remodeling subunit BRG1/SMARCA4 is frequently observed in intraductal papillary mucinous neoplasms of the pancreas. Hum Pathol. 2012 Apr; 43(4):585-91.Hum Pathol2011-09-21T00:00:002011Loss of expression of the SWI/SNF chromatin remodeling subunit BRG1/SMARCA4 is frequently observed in intraductal papillary mucinous neoplasms of the pancreas.21969517Von Hoff DD, Ramanathan RK, Borad MJ, Laheru DA, Smith LS, Wood TE, Korn RL, Desai N, Trieu V, Iglesias JL, Zhang H, Soon-Shiong P, Shi T, Rajeshkumar NV, Maitra A, Hidalgo MJournal of clinical oncology : official journal of the American Society of Clinical OncologyGemcitabine plus nab-paclitaxel is an active regimen in patients with advanced pancreatic cancer: a phase I/II trial. J Clin Oncol. 2011 Dec 01; 29(34):4548-54.J Clin Oncol2011-10-03T00:00:002011Gemcitabine plus nab-paclitaxel is an active regimen in patients with advanced pancreatic cancer: a phase I/II trial.22010213Gupta S, Pramanik D, Mukherjee R, Campbell NR, Elumalai S, de Wilde RF, Hong SM, Goggins MG, De Jesus-Acosta A, Laheru D, Maitra AClinical cancer research : an official journal of the American Association for Cancer ResearchMolecular determinants of retinoic acid sensitivity in pancreatic cancer. Clin Cancer Res. 2012 Jan 01; 18(1):280-9.Clin Cancer Res2011-10-18T00:00:002011Molecular determinants of retinoic acid sensitivity in pancreatic cancer.22158988Wu J, Jiao Y, Dal Molin M, Maitra A, de Wilde RF, Wood LD, Eshleman JR, Goggins MG, Wolfgang CL, Canto MI, Schulick RD, Edil BH, Choti MA, Adsay V, Klimstra DS, Offerhaus GJ, Klein AP, Kopelovich L, Carter H, Karchin R, Allen PJ, Schmidt CM, Naito Y, Diaz LA, Kinzler KW, Papadopoulos N, Hruban RH, Vogelstein BProceedings of the National Academy of Sciences of the United States of AmericaWhole-exome sequencing of neoplastic cysts of the pancreas reveals recurrent mutations in components of ubiquitin-dependent pathways. Proc Natl Acad Sci U S A. 2011 Dec 27; 108(52):21188-93.Proc Natl Acad Sci U S A2011-12-08T00:00:002011Whole-exome sequencing of neoplastic cysts of the pancreas reveals recurrent mutations in components of ubiquitin-dependent pathways.22221671Streppel MM, Siersema PD, de Leng WW, Morsink FH, Vleggaar FP, Maitra A, Montgomery EA, Offerhaus GJDiseases of the esophagus : official journal of the International Society for Diseases of the EsophagusSquamous cell carcinoma in Barrett's esophagus: field effect versus metastasis. Dis Esophagus. 2012 Sep-Oct; 25(7):630-7.Dis Esophagus2012-01-03T00:00:002012Squamous cell carcinoma in Barrett's esophagus: field effect versus metastasis.22226782Kanda M, Matthaei H, Wu J, Hong SM, Yu J, Borges M, Hruban RH, Maitra A, Kinzler K, Vogelstein B, Goggins MGastroenterologyPresence of somatic mutations in most early-stage pancreatic intraepithelial neoplasia. Gastroenterology. 2012 Apr; 142(4):730-733.e9.Gastroenterology2012-01-05T00:00:002012Presence of somatic mutations in most early-stage pancreatic intraepithelial neoplasia.22265420Rhim AD, Mirek ET, Aiello NM, Maitra A, Bailey JM, McAllister F, Reichert M, Beatty GL, Rustgi AK, Vonderheide RH, Leach SD, Stanger BZCellEMT and dissemination precede pancreatic tumor formation. Cell. 2012 Jan 20; 148(1-2):349-61.Cell2012-01-20T00:00:002012EMT and dissemination precede pancreatic tumor formation.22542127Streppel MM, Vincent A, Mukherjee R, Campbell NR, Chen SH, Konstantopoulos K, Goggins MG, Van Seuningen I, Maitra A, Montgomery EAHuman pathologyMucin 16 (cancer antigen 125) expression in human tissues and cell lines and correlation with clinical outcome in adenocarcinomas of the pancreas, esophagus, stomach, and colon. Hum Pathol. 2012 Oct; 43(10):1755-63.Hum Pathol2012-04-26T00:00:002012Mucin 16 (cancer antigen 125) expression in human tissues and cell lines and correlation with clinical outcome in adenocarcinomas of the pancreas, esophagus, stomach, and colon.22723372Matthaei H, Wylie D, Lloyd MB, Dal Molin M, Kemppainen J, Mayo SC, Wolfgang CL, Schulick RD, Langfield L, Andruss BF, Adai AT, Hruban RH, Szafranska-Schwarzbach AE, Maitra AClinical cancer research : an official journal of the American Association for Cancer ResearchmiRNA biomarkers in cyst fluid augment the diagnosis and management of pancreatic cysts. Clin Cancer Res. 2012 Sep 01; 18(17):4713-24.Clin Cancer Res2012-06-21T00:00:002012miRNA biomarkers in cyst fluid augment the diagnosis and management of pancreatic cysts.22814396Dallas MR, Chen SH, Streppel MM, Sharma S, Maitra A, Konstantopoulos KAmerican journal of physiology. Cell physiologySialofucosylated podocalyxin is a functional E- and L-selectin ligand expressed by metastatic pancreatic cancer cells. Am J Physiol Cell Physiol. 2012 Sep 15; 303(6):C616-24.Am J Physiol Cell Physiol2012-07-18T00:00:002012Sialofucosylated podocalyxin is a functional E- and L-selectin ligand expressed by metastatic pancreatic cancer cells.22831956Chun YS, Bisht S, Chenna V, Pramanik D, Yoshida T, Hong SM, de Wilde RF, Zhang Z, Huso DL, Zhao M, Rudek MA, Stearns V, Maitra A, Sukumar SCarcinogenesisIntraductal administration of a polymeric nanoparticle formulation of curcumin (NanoCurc) significantly attenuates incidence of mammary tumors in a rodent chemical carcinogenesis model: Implications for breast cancer chemoprevention in at-risk populations. Carcinogenesis. 2012 Nov; 33(11):2242-9.Carcinogenesis2012-07-25T00:00:002012Intraductal administration of a polymeric nanoparticle formulation of curcumin (NanoCurc) significantly attenuates incidence of mammary tumors in a rodent chemical carcinogenesis model: Implications for breast cancer chemoprevention in at-risk populations.22898640Hillion J, Smail SS, Di Cello F, Belton A, Shah SN, Huso T, Schuldenfrei A, Nelson DM, Cope L, Campbell N, Karikari C, Aderinto A, Maitra A, Huso DL, Resar LMPancreatology : official journal of the International Association of Pancreatology (IAP) ... [et al.]The HMGA1-COX-2 axis: a key molecular pathway and potential target in pancreatic adenocarcinoma. Pancreatology. 2012 Jul-Aug; 12(4):372-9.Pancreatology2012-05-29T00:00:002012The HMGA1-COX-2 axis: a key molecular pathway and potential target in pancreatic adenocarcinoma.23355199Zheng G, Martignoni G, Antonescu C, Montgomery E, Eberhart C, Netto G, Taube J, Westra W, Epstein JI, Lotan T, Maitra A, Gabrielson E, Torbenson M, Iacobuzio-Donahue C, Demarzo A, Shih IeM, Illei P, Wu TC, Argani PAmerican journal of clinical pathologyA broad survey of cathepsin K immunoreactivity in human neoplasms. Am J Clin Pathol. 2013 Feb; 139(2):151-9.Am J Clin Pathol2013-02-01T00:00:002013A broad survey of cathepsin K immunoreactivity in human neoplasms.23865431Streppel MM, Montgomery EA, Maitra ACurrent molecular medicineNew advances in the pathogenesis and progression of barrett's esophagus. Curr Mol Med. 2014 Jan; 14(1):58-68.Curr Mol Med2014-01-01T00:00:002014New advances in the pathogenesis and progression of barrett's esophagus.24333418Nimmagadda S, Pullambhatla M, Lisok A, Hu C, Maitra A, Pomper MGBiochemical and biophysical research communicationsImaging Axl expression in pancreatic and prostate cancer xenografts. Biochem Biophys Res Commun. 2014 Jan 10; 443(2):635-40.Biochem Biophys Res Commun2013-12-11T00:00:002013Imaging Axl expression in pancreatic and prostate cancer xenografts.24525507Matthaei H, Wu J, Dal Molin M, Shi C, Perner S, Kristiansen G, Lingohr P, Kalff JC, Wolfgang CL, Kinzler KW, Vogelstein B, Maitra A, Hruban RHThe American journal of surgical pathologyGNAS sequencing identifies IPMN-specific mutations in a subgroup of diminutive pancreatic cysts referred to as "incipient IPMNs". Am J Surg Pathol. 2014 Mar; 38(3):360-3.Am J Surg Pathol2014-03-01T00:00:002014GNAS sequencing identifies IPMN-specific mutations in a subgroup of diminutive pancreatic cysts referred to as "incipient IPMNs".24604757Amato E, Molin MD, Mafficini A, Yu J, Malleo G, Rusev B, Fassan M, Antonello D, Sadakari Y, Castelli P, Zamboni G, Maitra A, Salvia R, Hruban RH, Bassi C, Capelli P, Lawlor RT, Goggins M, Scarpa AThe Journal of pathologyTargeted next-generation sequencing of cancer genes dissects the molecular profiles of intraductal papillary neoplasms of the pancreas. J Pathol. 2014 Jul; 233(3):217-27.J Pathol2014-07-01T00:00:002014Targeted next-generation sequencing of cancer genes dissects the molecular profiles of intraductal papillary neoplasms of the pancreas.24607504Keenan BP, Saenger Y, Kafrouni MI, Leubner A, Lauer P, Maitra A, Rucki AA, Gunderson AJ, Coussens LM, Brockstedt DG, Dubensky TW, Hassan R, Armstrong TD, Jaffee EMGastroenterologyA Listeria vaccine and depletion of T-regulatory cells activate immunity against early stage pancreatic intraepithelial neoplasms and prolong survival of mice. Gastroenterology. 2014 Jun; 146(7):1784-94.e6.Gastroenterology2014-03-06T00:00:002014A Listeria vaccine and depletion of T-regulatory cells activate immunity against early stage pancreatic intraepithelial neoplasms and prolong survival of mice.24823639McAllister F, Bailey JM, Alsina J, Nirschl CJ, Sharma R, Fan H, Rattigan Y, Roeser JC, Lankapalli RH, Zhang H, Jaffee EM, Drake CG, Housseau F, Maitra A, Kolls JK, Sears CL, Pardoll DM, Leach SDCancer cellOncogenic Kras activates a hematopoietic-to-epithelial IL-17 signaling axis in preinvasive pancreatic neoplasia. Cancer Cell. 2014 May 12; 25(5):621-37.Cancer Cell2014-05-12T00:00:002014Oncogenic Kras activates a hematopoietic-to-epithelial IL-17 signaling axis in preinvasive pancreatic neoplasia.24855947Chivukula RR, Shi G, Acharya A, Mills EW, Zeitels LR, Anandam JL, Abdelnaby AA, Balch GC, Mansour JC, Yopp AC, Maitra A, Mendell JTCellAn essential mesenchymal function for miR-143/145 in intestinal epithelial regeneration. Cell. 2014 May 22; 157(5):1104-16.Cell2014-05-22T00:00:002014An essential mesenchymal function for miR-143/145 in intestinal epithelial regeneration.Authorship 2394821Authorship 2413362Authorship 2414592Authorship 2415032Authorship 2417586Authorship 2418001Authorship 2420884Authorship 2422971Authorship 2424211Authorship 2424951Authorship 2428522Authorship 2430321Authorship 2437283Authorship 2437711Authorship 2438001Authorship 2443846Authorship 2445202Authorship 2448231Authorship 2450198Authorship 2450278Authorship 2455406Authorship 2458911Authorship 2460212Authorship 2461986Authorship 2465213Authorship 2468527Authorship 2469697Authorship 2471348Authorship 2472517Authorship 2474074Authorship 2475686Authorship 2476386Authorship 2476429Authorship 2476978Authorship 2479151Authorship 2479303Authorship 2479543Authorship 2481499Authorship 2481854Authorship 2482169Authorship 2482928Authorship 24833323Authorship 2483416Authorship 2483821Authorship 2487779Authorship 2493675Authorship 24947612Authorship 24953312Authorship 2495673Authorship 2496128Authorship 2496389Authorship 24973216Authorship 24974812Authorship 2498966Authorship 2499112Authorship 25004513Authorship 2501932Authorship 2503321Authorship 25040210Authorship 2507545Authorship 2509734Authorship 2511995Authorship 2512632Authorship 2513845Authorship 25146614Authorship 2520279Authorship 2520552Authorship 2521013Authorship 25232010Authorship 2524066Authorship 2527815Authorship 25299114Authorship 25324510Authorship 2534226Authorship 2542054Authorship 2543828Authorship 2546077Authorship 2549324Authorship 2550186Authorship 2550239Authorship 2550868Authorship 25566413Authorship 2559273Authorship 2568487Authorship 2568524Authorship 25704112Authorship 2570845Authorship 2572323Authorship 2579177Authorship 25805710Authorship 25817812Authorship 25828710Authorship 2587533Authorship 25885912Authorship 25895412Authorship 2593072Authorship 2593543Authorship 25959416Authorship 2596883Authorship 25980212Authorship 2605289Authorship 2611696Authorship 2615355Authorship 262409629191559Maitra A, Hirany SV, Jialal IClinical chemistryComparison of two assays for measuring LDL cholesterol. Clin Chem. 1997 Jun; 43(6 Pt 1):1040-7.Clin Chem1997-06-01T00:00:001997Comparison of two assays for measuring LDL cholesterol.9751124Yashima K, Maitra A, Rogers BB, Timmons CF, Rathi A, Pinar H, Wright WE, Shay JW, Gazdar AFCell growth & differentiation : the molecular biology journal of the American Association for Cancer ResearchExpression of the RNA component of telomerase during human development and differentiation. Cell Growth Differ. 1998 Sep; 9(9):805-13.Cell Growth Differ1998-09-01T00:00:001998Expression of the RNA component of telomerase during human development and differentiation.10210636Euhus DM, Maitra A, Wistuba II, Alberts A, Albores-Saavedra J, Gazdar AFThe Journal of surgical researchLoss of heterozygosity at 3p in benign lesions preceding invasive breast cancer. J Surg Res. 1999 May 01; 83(1):13-8.J Surg Res1999-05-01T00:00:001999Loss of heterozygosity at 3p in benign lesions preceding invasive breast cancer.10603191Euhus DM, Maitra A, Wistuba II, Ashfaq R, Alberts A, Gibbons D, Gazdar AFCancerUse of archival fine-needle aspirates for the allelotyping of tumors. Cancer. 1999 Dec 25; 87(6):372-9.Cancer1999-12-25T00:00:001999Use of archival fine-needle aspirates for the allelotyping of tumors.10631863Maitra A, Ward PC, Kroft SH, Levinson BS, Jamal S, Fishleder AJ, Sendelbach KM, McKenna RWAmerican journal of clinical pathologyCytoplasmic inclusions in leukocytes. An unusual manifestation of cryoglobulinemia. Am J Clin Pathol. 2000 Jan; 113(1):107-12.Am J Clin Pathol2000-01-01T00:00:002000Cytoplasmic inclusions in leukocytes. An unusual manifestation of cryoglobulinemia.10890935Maitra A, Ramnani DM, Margraf LR, Gazdar AFPediatric and developmental pathology : the official journal of the Society for Pediatric Pathology and the Paediatric Pathology SocietySynchronous wilms tumor and fibrolamellar hepatocellular carcinoma: report of a case. Pediatr Dev Pathol. 2000 Sep-Oct; 3(5):492-6.Pediatr Dev Pathol2000-09-01T00:00:002000Synchronous wilms tumor and fibrolamellar hepatocellular carcinoma: report of a case.10920306Lin WM, Ashfaq R, Michalopulos EA, Maitra A, Gazdar AF, Muller CYAmerican journal of obstetrics and gynecologyMolecular Papanicolaou tests in the twenty-first century: molecular analyses with fluid-based Papanicolaou technology. Am J Obstet Gynecol. 2000 Jul; 183(1):39-45.Am J Obstet Gynecol2000-07-01T00:00:002000Molecular Papanicolaou tests in the twenty-first century: molecular analyses with fluid-based Papanicolaou technology.10944551Virmani AK, Rathi A, Z?chbauer-M?ller S, Sacchi N, Fukuyama Y, Bryant D, Maitra A, Heda S, Fong KM, Thunnissen F, Minna JD, Gazdar AFJournal of the National Cancer InstitutePromoter methylation and silencing of the retinoic acid receptor-beta gene in lung carcinomas. J Natl Cancer Inst. 2000 Aug 16; 92(16):1303-7.J Natl Cancer Inst2000-08-16T00:00:002000Promoter methylation and silencing of the retinoic acid receptor-beta gene in lung carcinomas.11021814Maitra A, Molberg K, Albores-Saavedra J, Lindberg GThe American journal of pathologyLoss of Dpc4 expression in colonic adenocarcinomas correlates with the presence of metastatic disease. Am J Pathol. 2000 Oct; 157(4):1105-11.Am J Pathol2000-10-01T00:00:002000Loss of Dpc4 expression in colonic adenocarcinomas correlates with the presence of metastatic disease.11075851Maitra A, Krueger JE, Tascilar M, Offerhaus GJ, Angeles-Angeles A, Klimstra DS, Hruban RH, Albores-Saavedra JThe American journal of surgical pathologyCarcinoid tumors of the extrahepatic bile ducts: a study of seven cases. Am J Surg Pathol. 2000 Nov; 24(11):1501-10.Am J Surg Pathol2000-11-01T00:00:002000Carcinoid tumors of the extrahepatic bile ducts: a study of seven cases.11230704Shivapurkar N, Maitra A, Milchgrub S, Gazdar AFHuman pathologyDeletions of chromosome 4 occur early during the pathogenesis of colorectal carcinoma. Hum Pathol. 2001 Feb; 32(2):169-77.Hum Pathol2001-02-01T00:00:002001Deletions of chromosome 4 occur early during the pathogenesis of colorectal carcinoma.11241308Maitra A, Roberts H, Weinberg AG, Geradts JInternational journal of cancerLoss of p16(INK4a) expression correlates with decreased survival in pediatric osteosarcomas. Int J Cancer. 2001 Jan 20; 95(1):34-8.Int J Cancer2001-01-20T00:00:002001Loss of p16(INK4a) expression correlates with decreased survival in pediatric osteosarcomas.11342770Maitra A, Tascilar M, Hruban RH, Offerhaus GJ, Albores-Saavedra JThe American journal of surgical pathologySmall cell carcinoma of the gallbladder: a clinicopathologic, immunohistochemical, and molecular pathology study of 12 cases. Am J Surg Pathol. 2001 May; 25(5):595-601.Am J Surg Pathol2001-05-01T00:00:002001Small cell carcinoma of the gallbladder: a clinicopathologic, immunohistochemical, and molecular pathology study of 12 cases.11520274Maitra A, Roberts H, Weinberg AG, Geradts JArchives of pathology & laboratory medicineAberrant expression of tumor suppressor proteins in the Ewing family of tumors. Arch Pathol Lab Med. 2001 Sep; 125(9):1207-12.Arch Pathol Lab Med2001-09-01T00:00:002001Aberrant expression of tumor suppressor proteins in the Ewing family of tumors.12082624Harada K, Toyooka S, Maitra A, Maruyama R, Toyooka KO, Timmons CF, Tomlinson GE, Mastrangelo D, Hay RJ, Minna JD, Gazdar AFOncogeneAberrant promoter methylation and silencing of the RASSF1A gene in pediatric tumors and cell lines. Oncogene. 2002 Jun 20; 21(27):4345-9.Oncogene2002-06-20T00:00:002002Aberrant promoter methylation and silencing of the RASSF1A gene in pediatric tumors and cell lines.12109856Maitra A, Iacobuzio-Donahue C, Rahman A, Sohn TA, Argani P, Meyer R, Yeo CJ, Cameron JL, Goggins M, Kern SE, Ashfaq R, Hruban RH, Wilentz REAmerican journal of clinical pathologyImmunohistochemical validation of a novel epithelial and a novel stromal marker of pancreatic ductal adenocarcinoma identified by global expression microarrays: sea urchin fascin homolog and heat shock protein 47. Am J Clin Pathol. 2002 Jul; 118(1):52-9.Am J Clin Pathol2002-07-01T00:00:002002Immunohistochemical validation of a novel epithelial and a novel stromal marker of pancreatic ductal adenocarcinoma identified by global expression microarrays: sea urchin fascin homolog and heat shock protein 47.12162677Maitra A, Ashfaq R, Gunn CR, Rahman A, Yeo CJ, Sohn TA, Cameron JL, Hruban RH, Wilentz REAmerican journal of clinical pathologyCyclooxygenase 2 expression in pancreatic adenocarcinoma and pancreatic intraepithelial neoplasia: an immunohistochemical analysis with automated cellular imaging. Am J Clin Pathol. 2002 Aug; 118(2):194-201.Am J Clin Pathol2002-08-01T00:00:002002Cyclooxygenase 2 expression in pancreatic adenocarcinoma and pancreatic intraepithelial neoplasia: an immunohistochemical analysis with automated cellular imaging.12615714Hempen PM, Zhang L, Bansal RK, Iacobuzio-Donahue CA, Murphy KM, Maitra A, Vogelstein B, Whitehead RH, Markowitz SD, Willson JK, Yeo CJ, Hruban RH, Kern SECancer researchEvidence of selection for clones having genetic inactivation of the activin A type II receptor (ACVR2) gene in gastrointestinal cancers. Cancer Res. 2003 Mar 01; 63(5):994-9.Cancer Res2003-03-01T00:00:002003Evidence of selection for clones having genetic inactivation of the activin A type II receptor (ACVR2) gene in gastrointestinal cancers.12861065Sahin F, Maitra A, Argani P, Sato N, Maehara N, Montgomery E, Goggins M, Hruban RH, Su GHModern pathology : an official journal of the United States and Canadian Academy of Pathology, IncLoss of Stk11/Lkb1 expression in pancreatic and biliary neoplasms. Mod Pathol. 2003 Jul; 16(7):686-91.Mod Pathol2003-07-01T00:00:002003Loss of Stk11/Lkb1 expression in pancreatic and biliary neoplasms.14506157Rathi A, Virmani AK, Harada K, Timmons CF, Miyajima K, Hay RJ, Mastrangelo D, Maitra A, Tomlinson GE, Gazdar AFClinical cancer research : an official journal of the American Association for Cancer ResearchAberrant methylation of the HIC1 promoter is a frequent event in specific pediatric neoplasms. Clin Cancer Res. 2003 Sep 01; 9(10 Pt 1):3674-8.Clin Cancer Res2003-09-01T00:00:002003Aberrant methylation of the HIC1 promoter is a frequent event in specific pediatric neoplasms.14527906House MG, Wistuba II, Argani P, Guo M, Schulick RD, Hruban RH, Herman JG, Maitra AAnnals of surgical oncologyProgression of gene hypermethylation in gallstone disease leading to gallbladder cancer. Ann Surg Oncol. 2003 Oct; 10(8):882-9.Ann Surg Oncol2003-10-01T00:00:002003Progression of gene hypermethylation in gallstone disease leading to gallbladder cancer.14716063Hansel DE, House MG, Ashfaq R, Rahman A, Yeo CJ, Maitra AInternational journal of gastrointestinal cancerMAGE1 is expressed by a subset of pancreatic endocrine neoplasms and associated lymph node and liver metastases. Int J Gastrointest Cancer. 2003; 33(2-3):141-7.Int J Gastrointest Cancer2003-01-01T00:00:002003MAGE1 is expressed by a subset of pancreatic endocrine neoplasms and associated lymph node and liver metastases.15083201Parker AR, Leonard CP, Hua L, Francis RO, Dhara S, Maitra A, Eshleman JRBritish journal of cancerA subgroup of microsatellite stable colorectal cancers has elevated mutation rates and different responses to alkylating and oxidising agents. Br J Cancer. 2004 Apr 19; 90(8):1666-71.Br J Cancer2004-04-19T00:00:002004A subgroup of microsatellite stable colorectal cancers has elevated mutation rates and different responses to alkylating and oxidising agents.15448002Hansel DE, Rahman A, House M, Ashfaq R, Berg K, Yeo CJ, Maitra AClinical cancer research : an official journal of the American Association for Cancer ResearchMet proto-oncogene and insulin-like growth factor binding protein 3 overexpression correlates with metastatic ability in well-differentiated pancreatic endocrine neoplasms. Clin Cancer Res. 2004 Sep 15; 10(18 Pt 1):6152-8.Clin Cancer Res2004-09-15T00:00:002004Met proto-oncogene and insulin-like growth factor binding protein 3 overexpression correlates with metastatic ability in well-differentiated pancreatic endocrine neoplasms.15477757Hustinx SR, Cao D, Maitra A, Sato N, Martin ST, Sudhir D, Iacobuzio-Donahue C, Cameron JL, Yeo CJ, Kern SE, Goggins M, Mollenhauer J, Pandey A, Hruban RHCancer biology & therapyDifferentially expressed genes in pancreatic ductal adenocarcinomas identified through serial analysis of gene expression. Cancer Biol Ther. 2004 Dec; 3(12):1254-61.Cancer Biol Ther2004-12-14T00:00:002004Differentially expressed genes in pancreatic ductal adenocarcinomas identified through serial analysis of gene expression.15696124Cao D, Maitra A, Saavedra JA, Klimstra DS, Adsay NV, Hruban RHModern pathology : an official journal of the United States and Canadian Academy of Pathology, IncExpression of novel markers of pancreatic ductal adenocarcinoma in pancreatic nonductal neoplasms: additional evidence of different genetic pathways. Mod Pathol. 2005 Jun; 18(6):752-61.Mod Pathol2005-06-01T00:00:002005Expression of novel markers of pancreatic ductal adenocarcinoma in pancreatic nonductal neoplasms: additional evidence of different genetic pathways.15722570Hansel DE, Rahman A, Wilentz RE, Shih IeM, McMaster MT, Yeo CJ, Maitra AInternational journal of gastrointestinal cancerHLA-G upregulation in pre-malignant and malignant lesions of the gastrointestinal tract. Int J Gastrointest Cancer. 2005; 35(1):15-23.Int J Gastrointest Cancer2005-01-01T00:00:002005HLA-G upregulation in pre-malignant and malignant lesions of the gastrointestinal tract.15753353Prasad NB, Biankin AV, Fukushima N, Maitra A, Dhara S, Elkahloun AG, Hruban RH, Goggins M, Leach SDCancer researchGene expression profiles in pancreatic intraepithelial neoplasia reflect the effects of Hedgehog signaling on pancreatic ductal epithelial cells. Cancer Res. 2005 Mar 01; 65(5):1619-26.Cancer Res2005-03-01T00:00:002005Gene expression profiles in pancreatic intraepithelial neoplasia reflect the effects of Hedgehog signaling on pancreatic ductal epithelial cells.15832197Hustinx SR, Leoni LM, Yeo CJ, Brown PN, Goggins M, Kern SE, Hruban RH, Maitra AModern pathology : an official journal of the United States and Canadian Academy of Pathology, IncConcordant loss of MTAP and p16/CDKN2A expression in pancreatic intraepithelial neoplasia: evidence of homozygous deletion in a noninvasive precursor lesion. Mod Pathol. 2005 Jul; 18(7):959-63.Mod Pathol2005-07-01T00:00:002005Concordant loss of MTAP and p16/CDKN2A expression in pancreatic intraepithelial neoplasia: evidence of homozygous deletion in a noninvasive precursor lesion.15970691Martin ST, Sato N, Dhara S, Chang R, Hustinx SR, Abe T, Maitra A, Goggins MCancer biology & therapyAberrant methylation of the Human Hedgehog interacting protein (HHIP) gene in pancreatic neoplasms. Cancer Biol Ther. 2005 Jul; 4(7):728-33.Cancer Biol Ther2005-07-04T00:00:002005Aberrant methylation of the Human Hedgehog interacting protein (HHIP) gene in pancreatic neoplasms.16036106Bashyam MD, Bair R, Kim YH, Wang P, Hernandez-Boussard T, Karikari CA, Tibshirani R, Maitra A, Pollack JRNeoplasia (New York, N.Y.)Array-based comparative genomic hybridization identifies localized DNA amplifications and homozygous deletions in pancreatic cancer. Neoplasia. 2005 Jun; 7(6):556-62.Neoplasia2005-06-01T00:00:002005Array-based comparative genomic hybridization identifies localized DNA amplifications and homozygous deletions in pancreatic cancer.16080956Nowak NJ, Gaile D, Conroy JM, McQuaid D, Cowell J, Carter R, Goggins MG, Hruban RH, Maitra ACancer genetics and cytogeneticsGenome-wide aberrations in pancreatic adenocarcinoma. Cancer Genet Cytogenet. 2005 Aug; 161(1):36-50.Cancer Genet Cytogenet2005-08-01T00:00:002005Genome-wide aberrations in pancreatic adenocarcinoma.16169459Maitra A, Hruban RHCancer cellA new mouse model of pancreatic cancer: PTEN gets its Akt together. Cancer Cell. 2005 Sep; 8(3):171-2.Cancer Cell2005-09-01T00:00:002005A new mouse model of pancreatic cancer: PTEN gets its Akt together.16215274Gr?nborg M, Kristiansen TZ, Iwahori A, Chang R, Reddy R, Sato N, Molina H, Jensen ON, Hruban RH, Goggins MG, Maitra A, Pandey AMolecular & cellular proteomics : MCPBiomarker discovery from pancreatic cancer secretome using a differential proteomic approach. Mol Cell Proteomics. 2006 Jan; 5(1):157-71.Mol Cell Proteomics2005-10-08T00:00:002005Biomarker discovery from pancreatic cancer secretome using a differential proteomic approach.16293579Plaia TW, Josephson R, Liu Y, Zeng X, Ording C, Toumadje A, Brimble SN, Sherrer ES, Uhl EW, Freed WJ, Schulz TC, Maitra A, Rao MS, Auerbach JMStem cells (Dayton, Ohio)Characterization of a new NIH-registered variant human embryonic stem cell line, BG01V: a tool for human embryonic stem cell research. Stem Cells. 2006 Mar; 24(3):531-46.Stem Cells2005-11-17T00:00:002005Characterization of a new NIH-registered variant human embryonic stem cell line, BG01V: a tool for human embryonic stem cell research.16373701Karikari CA, Mullendore M, Eshleman JR, Argani P, Leoni LM, Chattopadhyay S, Hidalgo M, Maitra AMolecular cancer therapeuticsHomozygous deletions of methylthioadenosine phosphorylase in human biliary tract cancers. Mol Cancer Ther. 2005 Dec; 4(12):1860-6.Mol Cancer Ther2005-12-01T00:00:002005Homozygous deletions of methylthioadenosine phosphorylase in human biliary tract cancers.16513366Henke RT, Eun Kim S, Maitra A, Paik S, Wellstein AMethods (San Diego, Calif.)Expression analysis of mRNA in formalin-fixed, paraffin-embedded archival tissues by mRNA in situ hybridization. Methods. 2006 Apr; 38(4):253-62.Methods2006-04-01T00:00:002006Expression analysis of mRNA in formalin-fixed, paraffin-embedded archival tissues by mRNA in situ hybridization.16549325Maitra A, Kern SE, Hruban RHBest practice & research. Clinical gastroenterologyMolecular pathogenesis of pancreatic cancer. Best Pract Res Clin Gastroenterol. 2006 Apr; 20(2):211-26.Best Pract Res Clin Gastroenterol2006-04-01T00:00:002006Molecular pathogenesis of pancreatic cancer.16633106Moff SL, Clark DP, Maitra A, Pandey A, Thuluvath PJJournal of clinical gastroenterologyUtility of bile duct brushings for the early detection of cholangiocarcinoma in patients with primary sclerosing cholangitis. J Clin Gastroenterol. 2006 Apr; 40(4):336-41.J Clin Gastroenterol2006-04-01T00:00:002006Utility of bile duct brushings for the early detection of cholangiocarcinoma in patients with primary sclerosing cholangitis.16760659Jiang P, Yamauchi K, Yang M, Tsuji K, Xu M, Maitra A, Bouvet M, Hoffman RMCell cycle (Georgetown, Tex.)Tumor cells genetically labeled with GFP in the nucleus and RFP in the cytoplasm for imaging cellular dynamics. Cell Cycle. 2006 Jun; 5(11):1198-201.Cell Cycle2006-06-01T00:00:002006Tumor cells genetically labeled with GFP in the nucleus and RFP in the cytoplasm for imaging cellular dynamics.16891476Hidalgo M, Amador ML, Jimeno A, Mezzadra H, Patel P, Chan A, Nielsen ME, Maitra A, Altiok SMolecular cancer therapeuticsAssessment of gefitinib- and CI-1040-mediated changes in epidermal growth factor receptor signaling in HuCCT-1 human cholangiocarcinoma by serial fine needle aspiration. Mol Cancer Ther. 2006 Jul; 5(7):1895-903.Mol Cancer Ther2006-07-01T00:00:002006Assessment of gefitinib- and CI-1040-mediated changes in epidermal growth factor receptor signaling in HuCCT-1 human cholangiocarcinoma by serial fine needle aspiration.16899657Bibikova M, Chudin E, Wu B, Zhou L, Garcia EW, Liu Y, Shin S, Plaia TW, Auerbach JM, Arking DE, Gonzalez R, Crook J, Davidson B, Schulz TC, Robins A, Khanna A, Sartipy P, Hyllner J, Vanguri P, Savant-Bhonsale S, Smith AK, Chakravarti A, Maitra A, Rao M, Barker DL, Loring JF, Fan JBGenome researchHuman embryonic stem cells have a unique epigenetic signature. Genome Res. 2006 Sep; 16(9):1075-83.Genome Res2006-08-09T00:00:002006Human embryonic stem cells have a unique epigenetic signature.16912165Calhoun ES, Hucl T, Gallmeier E, West KM, Arking DE, Maitra A, Iacobuzio-Donahue CA, Chakravarti A, Hruban RH, Kern SECancer researchIdentifying allelic loss and homozygous deletions in pancreatic cancer without matched normals using high-density single-nucleotide polymorphism arrays. Cancer Res. 2006 Aug 15; 66(16):7920-8.Cancer Res2006-08-15T00:00:002006Identifying allelic loss and homozygous deletions in pancreatic cancer without matched normals using high-density single-nucleotide polymorphism arrays.16919167Josephson R, Sykes G, Liu Y, Ording C, Xu W, Zeng X, Shin S, Loring J, Maitra A, Rao MS, Auerbach JMBMC biologyA molecular scheme for improved characterization of human embryonic stem cell lines. BMC Biol. 2006 Aug 18; 4:28.BMC Biol2006-08-18T00:00:002006A molecular scheme for improved characterization of human embryonic stem cell lines.16931588Zhou S, Kassauei K, Cutler DJ, Kennedy GC, Sidransky D, Maitra A, Califano JThe Journal of molecular diagnostics : JMDAn oligonucleotide microarray for high-throughput sequencing of the mitochondrial genome. J Mol Diagn. 2006 Sep; 8(4):476-82.J Mol Diagn2006-09-01T00:00:002006An oligonucleotide microarray for high-throughput sequencing of the mitochondrial genome.16931950Brune K, Abe T, Canto M, O'Malley L, Klein AP, Maitra A, Volkan Adsay N, Fishman EK, Cameron JL, Yeo CJ, Kern SE, Goggins M, Hruban RHThe American journal of surgical pathologyMultifocal neoplastic precursor lesions associated with lobular atrophy of the pancreas in patients having a strong family history of pancreatic cancer. Am J Surg Pathol. 2006 Sep; 30(9):1067-76.Am J Surg Pathol2006-09-01T00:00:002006Multifocal neoplastic precursor lesions associated with lobular atrophy of the pancreas in patients having a strong family history of pancreatic cancer.17116802Cunningham SC, Kamangar F, Kim MP, Hammoud S, Haque R, Iacobuzio-Donahue C, Ashfaq R, Kern SE, Maitra A, Heitmiller RE, Choti MA, Lillemoe KD, Cameron JL, Yeo CJ, Montgomery E, Schulick RDArchives of surgery (Chicago, Ill. : 1960)MKK4 status predicts survival after resection of gastric adenocarcinoma. Arch Surg. 2006 Nov; 141(11):1095-9; discussion 1100.Arch Surg2006-11-01T00:00:002006MKK4 status predicts survival after resection of gastric adenocarcinoma.17172725Beaty RM, Gronborg M, Pollack JR, Maitra AMethods in molecular biology (Clifton, N.J.)Target discovery and validation in pancreatic cancer. Methods Mol Biol. 2007; 360:57-89.Methods Mol Biol2007-01-01T00:00:002007Target discovery and validation in pancreatic cancer.17339366Karikari CA, Roy I, Tryggestad E, Feldmann G, Pinilla C, Welsh K, Reed JC, Armour EP, Wong J, Herman J, Rakheja D, Maitra AMolecular cancer therapeuticsTargeting the apoptotic machinery in pancreatic cancers using small-molecule antagonists of the X-linked inhibitor of apoptosis protein. Mol Cancer Ther. 2007 Mar; 6(3):957-66.Mol Cancer Ther2007-03-05T00:00:002007Targeting the apoptotic machinery in pancreatic cancers using small-molecule antagonists of the X-linked inhibitor of apoptosis protein.17357272Takaori K, Hruban RH, Maitra A, Tanigawa NAdvances in medical sciencesCurrent topics on precursors to pancreatic cancer. Adv Med Sci. 2006; 51:23-30.Adv Med Sci2006-01-01T00:00:002006Current topics on precursors to pancreatic cancer.17396143Cao D, Zhang Q, Wu LS, Salaria SN, Winter JW, Hruban RH, Goggins MS, Abbruzzese JL, Maitra A, Ho LModern pathology : an official journal of the United States and Canadian Academy of Pathology, IncPrognostic significance of maspin in pancreatic ductal adenocarcinoma: tissue microarray analysis of 223 surgically resected cases. Mod Pathol. 2007 May; 20(5):570-8.Mod Pathol2007-03-30T00:00:002007Prognostic significance of maspin in pancreatic ductal adenocarcinoma: tissue microarray analysis of 223 surgically resected cases.17449961Singh M, Maitra APancreatology : official journal of the International Association of Pancreatology (IAP) ... [et al.]Precursor lesions of pancreatic cancer: molecular pathology and clinical implications. Pancreatology. 2007; 7(1):9-19.Pancreatology2007-04-18T00:00:002007Precursor lesions of pancreatic cancer: molecular pathology and clinical implications.17456604Zhou S, Kachhap S, Sun W, Wu G, Chuang A, Poeta L, Grumbine L, Mithani SK, Chatterjee A, Koch W, Westra WH, Maitra A, Glazer C, Carducci M, Sidransky D, McFate T, Verma A, Califano JAProceedings of the National Academy of Sciences of the United States of AmericaFrequency and phenotypic implications of mitochondrial DNA mutations in human squamous cell cancers of the head and neck. Proc Natl Acad Sci U S A. 2007 May 01; 104(18):7540-5.Proc Natl Acad Sci U S A2007-04-24T00:00:002007Frequency and phenotypic implications of mitochondrial DNA mutations in human squamous cell cancers of the head and neck.17540599Chang TC, Wentzel EA, Kent OA, Ramachandran K, Mullendore M, Lee KH, Feldmann G, Yamakuchi M, Ferlito M, Lowenstein CJ, Arking DE, Beer MA, Maitra A, Mendell JTMolecular cellTransactivation of miR-34a by p53 broadly influences gene expression and promotes apoptosis. Mol Cell. 2007 Jun 08; 26(5):745-52.Mol Cell2007-05-31T00:00:002007Transactivation of miR-34a by p53 broadly influences gene expression and promotes apoptosis.17827523Kassauei K, Habbe N, Mullendore ME, Karikari CA, Maitra A, Feldmann GInternational journal of gastrointestinal cancerMitochondrial DNA mutations in pancreatic cancer. Int J Gastrointest Cancer. 2006; 37(2-3):57-64.Int J Gastrointest Cancer2006-01-01T00:00:002006Mitochondrial DNA mutations in pancreatic cancer.18039136Maitra A, Hruban RHAnnual review of pathologyPancreatic cancer. Annu Rev Pathol. 2008; 3:157-88.Annu Rev Pathol2008-01-01T00:00:002008Pancreatic cancer.18059179Tan AC, Fan JB, Karikari C, Bibikova M, Garcia EW, Zhou L, Barker D, Serre D, Feldmann G, Hruban RH, Klein AP, Goggins M, Couch FJ, Hudson TJ, Winslow RL, Maitra A, Chakravarti ACancer biology & therapyAllele-specific expression in the germline of patients with familial pancreatic cancer: an unbiased approach to cancer gene discovery. Cancer Biol Ther. 2008 Jan; 7(1):135-44.Cancer Biol Ther2007-10-19T00:00:002007Allele-specific expression in the germline of patients with familial pancreatic cancer: an unbiased approach to cancer gene discovery.18223320Karanjawala ZE, Illei PB, Ashfaq R, Infante JR, Murphy K, Pandey A, Schulick R, Winter J, Sharma R, Maitra A, Goggins M, Hruban RHThe American journal of surgical pathologyNew markers of pancreatic cancer identified through differential gene expression analyses: claudin 18 and annexin A8. Am J Surg Pathol. 2008 Feb; 32(2):188-96.Am J Surg Pathol2008-02-01T00:00:002008New markers of pancreatic cancer identified through differential gene expression analyses: claudin 18 and annexin A8.18249125Kumar SK, Roy I, Anchoori RK, Fazli S, Maitra A, Beachy PA, Khan SRBioorganic & medicinal chemistryTargeted inhibition of hedgehog signaling by cyclopamine prodrugs for advanced prostate cancer. Bioorg Med Chem. 2008 Mar 15; 16(6):2764-8.Bioorg Med Chem2008-01-11T00:00:002008Targeted inhibition of hedgehog signaling by cyclopamine prodrugs for advanced prostate cancer.18258927Feldmann G, Maitra AThe Journal of molecular diagnostics : JMDMolecular genetics of pancreatic ductal adenocarcinomas and recent implications for translational efforts. J Mol Diagn. 2008 Mar; 10(2):111-22.J Mol Diagn2008-02-07T00:00:002008Molecular genetics of pancreatic ductal adenocarcinomas and recent implications for translational efforts.18333084Winter JM, Maitra A, Yeo CJHPB : the official journal of the International Hepato Pancreato Biliary AssociationGenetics and pathology of pancreatic cancer. HPB (Oxford). 2006; 8(5):324-36.HPB (Oxford)2006-01-01T00:00:002006Genetics and pathology of pancreatic cancer.18451226Alvarez H, Corvalan A, Roa JC, Argani P, Murillo F, Edwards J, Beaty R, Feldmann G, Hong SM, Mullendore M, Roa I, Iba?ez L, Pimentel F, Diaz A, Riggins GJ, Maitra AClinical cancer research : an official journal of the American Association for Cancer ResearchSerial analysis of gene expression identifies connective tissue growth factor expression as a prognostic biomarker in gallbladder cancer. Clin Cancer Res. 2008 May 01; 14(9):2631-8.Clin Cancer Res2008-05-01T00:00:002008Serial analysis of gene expression identifies connective tissue growth factor expression as a prognostic biomarker in gallbladder cancer.18549880Park SW, Davison JM, Rhee J, Hruban RH, Maitra A, Leach SDGastroenterologyOncogenic KRAS induces progenitor cell expansion and malignant transformation in zebrafish exocrine pancreas. Gastroenterology. 2008 Jun; 134(7):2080-90.Gastroenterology2008-03-05T00:00:002008Oncogenic KRAS induces progenitor cell expansion and malignant transformation in zebrafish exocrine pancreas.18615728An W, Han JS, Schrum CM, Maitra A, Koentgen F, Boeke JDGenesis (New York, N.Y. : 2000)Conditional activation of a single-copy L1 transgene in mice by Cre. Genesis. 2008 Jul; 46(7):373-83.Genesis2008-07-01T00:00:002008Conditional activation of a single-copy L1 transgene in mice by Cre.18703216Steinhardt AA, Gayyed MF, Klein AP, Dong J, Maitra A, Pan D, Montgomery EA, Anders RAHuman pathologyExpression of Yes-associated protein in common solid tumors. Hum Pathol. 2008 Nov; 39(11):1582-9.Hum Pathol2008-08-13T00:00:002008Expression of Yes-associated protein in common solid tumors.18790753Feldmann G, Fendrich V, McGovern K, Bedja D, Bisht S, Alvarez H, Koorstra JB, Habbe N, Karikari C, Mullendore M, Gabrielson KL, Sharma R, Matsui W, Maitra AMolecular cancer therapeuticsAn orally bioavailable small-molecule inhibitor of Hedgehog signaling inhibits tumor initiation and metastasis in pancreatic cancer. Mol Cancer Ther. 2008 Sep; 7(9):2725-35.Mol Cancer Ther2008-09-01T00:00:002008An orally bioavailable small-molecule inhibitor of Hedgehog signaling inhibits tumor initiation and metastasis in pancreatic cancer.18839982Kristiansen TZ, Harsha HC, Gr?nborg M, Maitra A, Pandey AJournal of proteome researchDifferential membrane proteomics using 18O-labeling to identify biomarkers for cholangiocarcinoma. J Proteome Res. 2008 Nov; 7(11):4670-7.J Proteome Res2008-10-08T00:00:002008Differential membrane proteomics using 18O-labeling to identify biomarkers for cholangiocarcinoma.19074860Bisht S, Feldmann G, Koorstra JB, Mullendore M, Alvarez H, Karikari C, Rudek MA, Lee CK, Maitra A, Maitra AMolecular cancer therapeuticsIn vivo characterization of a polymeric nanoparticle platform with potential oral drug delivery capabilities. Mol Cancer Ther. 2008 Dec; 7(12):3878-88.Mol Cancer Ther2008-12-01T00:00:002008In vivo characterization of a polymeric nanoparticle platform with potential oral drug delivery capabilities.19097035Zou GM, Karikari C, Kabe Y, Handa H, Anders RA, Maitra AJournal of cellular physiologyThe Ape-1/Ref-1 redox antagonist E3330 inhibits the growth of tumor endothelium and endothelial progenitor cells: therapeutic implications in tumor angiogenesis. J Cell Physiol. 2009 Apr; 219(1):209-18.J Cell Physiol2009-04-01T00:00:002009The Ape-1/Ref-1 redox antagonist E3330 inhibits the growth of tumor endothelium and endothelial progenitor cells: therapeutic implications in tumor angiogenesis.19106647Habbe N, Koorstra JB, Mendell JT, Offerhaus GJ, Ryu JK, Feldmann G, Mullendore ME, Goggins MG, Hong SM, Maitra ACancer biology & therapyMicroRNA miR-155 is a biomarker of early pancreatic neoplasia. Cancer Biol Ther. 2009 Feb; 8(4):340-6.Cancer Biol Ther2009-02-03T00:00:002009MicroRNA miR-155 is a biomarker of early pancreatic neoplasia.19407485Lee KH, Lotterman C, Karikari C, Omura N, Feldmann G, Habbe N, Goggins MG, Mendell JT, Maitra APancreatology : official journal of the International Association of Pancreatology (IAP) ... [et al.]Epigenetic silencing of MicroRNA miR-107 regulates cyclin-dependent kinase 6 expression in pancreatic cancer. Pancreatology. 2009; 9(3):293-301.Pancreatology2009-04-29T00:00:002009Epigenetic silencing of MicroRNA miR-107 regulates cyclin-dependent kinase 6 expression in pancreatic cancer.19496751Bisht S, Maitra ACurrent drug discovery technologiesSystemic delivery of curcumin: 21st century solutions for an ancient conundrum. Curr Drug Discov Technol. 2009 Sep; 6(3):192-9.Curr Drug Discov Technol2009-09-01T00:00:002009Systemic delivery of curcumin: 21st century solutions for an ancient conundrum.19880966Fendrich V, Chen NM, Neef M, Waldmann J, Buchholz M, Feldmann G, Slater EP, Maitra A, Bartsch DKGutThe angiotensin-I-converting enzyme inhibitor enalapril and aspirin delay progression of pancreatic intraepithelial neoplasia and cancer formation in a genetically engineered mouse model of pancreatic cancer. Gut. 2010 May; 59(5):630-7.Gut2009-11-01T00:00:002009The angiotensin-I-converting enzyme inhibitor enalapril and aspirin delay progression of pancreatic intraepithelial neoplasia and cancer formation in a genetically engineered mouse model of pancreatic cancer.20133848Le A, Cooper CR, Gouw AM, Dinavahi R, Maitra A, Deck LM, Royer RE, Vander Jagt DL, Semenza GL, Dang CVProceedings of the National Academy of Sciences of the United States of AmericaInhibition of lactate dehydrogenase A induces oxidative stress and inhibits tumor progression. Proc Natl Acad Sci U S A. 2010 Feb 02; 107(5):2037-42.Proc Natl Acad Sci U S A2010-01-19T00:00:002010Inhibition of lactate dehydrogenase A induces oxidative stress and inhibits tumor progression.20332664Ryu JK, Hong SM, Karikari CA, Hruban RH, Goggins MG, Maitra APancreatology : official journal of the International Association of Pancreatology (IAP) ... [et al.]Aberrant MicroRNA-155 expression is an early event in the multistep progression of pancreatic adenocarcinoma. Pancreatology. 2010; 10(1):66-73.Pancreatology2010-03-20T00:00:002010Aberrant MicroRNA-155 expression is an early event in the multistep progression of pancreatic adenocarcinoma.20484029Feldmann G, Mishra A, Hong SM, Bisht S, Strock CJ, Ball DW, Goggins M, Maitra A, Nelkin BDCancer researchInhibiting the cyclin-dependent kinase CDK5 blocks pancreatic cancer formation and progression through the suppression of Ras-Ral signaling. Cancer Res. 2010 Jun 01; 70(11):4460-9.Cancer Res2010-05-18T00:00:002010Inhibiting the cyclin-dependent kinase CDK5 blocks pancreatic cancer formation and progression through the suppression of Ras-Ral signaling.20703831Iwatate M, Matsubayashi H, Sasaki K, Kishida N, Yoshikawa S, Ono H, Maitra AJournal of gastrointestinal cancerFunctional pancreatic acinar cell carcinoma extending into the main pancreatic duct and splenic vein. J Gastrointest Cancer. 2012 Jun; 43(2):373-8.J Gastrointest Cancer2012-06-01T00:00:002012Functional pancreatic acinar cell carcinoma extending into the main pancreatic duct and splenic vein.20930270Ray B, Bisht S, Maitra A, Maitra A, Lahiri DKJournal of Alzheimer's disease : JADNeuroprotective and neurorescue effects of a novel polymeric nanoparticle formulation of curcumin (NanoCurc?) in the neuronal cell culture and animal model: implications for Alzheimer's disease. J Alzheimers Dis. 2011; 23(1):61-77.J Alzheimers Dis2011-01-01T00:00:002011Neuroprotective and neurorescue effects of a novel polymeric nanoparticle formulation of curcumin (NanoCurc?) in the neuronal cell culture and animal model: implications for Alzheimer's disease.21159816Kent OA, Chivukula RR, Mullendore M, Wentzel EA, Feldmann G, Lee KH, Liu S, Leach SD, Maitra A, Mendell JTGenes & developmentRepression of the miR-143/145 cluster by oncogenic Ras initiates a tumor-promoting feed-forward pathway. Genes Dev. 2010 Dec 15; 24(24):2754-9.Genes Dev2010-12-15T00:00:002010Repression of the miR-143/145 cluster by oncogenic Ras initiates a tumor-promoting feed-forward pathway.21193839Lim KJ, Bisht S, Bar EE, Maitra A, Eberhart CGCancer biology & therapyA polymeric nanoparticle formulation of curcumin inhibits growth, clonogenicity and stem-like fraction in malignant brain tumors. Cancer Biol Ther. 2011 Mar 01; 11(5):464-73.Cancer Biol Ther2011-03-01T00:00:002011A polymeric nanoparticle formulation of curcumin inhibits growth, clonogenicity and stem-like fraction in malignant brain tumors.21403843Fendrich V, Schneider R, Maitra A, Jacobsen ID, Opfermann T, Bartsch DKNeoplasia (New York, N.Y.)Detection of precursor lesions of pancreatic adenocarcinoma in PET-CT in a genetically engineered mouse model of pancreatic cancer. Neoplasia. 2011 Feb; 13(2):180-6.Neoplasia2011-02-01T00:00:002011Detection of precursor lesions of pancreatic adenocarcinoma in PET-CT in a genetically engineered mouse model of pancreatic cancer.21498712Chiu SS, Lui E, Majeed M, Vishwanatha JK, Ranjan AP, Maitra A, Pramanik D, Smith JA, Helson LAnticancer researchDifferential distribution of intravenous curcumin formulations in the rat brain. Anticancer Res. 2011 Mar; 31(3):907-11.Anticancer Res2011-03-01T00:00:002011Differential distribution of intravenous curcumin formulations in the rat brain.21537863Matthaei H, Hong SM, Mayo SC, dal Molin M, Olino K, Venkat R, Goggins M, Herman JM, Edil BH, Wolfgang CL, Cameron JL, Schulick RD, Maitra A, Hruban RHAnnals of surgical oncologyPresence of pancreatic intraepithelial neoplasia in the pancreatic transection margin does not influence outcome in patients with R0 resected pancreatic cancer. Ann Surg Oncol. 2011 Nov; 18(12):3493-9.Ann Surg Oncol2011-05-03T00:00:002011Presence of pancreatic intraepithelial neoplasia in the pancreatic transection margin does not influence outcome in patients with R0 resected pancreatic cancer.21691262Bisht S, Khan MA, Bekhit M, Bai H, Cornish T, Mizuma M, Rudek MA, Zhao M, Maitra A, Ray B, Lahiri D, Maitra A, Anders RALaboratory investigation; a journal of technical methods and pathologyA polymeric nanoparticle formulation of curcumin (NanoCurc?) ameliorates CCl4-induced hepatic injury and fibrosis through reduction of pro-inflammatory cytokines and stellate cell activation. Lab Invest. 2011 Sep; 91(9):1383-95.Lab Invest2011-06-20T00:00:002011A polymeric nanoparticle formulation of curcumin (NanoCurc?) ameliorates CCl4-induced hepatic injury and fibrosis through reduction of pro-inflammatory cytokines and stellate cell activation.21860420Caldwell ME, DeNicola GM, Martins CP, Jacobetz MA, Maitra A, Hruban RH, Tuveson DAOncogeneCellular features of senescence during the evolution of human and murine ductal pancreatic cancer. Oncogene. 2012 Mar 22; 31(12):1599-608.Oncogene2011-08-22T00:00:002011Cellular features of senescence during the evolution of human and murine ductal pancreatic cancer.22027695Chenna V, Hu C, Pramanik D, Aftab BT, Karikari C, Campbell NR, Hong SM, Zhao M, Rudek MA, Khan SR, Rudin CM, Maitra AMolecular cancer therapeuticsA polymeric nanoparticle encapsulated small-molecule inhibitor of Hedgehog signaling (NanoHHI) bypasses secondary mutational resistance to Smoothened antagonists. Mol Cancer Ther. 2012 Jan; 11(1):165-73.Mol Cancer Ther2011-10-25T00:00:002011A polymeric nanoparticle encapsulated small-molecule inhibitor of Hedgehog signaling (NanoHHI) bypasses secondary mutational resistance to Smoothened antagonists.22028618Fendrich V, Oh E, Bang S, Karikari C, Ottenhof N, Bisht S, Lauth M, Brossart P, Katsanis N, Maitra A, Feldmann GNeoplasia (New York, N.Y.)Ectopic overexpression of Sonic Hedgehog (Shh) induces stromal expansion and metaplasia in the adult murine pancreas. Neoplasia. 2011 Oct; 13(10):923-30.Neoplasia2011-10-01T00:00:002011Ectopic overexpression of Sonic Hedgehog (Shh) induces stromal expansion and metaplasia in the adult murine pancreas.22306154Lee KH, Galloway JF, Park J, Dvoracek CM, Dallas M, Konstantopoulos K, Maitra A, Searson PCNanomedicine : nanotechnology, biology, and medicineQuantitative molecular profiling of biomarkers for pancreatic cancer with functionalized quantum dots. Nanomedicine. 2012 Oct; 8(7):1043-51.Nanomedicine2012-02-01T00:00:002012Quantitative molecular profiling of biomarkers for pancreatic cancer with functionalized quantum dots.22310917de Wilde RF, Edil BH, Hruban RH, Maitra ANature reviews. Gastroenterology & hepatologyWell-differentiated pancreatic neuroendocrine tumors: from genetics to therapy. Nat Rev Gastroenterol Hepatol. 2012 Feb 07; 9(4):199-208.Nat Rev Gastroenterol Hepatol2012-02-07T00:00:002012Well-differentiated pancreatic neuroendocrine tumors: from genetics to therapy.22363658Zhang G, Schetter A, He P, Funamizu N, Gaedcke J, Ghadimi BM, Ried T, Hassan R, Yfantis HG, Lee DH, Lacy C, Maitra A, Hanna N, Alexander HR, Hussain SPPloS oneDPEP1 inhibits tumor cell invasiveness, enhances chemosensitivity and predicts clinical outcome in pancreatic ductal adenocarcinoma. PLoS One. 2012; 7(2):e31507.PLoS One2012-02-20T00:00:002012DPEP1 inhibits tumor cell invasiveness, enhances chemosensitivity and predicts clinical outcome in pancreatic ductal adenocarcinoma.22575867de Wilde RF, Heaphy CM, Maitra A, Meeker AK, Edil BH, Wolfgang CL, Ellison TA, Schulick RD, Molenaar IQ, Valk GD, Vriens MR, Borel Rinkes IH, Offerhaus GJ, Hruban RH, Matsukuma KEModern pathology : an official journal of the United States and Canadian Academy of Pathology, IncLoss of ATRX or DAXX expression and concomitant acquisition of the alternative lengthening of telomeres phenotype are late events in a small subset of MEN-1 syndrome pancreatic neuroendocrine tumors. Mod Pathol. 2012 Jul; 25(7):1033-9.Mod Pathol2012-05-11T00:00:002012Loss of ATRX or DAXX expression and concomitant acquisition of the alternative lengthening of telomeres phenotype are late events in a small subset of MEN-1 syndrome pancreatic neuroendocrine tumors.22785131Yamanaka S, Campbell NR, An F, Kuo SC, Potter JJ, Mezey E, Maitra A, Selaru FMCell cycle (Georgetown, Tex.)Coordinated effects of microRNA-494 induce G2/M arrest in human cholangiocarcinoma. Cell Cycle. 2012 Jul 15; 11(14):2729-38.Cell Cycle2012-07-15T00:00:002012Coordinated effects of microRNA-494 induce G2/M arrest in human cholangiocarcinoma.22896694Penchev VR, Rasheed ZA, Maitra A, Matsui WClinical cancer research : an official journal of the American Association for Cancer ResearchHeterogeneity and targeting of pancreatic cancer stem cells. Clin Cancer Res. 2012 Aug 15; 18(16):4277-84.Clin Cancer Res2012-08-15T00:00:002012Heterogeneity and targeting of pancreatic cancer stem cells.22985314Kim MS, Kuppireddy SV, Sakamuri S, Singal M, Getnet D, Harsha HC, Goel R, Balakrishnan L, Jacob HK, Kashyap MK, Tankala SG, Maitra A, Iacobuzio-Donahue CA, Jaffee E, Goggins MG, Velculescu VE, Hruban RH, Pandey AJournal of proteome researchRapid characterization of candidate biomarkers for pancreatic cancer using cell microarrays (CMAs). J Proteome Res. 2012 Nov 02; 11(11):5556-63.J Proteome Res2012-10-11T00:00:002012Rapid characterization of candidate biomarkers for pancreatic cancer using cell microarrays (CMAs).23084584O'Neal RL, Nam KT, LaFleur BJ, Barlow B, Nozaki K, Lee HJ, Kim WH, Yang HK, Shi C, Maitra A, Montgomery E, Washington MK, El Rifai W, Drapkin RI, Goldenring JRHuman pathologyHuman epididymis protein 4 is up-regulated in gastric and pancreatic adenocarcinomas. Hum Pathol. 2013 May; 44(5):734-42.Hum Pathol2012-10-16T00:00:002012Human epididymis protein 4 is up-regulated in gastric and pancreatic adenocarcinomas.23318448Streppel MM, Lata S, DelaBastide M, Montgomery EA, Wang JS, Canto MI, Macgregor-Das AM, Pai S, Morsink FH, Offerhaus GJ, Antoniou E, Maitra A, McCombie WROncogeneNext-generation sequencing of endoscopic biopsies identifies ARID1A as a tumor-suppressor gene in Barrett's esophagus. Oncogene. 2014 Jan 16; 33(3):347-57.Oncogene2013-01-14T00:00:002013Next-generation sequencing of endoscopic biopsies identifies ARID1A as a tumor-suppressor gene in Barrett's esophagus.23359146Matthaei H, Dal Molin M, Maitra AMethods in molecular biology (Clifton, N.J.)Identification and analysis of precursors to invasive pancreatic cancer. Methods Mol Biol. 2013; 980:1-12.Methods Mol Biol2013-01-01T00:00:002013Identification and analysis of precursors to invasive pancreatic cancer.23475875Yegnasubramanian S, Maitra ACancer discoveryAiming for the outliers: cancer precision medicine through targeting kinases with extreme expression. Cancer Discov. 2013 Mar; 3(3):252-4.Cancer Discov2013-03-01T00:00:002013Aiming for the outliers: cancer precision medicine through targeting kinases with extreme expression.23534919Zou P, Helson L, Maitra A, Stern ST, McNeil SEMolecular pharmaceuticsPolymeric curcumin nanoparticle pharmacokinetics and metabolism in bile duct cannulated rats. Mol Pharm. 2013 May 06; 10(5):1977-87.Mol Pharm2013-04-22T00:00:002013Polymeric curcumin nanoparticle pharmacokinetics and metabolism in bile duct cannulated rats.23757351Streppel MM, Pai S, Campbell NR, Hu C, Yabuuchi S, Canto MI, Wang JS, Montgomery EA, Maitra AClinical cancer research : an official journal of the American Association for Cancer ResearchMicroRNA 223 is upregulated in the multistep progression of Barrett's esophagus and modulates sensitivity to chemotherapy by targeting PARP1. Clin Cancer Res. 2013 Aug 01; 19(15):4067-78.Clin Cancer Res2013-06-11T00:00:002013MicroRNA 223 is upregulated in the multistep progression of Barrett's esophagus and modulates sensitivity to chemotherapy by targeting PARP1.23762417Wild AT, Gandhi N, Chettiar ST, Aziz K, Gajula RP, Williams RD, Kumar R, Taparra K, Zeng J, Cades JA, Velarde E, Menon S, Geschwind JF, Cosgrove D, Pawlik TM, Maitra A, Wong J, Hales RK, Torbenson MS, Herman JM, Tran PTPloS oneConcurrent versus sequential sorafenib therapy in combination with radiation for hepatocellular carcinoma. PLoS One. 2013; 8(6):e65726.PLoS One2013-06-06T00:00:002013Concurrent versus sequential sorafenib therapy in combination with radiation for hepatocellular carcinoma.24152959Liddle RA, Freeman M, Simeone DM, Saluja AK, Castillo CF, Maitra A, Pandol SJ, Go VLPancreasMinutes of the business meeting of the American Pancreatic Association, Friday, November 2, 2012, Miami, Florida. Pancreas. 2013 Nov; 42(8):1333-4.Pancreas2013-11-01T00:00:002013Minutes of the business meeting of the American Pancreatic Association, Friday, November 2, 2012, Miami, Florida.24293293Jiao Y, Yonescu R, Offerhaus GJ, Klimstra DS, Maitra A, Eshleman JR, Herman JG, Poh W, Pelosof L, Wolfgang CL, Vogelstein B, Kinzler KW, Hruban RH, Papadopoulos N, Wood LDThe Journal of pathologyWhole-exome sequencing of pancreatic neoplasms with acinar differentiation. J Pathol. 2014 Mar; 232(4):428-35.J Pathol2014-03-01T00:00:002014Whole-exome sequencing of pancreatic neoplasms with acinar differentiation.24870542Kim MS, Pinto SM, Getnet D, Nirujogi RS, Manda SS, Chaerkady R, Madugundu AK, Kelkar DS, Isserlin R, Jain S, Thomas JK, Muthusamy B, Leal-Rojas P, Kumar P, Sahasrabuddhe NA, Balakrishnan L, Advani J, George B, Renuse S, Selvan LD, Patil AH, Nanjappa V, Radhakrishnan A, Prasad S, Subbannayya T, Raju R, Kumar M, Sreenivasamurthy SK, Marimuthu A, Sathe GJ, Chavan S, Datta KK, Subbannayya Y, Sahu A, Yelamanchi SD, Jayaram S, Rajagopalan P, Sharma J, Murthy KR, Syed N, Goel R, Khan AA, Ahmad S, Dey G, Mudgal K, Chatterjee A, Huang TC, Zhong J, Wu X, Shaw PG, Freed D, Zahari MS, Mukherjee KK, Shankar S, Mahadevan A, Lam H, Mitchell CJ, Shankar SK, Satishchandra P, Schroeder JT, Sirdeshmukh R, Maitra A, Leach SD, Drake CG, Halushka MK, Prasad TS, Hruban RH, Kerr CL, Bader GD, Iacobuzio-Donahue CA, Gowda H, Pandey ANatureA draft map of the human proteome. Nature. 2014 May 29; 509(7502):575-81.Nature2014-05-29T00:00:002014A draft map of the human proteome.Authorship 2641271Authorship 2646341Authorship 2652233Authorship 2652468Authorship 2653145Authorship 2657992Authorship 2659912Authorship 2661002Authorship 2661121Authorship 2661142Authorship 2662386Authorship 26624811Authorship 2666834Authorship 2671981Authorship 2673244Authorship 2674415Authorship 2675504Authorship 2676444Authorship 2676899Authorship 26795517Authorship 2679902Authorship 2685003Authorship 2687189Authorship 2687806Authorship 26878111Authorship 2688372Authorship 2688399Authorship 26884410Authorship 2693075Authorship 26966014Authorship 2699242Authorship 27005815Authorship 2701002Authorship 27040110Authorship 2706807Authorship 27068814Authorship 2710919Authorship 27109313Authorship 27143510Authorship 27176513Authorship 27222899724348Maitra A, Weinberg AGPediatric and developmental pathology : the official journal of the Society for Pediatric Pathology and the Paediatric Pathology SocietyInclusions in lymphoblasts. Pediatr Dev Pathol. 1998 Nov-Dec; 1(6):573.Pediatr Dev Pathol1998-11-01T00:00:001998Inclusions in lymphoblasts.10479494Maitra A, Wistuba II, Gibbons D, Gazdar AF, Albores-Saavedra JGynecologic oncologyAllelic losses at chromosome 3p are seen in human papilloma virus 16 associated transitional cell carcinoma of the cervix. Gynecol Oncol. 1999 Sep; 74(3):361-8.Gynecol Oncol1999-09-01T00:00:001999Allelic losses at chromosome 3p are seen in human papilloma virus 16 associated transitional cell carcinoma of the cervix.11045784Behrens C, Travis LB, Wistuba II, Davis S, Maitra A, Clarke EA, Lynch CF, Glimelius B, Wiklund T, Tarone R, Gazdar AFCancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive OncologyMolecular changes in second primary lung and breast cancers after therapy for Hodgkin's disease. Cancer Epidemiol Biomarkers Prev. 2000 Oct; 9(10):1027-35.Cancer Epidemiol Biomarkers Prev2000-10-01T00:00:002000Molecular changes in second primary lung and breast cancers after therapy for Hodgkin's disease.11486176Hoang MP, Maitra A, Gazdar AF, Albores-Saavedra JHuman pathologyPrimary mammary small-cell carcinoma: a molecular analysis of 2 cases. Hum Pathol. 2001 Jul; 32(7):753-7.Hum Pathol2001-07-01T00:00:002001Primary mammary small-cell carcinoma: a molecular analysis of 2 cases.12839967Sato N, Fukushima N, Maitra A, Matsubayashi H, Yeo CJ, Cameron JL, Hruban RH, Goggins MCancer researchDiscovery of novel targets for aberrant methylation in pancreatic carcinoma using high-throughput microarrays. Cancer Res. 2003 Jul 01; 63(13):3735-42.Cancer Res2003-07-01T00:00:002003Discovery of novel targets for aberrant methylation in pancreatic carcinoma using high-throughput microarrays.12861060Hansel DE, Rahman A, Hermans J, de Krijger RR, Ashfaq R, Yeo CJ, Cameron JL, Maitra AModern pathology : an official journal of the United States and Canadian Academy of Pathology, IncLiver metastases arising from well-differentiated pancreatic endocrine neoplasms demonstrate increased VEGF-C expression. Mod Pathol. 2003 Jul; 16(7):652-9.Mod Pathol2003-07-01T00:00:002003Liver metastases arising from well-differentiated pancreatic endocrine neoplasms demonstrate increased VEGF-C expression.14576479Torbenson M, Wang J, Abraham S, Maitra A, Boitnott JThe American journal of surgical pathologyBile ducts and ductules are positive for CD56 (N-CAM) in most cases of extrahepatic biliary atresia. Am J Surg Pathol. 2003 Nov; 27(11):1454-7.Am J Surg Pathol2003-11-01T00:00:002003Bile ducts and ductules are positive for CD56 (N-CAM) in most cases of extrahepatic biliary atresia.15136764Van Heek NT, Maitra A, Koopmann J, Fedarko N, Jain A, Rahman A, Iacobuzio-Donahue CA, Adsay V, Ashfaq R, Yeo CJ, Cameron JL, Offerhaus JA, Hruban RH, Berg KD, Goggins MCancer biology & therapyGene expression profiling identifies markers of ampullary adenocarcinoma. Cancer Biol Ther. 2004 Jul; 3(7):651-6.Cancer Biol Ther2004-07-09T00:00:002004Gene expression profiling identifies markers of ampullary adenocarcinoma.15361885Karhadkar SS, Bova GS, Abdallah N, Dhara S, Gardner D, Maitra A, Isaacs JT, Berman DM, Beachy PANatureHedgehog signalling in prostate regeneration, neoplasia and metastasis. Nature. 2004 Oct 07; 431(7009):707-12.Nature2004-09-12T00:00:002004Hedgehog signalling in prostate regeneration, neoplasia and metastasis.15378479Koopmann J, Thuluvath PJ, Zahurak ML, Kristiansen TZ, Pandey A, Schulick R, Argani P, Hidalgo M, Iacobelli S, Goggins M, Maitra ACancerMac-2-binding protein is a diagnostic marker for biliary tract carcinoma. Cancer. 2004 Oct 01; 101(7):1609-15.Cancer2004-10-01T00:00:002004Mac-2-binding protein is a diagnostic marker for biliary tract carcinoma.15578441Henke RT, Maitra A, Paik S, Wellstein AHistology and histopathologyGene expression analysis in sections and tissue microarrays of archival tissues by mRNA in situ hybridization. Histol Histopathol. 2005 01; 20(1):225-37.Histol Histopathol2005-01-01T00:00:002005Gene expression analysis in sections and tissue microarrays of archival tissues by mRNA in situ hybridization.15731576Maitra A, Fukushima N, Takaori K, Hruban RHAdvances in anatomic pathologyPrecursors to invasive pancreatic cancer. Adv Anat Pathol. 2005 Mar; 12(2):81-91.Adv Anat Pathol2005-03-01T00:00:002005Precursors to invasive pancreatic cancer.15774774Hansel DE, Maitra A, Lin JW, Goggins M, Argani P, Yeo CJ, Piantadosi S, Leach SD, Biankin AVJournal of clinical oncology : official journal of the American Society of Clinical OncologyExpression of the caudal-type homeodomain transcription factors CDX 1/2 and outcome in carcinomas of the ampulla of Vater. J Clin Oncol. 2005 Mar 20; 23(9):1811-8.J Clin Oncol2005-03-20T00:00:002005Expression of the caudal-type homeodomain transcription factors CDX 1/2 and outcome in carcinomas of the ampulla of Vater.16142235Maitra A, Arking DE, Shivapurkar N, Ikeda M, Stastny V, Kassauei K, Sui G, Cutler DJ, Liu Y, Brimble SN, Noaksson K, Hyllner J, Schulz TC, Zeng X, Freed WJ, Crook J, Abraham S, Colman A, Sartipy P, Matsui S, Carpenter M, Gazdar AF, Rao M, Chakravarti ANature geneticsGenomic alterations in cultured human embryonic stem cells. Nat Genet. 2005 Oct; 37(10):1099-103.Nat Genet2005-09-04T00:00:002005Genomic alterations in cultured human embryonic stem cells.16227634Cao D, Wilentz RE, Abbruzzese JL, Ho L, Maitra AInternational journal of gastrointestinal cancerAberrant expression of maspin in idiopathic inflammatory bowel disease is associated with disease activity and neoplastic transformation. Int J Gastrointest Cancer. 2005; 36(1):39-46.Int J Gastrointest Cancer2005-01-01T00:00:002005Aberrant expression of maspin in idiopathic inflammatory bowel disease is associated with disease activity and neoplastic transformation.16822088Rakheja D, Maitra A, Kapur P, Weinberg AGPediatric and developmental pathology : the official journal of the Society for Pediatric Pathology and the Paediatric Pathology SocietyExtrahepatic biliary atresia demonstrates abnormal persistence of HES1 protein in neonatal biliary epithelium: an immunohistochemical study. Pediatr Dev Pathol. 2006 Mar-Apr; 9(2):98-102.Pediatr Dev Pathol2006-06-16T00:00:002006Extrahepatic biliary atresia demonstrates abnormal persistence of HES1 protein in neonatal biliary epithelium: an immunohistochemical study.17288490Yong KT, Qian J, Roy I, Lee HH, Bergey EJ, Tramposch KM, He S, Swihart MT, Maitra A, Prasad PNNano lettersQuantum rod bioconjugates as targeted probes for confocal and two-photon fluorescence imaging of cancer cells. Nano Lett. 2007 Mar; 7(3):761-5.Nano Lett2007-02-09T00:00:002007Quantum rod bioconjugates as targeted probes for confocal and two-photon fluorescence imaging of cancer cells.17445507Foss CA, Fox JJ, Feldmann G, Maitra A, Iacobuzio-Donohue C, Kern SE, Hruban R, Pomper MGMolecular imagingRadiolabeled anti-claudin 4 and anti-prostate stem cell antigen: initial imaging in experimental models of pancreatic cancer. Mol Imaging. 2007 Mar-Apr; 6(2):131-9.Mol Imaging2007-03-01T00:00:002007Radiolabeled anti-claudin 4 and anti-prostate stem cell antigen: initial imaging in experimental models of pancreatic cancer.17520196Feldmann G, Beaty R, Hruban RH, Maitra AJournal of hepato-biliary-pancreatic surgeryMolecular genetics of pancreatic intraepithelial neoplasia. J Hepatobiliary Pancreat Surg. 2007; 14(3):224-32.J Hepatobiliary Pancreat Surg2007-05-29T00:00:002007Molecular genetics of pancreatic intraepithelial neoplasia.18283486Koorstra JB, Feldmann G, Habbe N, Maitra ALangenbeck's archives of surgeryMorphogenesis of pancreatic cancer: role of pancreatic intraepithelial neoplasia (PanINs). Langenbecks Arch Surg. 2008 Jul; 393(4):561-70.Langenbecks Arch Surg2008-02-19T00:00:002008Morphogenesis of pancreatic cancer: role of pancreatic intraepithelial neoplasia (PanINs).18535672Kwei KA, Bashyam MD, Kao J, Ratheesh R, Reddy EC, Kim YH, Montgomery K, Giacomini CP, Choi YL, Chatterjee S, Karikari CA, Salari K, Wang P, Hernandez-Boussard T, Swarnalata G, van de Rijn M, Maitra A, Pollack JRPLoS geneticsGenomic profiling identifies GATA6 as a candidate oncogene amplified in pancreatobiliary cancer. PLoS Genet. 2008 May 23; 4(5):e1000081.PLoS Genet2008-05-23T00:00:002008Genomic profiling identifies GATA6 as a candidate oncogene amplified in pancreatobiliary cancer.18645011Zou GM, Maitra AMolecular cancer therapeuticsSmall-molecule inhibitor of the AP endonuclease 1/REF-1 E3330 inhibits pancreatic cancer cell growth and migration. Mol Cancer Ther. 2008 Jul; 7(7):2012-21.Mol Cancer Ther2008-07-01T00:00:002008Small-molecule inhibitor of the AP endonuclease 1/REF-1 E3330 inhibits pancreatic cancer cell growth and migration.18813118Koorstra JB, Maitra A, Morsink FH, Drillenburg P, ten Kate FJ, Hruban RH, Offerhaus JAThe American journal of surgical pathologyUndifferentiated carcinoma with osteoclastic giant cells (UCOCGC) of the pancreas associated with the familial atypical multiple mole melanoma syndrome (FAMMM). Am J Surg Pathol. 2008 Dec; 32(12):1905-9.Am J Surg Pathol2008-12-01T00:00:002008Undifferentiated carcinoma with osteoclastic giant cells (UCOCGC) of the pancreas associated with the familial atypical multiple mole melanoma syndrome (FAMMM).18821783Harsha HC, Jimeno A, Molina H, Mihalas AB, Goggins MG, Hruban RH, Schulick RD, Kamath U, Maitra A, Hidalgo M, Pandey AJournal of proteome researchActivated epidermal growth factor receptor as a novel target in pancreatic cancer therapy. J Proteome Res. 2008 Nov; 7(11):4651-8.J Proteome Res2008-09-27T00:00:002008Activated epidermal growth factor receptor as a novel target in pancreatic cancer therapy.18834532Jakupciak JP, Maragh S, Markowitz ME, Greenberg AK, Hoque MO, Maitra A, Barker PE, Wagner PD, Rom WN, Srivastava S, Sidransky D, O'Connell CDBMC cancerPerformance of mitochondrial DNA mutations detecting early stage cancer. BMC Cancer. 2008 Oct 03; 8:285.BMC Cancer2008-10-03T00:00:002008Performance of mitochondrial DNA mutations detecting early stage cancer.18836286Chen S, Auletta T, Dovirak O, Hutter C, Kuntz K, El-ftesi S, Kendall J, Han H, Von Hoff DD, Ashfaq R, Maitra A, Iacobuzio-Donahue CA, Hruban RH, Lucito RCancer biology & therapyCopy number alterations in pancreatic cancer identify recurrent PAK4 amplification. Cancer Biol Ther. 2008 Nov; 7(11):1793-802.Cancer Biol Ther2008-11-21T00:00:002008Copy number alterations in pancreatic cancer identify recurrent PAK4 amplification.18849643Cheung W, Darfler MM, Alvarez H, Hood BL, Conrads TP, Habbe N, Krizman DB, Mollenhauer J, Feldmann G, Maitra APancreatology : official journal of the International Association of Pancreatology (IAP) ... [et al.]Application of a global proteomic approach to archival precursor lesions: deleted in malignant brain tumors 1 and tissue transglutaminase 2 are upregulated in pancreatic cancer precursors. Pancreatology. 2008; 8(6):608-16.Pancreatology2008-10-13T00:00:002008Application of a global proteomic approach to archival precursor lesions: deleted in malignant brain tumors 1 and tissue transglutaminase 2 are upregulated in pancreatic cancer precursors.19210111Anders RA, Montgomery E, Maitra AExpert review of gastroenterology & hepatologyJohns Hopkins course: 8th annual Current Topics in Gastrointestinal and Liver Pathology. Expert Rev Gastroenterol Hepatol. 2009 Feb; 3(1):33-7.Expert Rev Gastroenterol Hepatol2009-02-01T00:00:002009Johns Hopkins course: 8th annual Current Topics in Gastrointestinal and Liver Pathology.19258443Mullendore ME, Koorstra JB, Li YM, Offerhaus GJ, Fan X, Henderson CM, Matsui W, Eberhart CG, Maitra A, Feldmann GClinical cancer research : an official journal of the American Association for Cancer ResearchLigand-dependent Notch signaling is involved in tumor initiation and tumor maintenance in pancreatic cancer. Clin Cancer Res. 2009 Apr 01; 15(7):2291-301.Clin Cancer Res2009-03-03T00:00:002009Ligand-dependent Notch signaling is involved in tumor initiation and tumor maintenance in pancreatic cancer.20804964Ishizawa K, Rasheed ZA, Karisch R, Wang Q, Kowalski J, Susky E, Pereira K, Karamboulas C, Moghal N, Rajeshkumar NV, Hidalgo M, Tsao M, Ailles L, Waddell TK, Maitra A, Neel BG, Matsui WCell stem cellTumor-initiating cells are rare in many human tumors. Cell Stem Cell. 2010 Sep 03; 7(3):279-82.Cell Stem Cell2010-09-03T00:00:002010Tumor-initiating cells are rare in many human tumors.21297446Park JY, Hong SM, Klimstra DS, Goggins MG, Maitra A, Hruban RHApplied immunohistochemistry & molecular morphology : AIMMPdx1 expression in pancreatic precursor lesions and neoplasms. Appl Immunohistochem Mol Morphol. 2011 Oct; 19(5):444-9.Appl Immunohistochem Mol Morphol2011-10-01T00:00:002011Pdx1 expression in pancreatic precursor lesions and neoplasms.21455033Feldmann G, Karikari C, dal Molin M, Duringer S, Volkmann P, Bartsch DK, Bisht S, Koorstra JB, Brossart P, Maitra A, Fendrich VCancer biology & therapyInactivation of Brca2 cooperates with Trp53(R172H) to induce invasive pancreatic ductal adenocarcinomas in mice: a mouse model of familial pancreatic cancer. Cancer Biol Ther. 2011 Jun 01; 11(11):959-68.Cancer Biol Ther2011-06-01T00:00:002011Inactivation of Brca2 cooperates with Trp53(R172H) to induce invasive pancreatic ductal adenocarcinomas in mice: a mouse model of familial pancreatic cancer.21572519Zheng L, Foley K, Huang L, Leubner A, Mo G, Olino K, Edil BH, Mizuma M, Sharma R, Le DT, Anders RA, Illei PB, Van Eyk JE, Maitra A, Laheru D, Jaffee EMPloS oneTyrosine 23 phosphorylation-dependent cell-surface localization of annexin A2 is required for invasion and metastases of pancreatic cancer. PLoS One. 2011 Apr 29; 6(4):e19390.PLoS One2011-04-29T00:00:002011Tyrosine 23 phosphorylation-dependent cell-surface localization of annexin A2 is required for invasion and metastases of pancreatic cancer.21750403Zhang YA, Maitra A, Hsieh JT, Rudin CM, Peacock CD, Karikari C, Brekken RA, Stastny V, Gao B, Girard L, Wistuba I, Frenkel E, Minna JD, Gazdar AFCancer biology & therapyFrequent detection of infectious xenotropic murine leukemia virus (XMLV) in human cultures established from mouse xenografts. Cancer Biol Ther. 2011 Oct 01; 12(7):617-28.Cancer Biol Ther2011-10-01T00:00:002011Frequent detection of infectious xenotropic murine leukemia virus (XMLV) in human cultures established from mouse xenografts.22785208Chen R, Pan S, Ottenhof NA, de Wilde RF, Wolfgang CL, Lane Z, Post J, Bronner MP, Willmann JK, Maitra A, Brentnall TACancer biology & therapyStromal galectin-1 expression is associated with long-term survival in resectable pancreatic ductal adenocarcinoma. Cancer Biol Ther. 2012 Aug; 13(10):899-907.Cancer Biol Ther2012-08-01T00:00:002012Stromal galectin-1 expression is associated with long-term survival in resectable pancreatic ductal adenocarcinoma.22791660Pramanik D, Campbell NR, Das S, Gupta S, Chenna V, Bisht S, Sysa-Shah P, Bedja D, Karikari C, Steenbergen C, Gabrielson KL, Maitra A, Maitra AOncotargetA composite polymer nanoparticle overcomes multidrug resistance and ameliorates doxorubicin-associated cardiomyopathy. Oncotarget. 2012 Jun; 3(6):640-50.Oncotarget2012-06-01T00:00:002012A composite polymer nanoparticle overcomes multidrug resistance and ameliorates doxorubicin-associated cardiomyopathy.22808291Agarwal A, Polineni R, Hussein Z, Vigoda I, Bhagat TD, Bhattacharyya S, Maitra A, Verma AInternational journal of clinical and experimental pathologyRole of epigenetic alterations in the pathogenesis of Barrett's esophagus and esophageal adenocarcinoma. Int J Clin Exp Pathol. 2012; 5(5):382-96.Int J Clin Exp Pathol2012-05-23T00:00:002012Role of epigenetic alterations in the pathogenesis of Barrett's esophagus and esophageal adenocarcinoma.22954004Matthaei H, Wu J, Dal Molin M, Debeljak M, Lingohr P, Katabi N, Klimstra DS, Adsay NV, Eshleman JR, Schulick RD, Kinzler KW, Vogelstein B, Hruban RH, Maitra AHPB : the official journal of the International Hepato Pancreato Biliary AssociationGNAS codon 201 mutations are uncommon in intraductal papillary neoplasms of the bile duct. HPB (Oxford). 2012 Oct; 14(10):677-83.HPB (Oxford)2012-06-18T00:00:002012GNAS codon 201 mutations are uncommon in intraductal papillary neoplasms of the bile duct.23402814Yabuuchi S, Pai SG, Campbell NR, de Wilde RF, De Oliveira E, Korangath P, Streppel MM, Rasheed ZA, Hidalgo M, Maitra A, Rajeshkumar NVCancer lettersNotch signaling pathway targeted therapy suppresses tumor progression and metastatic spread in pancreatic cancer. Cancer Lett. 2013 Jul 10; 335(1):41-51.Cancer Lett2013-02-10T00:00:002013Notch signaling pathway targeted therapy suppresses tumor progression and metastatic spread in pancreatic cancer.23861445Bhattacharyya S, Yu Y, Suzuki M, Campbell N, Mazdo J, Vasanthakumar A, Bhagat TD, Nischal S, Christopeit M, Parekh S, Steidl U, Godley L, Maitra A, Greally JM, Verma ANucleic acids researchGenome-wide hydroxymethylation tested using the HELP-GT assay shows redistribution in cancer. Nucleic Acids Res. 2013 Sep; 41(16):e157.Nucleic Acids Res2013-07-16T00:00:002013Genome-wide hydroxymethylation tested using the HELP-GT assay shows redistribution in cancer.24185509Jiao Y, Pawlik TM, Anders RA, Selaru FM, Streppel MM, Lucas DJ, Niknafs N, Guthrie VB, Maitra A, Argani P, Offerhaus GJA, Roa JC, Roberts LR, Gores GJ, Popescu I, Alexandrescu ST, Dima S, Fassan M, Simbolo M, Mafficini A, Capelli P, Lawlor RT, Ruzzenente A, Guglielmi A, Tortora G, de Braud F, Scarpa A, Jarnagin W, Klimstra D, Karchin R, Velculescu VE, Hruban RH, Vogelstein B, Kinzler KW, Papadopoulos N, Wood LDNature geneticsExome sequencing identifies frequent inactivating mutations in BAP1, ARID1A and PBRM1 in intrahepatic cholangiocarcinomas. Nat Genet. 2013 Dec; 45(12):1470-1473.Nat Genet2013-11-03T00:00:002013Exome sequencing identifies frequent inactivating mutations in BAP1, ARID1A and PBRM1 in intrahepatic cholangiocarcinomas.Authorship 2725474Authorship 2726527Authorship 2729621Authorship 27297512Authorship 2732586Authorship 27331412Authorship 2733564Authorship 2734919Authorship 2736821Authorship 2739108Authorship 2739929Authorship 2740305Authorship 27424411Authorship 27431610Authorship 2744888Authorship 27488413Authorship 2749067Authorship 2749273Authorship 2749597Authorship 2751742Authorship 2767481Authorship 2769461Authorship 2771142Authorship 2773571Authorship 277495810896331Maitra A, Ashfaq R, Saboorian MH, Lindberg G, Gokaslan STCancerThe role of fine-needle aspiration biopsy in the primary diagnosis of mesenchymal lesions: a community hospital-based experience. Cancer. 2000 Jun 25; 90(3):178-85.Cancer2000-06-25T00:00:002000The role of fine-needle aspiration biopsy in the primary diagnosis of mesenchymal lesions: a community hospital-based experience.11225009Maitra A, Gazdar AFCancer treatment and researchTissue microdissection and processing. Cancer Treat Res. 2001; 106:63-84.Cancer Treat Res2001-01-01T00:00:002001Tissue microdissection and processing.11505415Maitra A, Wanzer D, Weinberg AG, Ashfaq RCancerAmplification of the HER-2/neu oncogene is uncommon in pediatric osteosarcomas. Cancer. 2001 Aug 01; 92(3):677-83.Cancer2001-08-01T00:00:002001Amplification of the HER-2/neu oncogene is uncommon in pediatric osteosarcomas.11978893Maitra A, Domiati-Saad R, Yost N, Cunningham G, Rogers BB, Bennett MJPediatric researchAbsence of the G1528C (E474Q) mutation in the alpha-subunit of the mitochondrial trifunctional protein in women with acute fatty liver of pregnancy. Pediatr Res. 2002 May; 51(5):658-61.Pediatr Res2002-05-01T00:00:002002Absence of the G1528C (E474Q) mutation in the alpha-subunit of the mitochondrial trifunctional protein in women with acute fatty liver of pregnancy.12966350McCarthy DM, Maitra A, Argani P, Rader AE, Faigel DO, Van Heek NT, Hruban RH, Wilentz REApplied immunohistochemistry & molecular morphology : AIMMNovel markers of pancreatic adenocarcinoma in fine-needle aspiration: mesothelin and prostate stem cell antigen labeling increases accuracy in cytologically borderline cases. Appl Immunohistochem Mol Morphol. 2003 Sep; 11(3):238-43.Appl Immunohistochem Mol Morphol2003-09-01T00:00:002003Novel markers of pancreatic adenocarcinoma in fine-needle aspiration: mesothelin and prostate stem cell antigen labeling increases accuracy in cytologically borderline cases.15084671Kristiansen TZ, Bunkenborg J, Gronborg M, Molina H, Thuluvath PJ, Argani P, Goggins MG, Maitra A, Pandey AMolecular & cellular proteomics : MCPA proteomic analysis of human bile. Mol Cell Proteomics. 2004 Jul; 3(7):715-28.Mol Cell Proteomics2004-04-14T00:00:002004A proteomic analysis of human bile.15725809Hansel DE, Dhara S, Huang RC, Ashfaq R, Deasel M, Shimada Y, Bernstein HS, Harmon J, Brock M, Forastiere A, Washington MK, Maitra A, Montgomery EThe American journal of surgical pathologyCDC2/CDK1 expression in esophageal adenocarcinoma and precursor lesions serves as a diagnostic and cancer progression marker and potential novel drug target. Am J Surg Pathol. 2005 Mar; 29(3):390-9.Am J Surg Pathol2005-03-01T00:00:002005CDC2/CDK1 expression in esophageal adenocarcinoma and precursor lesions serves as a diagnostic and cancer progression marker and potential novel drug target.15862270Cunningham SC, Kamangar F, Kim MP, Hammoud S, Haque R, Maitra A, Montgomery E, Heitmiller RE, Choti MA, Lillemoe KD, Cameron JL, Yeo CJ, Schulick RDJournal of gastrointestinal surgery : official journal of the Society for Surgery of the Alimentary TractSurvival after gastric adenocarcinoma resection: eighteen-year experience at a single institution. J Gastrointest Surg. 2005 May-Jun; 9(5):718-25.J Gastrointest Surg2005-05-01T00:00:002005Survival after gastric adenocarcinoma resection: eighteen-year experience at a single institution.16424058Tassi E, Henke RT, Bowden ET, Swift MR, Kodack DP, Kuo AH, Maitra A, Wellstein ACancer researchExpression of a fibroblast growth factor-binding protein during the development of adenocarcinoma of the pancreas and colon. Cancer Res. 2006 Jan 15; 66(2):1191-8.Cancer Res2006-01-15T00:00:002006Expression of a fibroblast growth factor-binding protein during the development of adenocarcinoma of the pancreas and colon.16525203Tsuji K, Yang M, Jiang P, Maitra A, Kaushal S, Yamauchi K, Katz MH, Moossa AR, Hoffman RM, Bouvet MJOP : Journal of the pancreasCommon bile duct injection as a novel method for establishing red fluorescent protein (RFP)-expressing human pancreatic cancer in nude mice. JOP. 2006 Mar 09; 7(2):193-9.JOP2006-03-09T00:00:002006Common bile duct injection as a novel method for establishing red fluorescent protein (RFP)-expressing human pancreatic cancer in nude mice.16540726Montgomery E, Mamelak AJ, Gibson M, Maitra A, Sheikh S, Amr SS, Yang S, Brock M, Forastiere A, Zhang S, Murphy KM, Berg KDApplied immunohistochemistry & molecular morphology : AIMMOverexpression of claudin proteins in esophageal adenocarcinoma and its precursor lesions. Appl Immunohistochem Mol Morphol. 2006 Mar; 14(1):24-30.Appl Immunohistochem Mol Morphol2006-03-01T00:00:002006Overexpression of claudin proteins in esophageal adenocarcinoma and its precursor lesions.17320581Bonde P, Sui G, Dhara S, Wang J, Broor A, Kim IF, Wiley JE, Marti G, Duncan M, Jaffee E, Montgomery E, Maitra A, Harmon JWThe Journal of thoracic and cardiovascular surgeryCytogenetic characterization and gene expression profiling in the rat reflux-induced esophageal tumor model. J Thorac Cardiovasc Surg. 2007 Mar; 133(3):763-9.J Thorac Cardiovasc Surg2007-03-01T00:00:002007Cytogenetic characterization and gene expression profiling in the rat reflux-induced esophageal tumor model.17889654Dong J, Feldmann G, Huang J, Wu S, Zhang N, Comerford SA, Gayyed MF, Anders RA, Maitra A, Pan DCellElucidation of a universal size-control mechanism in Drosophila and mammals. Cell. 2007 Sep 21; 130(6):1120-33.Cell2007-09-21T00:00:002007Elucidation of a universal size-control mechanism in Drosophila and mammals.19668150Koorstra JB, Hong SM, Shi C, Meeker AK, Ryu JK, Offerhaus GJ, Goggins MG, Hruban RH, Maitra AModern pathology : an official journal of the United States and Canadian Academy of Pathology, IncWidespread activation of the DNA damage response in human pancreatic intraepithelial neoplasia. Mod Pathol. 2009 Nov; 22(11):1439-45.Mod Pathol2009-08-07T00:00:002009Widespread activation of the DNA damage response in human pancreatic intraepithelial neoplasia.20100446Maitra AGastroenterologyTracking down the hedgehog's lair in the pancreas. Gastroenterology. 2010 Mar; 138(3):823-5.Gastroenterology2010-01-25T00:00:002010Tracking down the hedgehog's lair in the pancreas.20160901Yong KT, Hu R, Roy I, Ding H, Vathy LA, Bergey EJ, Mizuma M, Maitra A, Prasad PNACS applied materials & interfacesTumor targeting and imaging in live animals with functionalized semiconductor quantum rods. ACS Appl Mater Interfaces. 2009 Mar; 1(3):710-9.ACS Appl Mater Interfaces2009-03-01T00:00:002009Tumor targeting and imaging in live animals with functionalized semiconductor quantum rods.21135251Villarroel MC, Rajeshkumar NV, Garrido-Laguna I, De Jesus-Acosta A, Jones S, Maitra A, Hruban RH, Eshleman JR, Klein A, Laheru D, Donehower R, Hidalgo MMolecular cancer therapeuticsPersonalizing cancer treatment in the age of global genomic analyses: PALB2 gene mutations and the response to DNA damaging agents in pancreatic cancer. Mol Cancer Ther. 2011 Jan; 10(1):3-8.Mol Cancer Ther2010-12-06T00:00:002010Personalizing cancer treatment in the age of global genomic analyses: PALB2 gene mutations and the response to DNA damaging agents in pancreatic cancer.21757972Ryu JK, Matthaei H, Dal Molin M, Hong SM, Canto MI, Schulick RD, Wolfgang C, Goggins MG, Hruban RH, Cope L, Maitra APancreatology : official journal of the International Association of Pancreatology (IAP) ... [et al.]Elevated microRNA miR-21 levels in pancreatic cyst fluid are predictive of mucinous precursor lesions of ductal adenocarcinoma. Pancreatology. 2011; 11(3):343-50.Pancreatology2011-07-12T00:00:002011Elevated microRNA miR-21 levels in pancreatic cyst fluid are predictive of mucinous precursor lesions of ductal adenocarcinoma.21868763Xu Y, Chenna V, Hu C, Sun HX, Khan M, Bai H, Yang XR, Zhu QF, Sun YF, Maitra A, Fan J, Anders RAClinical cancer research : an official journal of the American Association for Cancer ResearchPolymeric nanoparticle-encapsulated hedgehog pathway inhibitor HPI-1 (NanoHHI) inhibits systemic metastases in an orthotopic model of human hepatocellular carcinoma. Clin Cancer Res. 2012 Mar 01; 18(5):1291-302.Clin Cancer Res2011-08-25T00:00:002011Polymeric nanoparticle-encapsulated hedgehog pathway inhibitor HPI-1 (NanoHHI) inhibits systemic metastases in an orthotopic model of human hepatocellular carcinoma.21887346Kwei KA, Shain AH, Bair R, Montgomery K, Karikari CA, van de Rijn M, Hidalgo M, Maitra A, Bashyam MD, Pollack JRPloS oneSMURF1 amplification promotes invasiveness in pancreatic cancer. PLoS One. 2011; 6(8):e23924.PLoS One2011-08-22T00:00:002011SMURF1 amplification promotes invasiveness in pancreatic cancer.22699621P?rez-Mancera PA, Rust AG, van der Weyden L, Kristiansen G, Li A, Sarver AL, Silverstein KA, Gr?tzmann R, Aust D, R?mmele P, Kn?sel T, Herd C, Stemple DL, Kettleborough R, Brosnan JA, Li A, Morgan R, Knight S, Yu J, Stegeman S, Collier LS, ten Hoeve JJ, de Ridder J, Klein AP, Goggins M, Hruban RH, Chang DK, Biankin AV, Grimmond SM, Australian Pancreatic Cancer Genome Initiative, Wessels LF, Wood SA, Iacobuzio-Donahue CA, Pilarsky C, Largaespada DA, Adams DJ, Tuveson DANatureThe deubiquitinase USP9X suppresses pancreatic ductal adenocarcinoma. Nature. 2012 Apr 29; 486(7402):266-70.Nature2012-04-29T00:00:002012The deubiquitinase USP9X suppresses pancreatic ductal adenocarcinoma.22896695Le A, Rajeshkumar NV, Maitra A, Dang CVClinical cancer research : an official journal of the American Association for Cancer ResearchConceptual framework for cutting the pancreatic cancer fuel supply. Clin Cancer Res. 2012 Aug 15; 18(16):4285-90.Clin Cancer Res2012-08-15T00:00:002012Conceptual framework for cutting the pancreatic cancer fuel supply.23060061McDonald OG, Maitra A, Hruban RHAdvances in anatomic pathologyHuman correlates of provocative questions in pancreatic pathology. Adv Anat Pathol. 2012 Nov; 19(6):351-62.Adv Anat Pathol2012-11-01T00:00:002012Human correlates of provocative questions in pancreatic pathology.23094050Cardoso AA, Jiang Y, Luo M, Reed AM, Shahda S, He Y, Maitra A, Kelley MR, Fishel MLPloS oneAPE1/Ref-1 regulates STAT3 transcriptional activity and APE1/Ref-1-STAT3 dual-targeting effectively inhibits pancreatic cancer cell survival. PLoS One. 2012; 7(10):e47462.PLoS One2012-10-19T00:00:002012APE1/Ref-1 regulates STAT3 transcriptional activity and APE1/Ref-1-STAT3 dual-targeting effectively inhibits pancreatic cancer cell survival.23361300Khalaileh A, Dreazen A, Khatib A, Apel R, Swisa A, Kidess-Bassir N, Maitra A, Meyuhas O, Dor Y, Zamir GCancer researchPhosphorylation of ribosomal protein S6 attenuates DNA damage and tumor suppression during development of pancreatic cancer. Cancer Res. 2013 Mar 15; 73(6):1811-20.Cancer Res2013-01-29T00:00:002013Phosphorylation of ribosomal protein S6 attenuates DNA damage and tumor suppression during development of pancreatic cancer.Authorship 2816187Authorship 2825682Authorship 2830372Authorship 2847323Authorship 28611713Authorship 28622119Authorship 28766211Authorship 2883832Authorship 2890729Authorship 2891663Authorship 2894006Authorship 28940212Authorship 28979112Authorship 2901918Authorship 29235515Authorship 29263711Authorship 2927449Authorship 2928117Authorship 29298227Authorship 29353810Authorship 29376212Authorship 2943625Authorship 29540169Authorship 2970712Authorship 29715611Authorship 29858614Authorship 29946511Authorship 3004472Authorship 3009222Authorship 3009471Authorship 30187917Authorship 30245213Authorship 30266910Authorship 30289110Authorship 3029659Authorship 30326918Authorship 3035877Authorship 30447813Authorship 3048902Authorship 3051327Authorship 3052492Authorship 3053622Authorship 3059161922821831Funamizu N, Hu C, Lacy C, Schetter A, Zhang G, He P, Gaedcke J, Ghadimi MB, Ried T, Yfantis HG, Lee DH, Subleski J, Chan T, Weiss JM, Back TC, Yanaga K, Hanna N, Alexander HR, Maitra A, Hussain SPInternational journal of cancerMacrophage migration inhibitory factor induces epithelial to mesenchymal transition, enhances tumor aggressiveness and predicts clinical outcome in resected pancreatic ductal adenocarcinoma. Int J Cancer. 2013 Feb 15; 132(4):785-94.Int J Cancer2013-02-15T00:00:002013Macrophage migration inhibitory factor induces epithelial to mesenchymal transition, enhances tumor aggressiveness and predicts clinical outcome in resected pancreatic ductal adenocarcinoma.17439648Bisht S, Feldmann G, Soni S, Ravi R, Karikar C, Maitra A, Maitra AJournal of nanobiotechnologyPolymeric nanoparticle-encapsulated curcumin ("nanocurcumin"): a novel strategy for human cancer therapy. J Nanobiotechnology. 2007 Apr 17; 5:3.J Nanobiotechnology2007-04-17T00:00:002007Polymeric nanoparticle-encapsulated curcumin ("nanocurcumin"): a novel strategy for human cancer therapy.18787611Hruban RH, Maitra A, Goggins MInternational journal of clinical and experimental pathologyUpdate on pancreatic intraepithelial neoplasia. Int J Clin Exp Pathol. 2008 Jan 01; 1(4):306-16.Int J Clin Exp Pathol2008-01-01T00:00:002008Update on pancreatic intraepithelial neoplasia.19343140Hruban RH, Maitra A, Schulick R, Laheru D, Herman J, Kern SE, Goggins MGastrointestinal cancer research : GCREmerging molecular biology of pancreatic cancer. Gastrointest Cancer Res. 2008 Jul; 2(4 Suppl):S10-5.Gastrointest Cancer Res2008-07-01T00:00:002008Emerging molecular biology of pancreatic cancer.21512581Ottenhof NA, de Wilde RF, Maitra A, Hruban RH, Offerhaus GJPathology research internationalMolecular characteristics of pancreatic ductal adenocarcinoma. Patholog Res Int. 2011 Mar 27; 2011:620601.Patholog Res Int2011-03-27T00:00:002011Molecular characteristics of pancreatic ductal adenocarcinoma.22696140Matthaei H, Hong SM, Mayo SC, Dal Molin M, Olino K, Venkat R, Goggins M, Herman JM, Edil BH, Wolfgang CL, Cameron JL, Schulick RD, Maitra A, Hruban RHIndian journal of surgical oncologyPresence of pancreatic intraepithelial neoplasia in the pancreatic transection margin does not influence outcome in patients with R0 resected pancreatic cancer. Indian J Surg Oncol. 2011 Mar; 2(1):9-15.Indian J Surg Oncol2011-06-30T00:00:002011Presence of pancreatic intraepithelial neoplasia in the pancreatic transection margin does not influence outcome in patients with R0 resected pancreatic cancer.24096005Bailey JM, Alsina J, Rasheed ZA, McAllister FM, Fu YY, Plentz R, Zhang H, Pasricha PJ, Bardeesy N, Matsui W, Maitra A, Leach SDGastroenterologyDCLK1 marks a morphologically distinct subpopulation of cells with stem cell properties in preinvasive pancreatic cancer. Gastroenterology. 2014 Jan; 146(1):245-56.Gastroenterology2013-10-02T00:00:002013DCLK1 marks a morphologically distinct subpopulation of cells with stem cell properties in preinvasive pancreatic cancer.24445769Cowan RW, Maitra ACancer journal (Sudbury, Mass.)Genetic progression of pancreatic cancer. Cancer J. 2014 Jan-Feb; 20(1):80-4.Cancer J2014-01-01T00:00:002014Genetic progression of pancreatic cancer.24607009Rodic N, Sharma R, Sharma R, Zampella J, Dai L, Taylor MS, Hruban RH, Iacobuzio-Donahue CA, Maitra A, Torbenson MS, Goggins M, Shih IeM, Duffield AS, Montgomery EA, Gabrielson E, Netto GJ, Lotan TL, De Marzo AM, Westra W, Binder ZA, Orr BA, Gallia GL, Eberhart CG, Boeke JD, Harris CR, Burns KHThe American journal of pathologyLong interspersed element-1 protein expression is a hallmark of many human cancers. Am J Pathol. 2014 May; 184(5):1280-6.Am J Pathol2014-03-06T00:00:002014Long interspersed element-1 protein expression is a hallmark of many human cancers.24668033De Jesus-Acosta A, Laheru D, Maitra A, Arcaroli J, Rudek MA, Dasari A, Blatchford PJ, Quackenbush K, Messersmith WInvestigational new drugsA phase II study of the gamma secretase inhibitor RO4929097 in patients with previously treated metastatic pancreatic adenocarcinoma. Invest New Drugs. 2014 Aug; 32(4):739-45.Invest New Drugs2014-03-27T00:00:002014A phase II study of the gamma secretase inhibitor RO4929097 in patients with previously treated metastatic pancreatic adenocarcinoma.24810628Das S, Bedja D, Campbell N, Dunkerly B, Chenna V, Maitra A, Steenbergen CPloS onemiR-181c regulates the mitochondrial genome, bioenergetics, and propensity for heart failure in vivo. PLoS One. 2014; 9(5):e96820.PLoS One2014-05-08T00:00:002014miR-181c regulates the mitochondrial genome, bioenergetics, and propensity for heart failure in vivo.24810906Vincent A, Hong SM, Hu C, Omura N, Young A, Kim H, Yu J, Knight S, Ayars M, Griffith M, Van Seuningen I, Maitra A, Goggins MOncotargetEpigenetic silencing of EYA2 in pancreatic adenocarcinomas promotes tumor growth. Oncotarget. 2014 May 15; 5(9):2575-87.Oncotarget2014-05-15T00:00:002014Epigenetic silencing of EYA2 in pancreatic adenocarcinomas promotes tumor growth.24875860Yang A, Rajeshkumar NV, Wang X, Yabuuchi S, Alexander BM, Chu GC, Von Hoff DD, Maitra A, Kimmelman ACCancer discoveryAutophagy is critical for pancreatic tumor growth and progression in tumors with p53 alterations. Cancer Discov. 2014 Aug; 4(8):905-13.Cancer Discov2014-05-29T00:00:002014Autophagy is critical for pancreatic tumor growth and progression in tumors with p53 alterations.24895378Kim MS, Zhong Y, Yachida S, Rajeshkumar NV, Abel ML, Marimuthu A, Mudgal K, Hruban RH, Poling JS, Tyner JW, Maitra A, Iacobuzio-Donahue CA, Pandey AMolecular & cellular proteomics : MCPHeterogeneity of pancreatic cancer metastases in a single patient revealed by quantitative proteomics. Mol Cell Proteomics. 2014 Nov; 13(11):2803-11.Mol Cell Proteomics2014-06-03T00:00:002014Heterogeneity of pancreatic cancer metastases in a single patient revealed by quantitative proteomics.25347153Chen R, Dawson DW, Pan S, Ottenhof NA, de Wilde RF, Wolfgang CL, May DH, Crispin DA, Lai LA, Lay AR, Waghray M, Wang S, McIntosh MW, Simeone DM, Maitra A, Brentnall TALaboratory investigation; a journal of technical methods and pathologyProteins associated with pancreatic cancer survival in patients with resectable pancreatic ductal adenocarcinoma. Lab Invest. 2015 Jan; 95(1):43-55.Lab Invest2014-10-27T00:00:002014Proteins associated with pancreatic cancer survival in patients with resectable pancreatic ductal adenocarcinoma.25370468Penet MF, Shah T, Bharti S, Krishnamachary B, Artemov D, Mironchik Y, Wildes F, Maitra A, Bhujwalla ZMClinical cancer research : an official journal of the American Association for Cancer ResearchMetabolic imaging of pancreatic ductal adenocarcinoma detects altered choline metabolism. Clin Cancer Res. 2015 Jan 15; 21(2):386-95.Clin Cancer Res2014-11-04T00:00:002014Metabolic imaging of pancreatic ductal adenocarcinoma detects altered choline metabolism.25427073Koay EJ, Baio FE, Ondari A, Truty MJ, Cristini V, Thomas RM, Chen R, Chatterjee D, Kang Y, Zhang J, Court L, Bhosale PR, Tamm EP, Qayyum A, Crane CH, Javle M, Katz MH, Gottumukkala VN, Rozner MA, Shen H, Lee JE, Wang H, Chen Y, Plunkett W, Abbruzzese JL, Wolff RA, Maitra A, Ferrari M, Varadhachary GR, Fleming JBPhysical biologyIntra-tumoral heterogeneity of gemcitabine delivery and mass transport in human pancreatic cancer. Phys Biol. 2014 Nov 26; 11(6):065002.Phys Biol2014-11-26T00:00:002014Intra-tumoral heterogeneity of gemcitabine delivery and mass transport in human pancreatic cancer.25492865Fishel ML, Wu X, Devlin CM, Logsdon DP, Jiang Y, Luo M, He Y, Yu Z, Tong Y, Lipking KP, Maitra A, Rajeshkumar NV, Scandura G, Kelley MR, Ivan MThe Journal of biological chemistryApurinic/apyrimidinic endonuclease/redox factor-1 (APE1/Ref-1) redox function negatively regulates NRF2. J Biol Chem. 2015 Jan 30; 290(5):3057-68.J Biol Chem2014-12-09T00:00:002014Apurinic/apyrimidinic endonuclease/redox factor-1 (APE1/Ref-1) redox function negatively regulates NRF2.25523391Hendley AM, Provost E, Bailey JM, Wang YJ, Cleveland MH, Blake D, Bittman RW, Roeser JC, Maitra A, Reynolds AB, Leach SDDevelopmental biologyp120 Catenin is required for normal tubulogenesis but not epithelial integrity in developing mouse pancreas. Dev Biol. 2015 Mar 01; 399(1):41-53.Dev Biol2014-12-16T00:00:002014p120 Catenin is required for normal tubulogenesis but not epithelial integrity in developing mouse pancreas.25561062Hexige S, Ardito-Abraham CM, Wu Y, Wei Y, Fang Y, Han X, Li J, Zhou P, Yi Q, Maitra A, Liu JO, Tuveson DA, Lou W, Yu LThe Journal of pathologyIdentification of novel vascular projections with cellular trafficking abilities on the microvasculature of pancreatic ductal adenocarcinoma. J Pathol. 2015 Jun; 236(2):142-154.J Pathol2015-02-17T00:00:002015Identification of novel vascular projections with cellular trafficking abilities on the microvasculature of pancreatic ductal adenocarcinoma.25623214Dal Molin M, Zhang M, de Wilde RF, Ottenhof NA, Rezaee N, Wolfgang CL, Blackford A, Vogelstein B, Kinzler KW, Papadopoulos N, Hruban RH, Maitra A, Wood LDClinical cancer research : an official journal of the American Association for Cancer ResearchVery Long-term Survival Following Resection for Pancreatic Cancer Is Not Explained by Commonly Mutated Genes: Results of Whole-Exome Sequencing Analysis. Clin Cancer Res. 2015 Apr 15; 21(8):1944-50.Clin Cancer Res2015-01-26T00:00:002015Very Long-term Survival Following Resection for Pancreatic Cancer Is Not Explained by Commonly Mutated Genes: Results of Whole-Exome Sequencing Analysis.25675155Bhutani M, Koduru P, Lanke G, Bruno M, Maitra A, Giovannini MMinerva gastroenterologica e dietologicaThe emerging role of endoscopic ultrasound-guided core biopsy for the evaluation of solid pancreatic masses. Minerva Gastroenterol Dietol. 2015 Jun; 61(2):51-9.Minerva Gastroenterol Dietol2015-06-01T00:00:002015The emerging role of endoscopic ultrasound-guided core biopsy for the evaluation of solid pancreatic masses.25719666Waddell N, Pajic M, Patch AM, Chang DK, Kassahn KS, Bailey P, Johns AL, Miller D, Nones K, Quek K, Quinn MC, Robertson AJ, Fadlullah MZ, Bruxner TJ, Christ AN, Harliwong I, Idrisoglu S, Manning S, Nourse C, Nourbakhsh E, Wani S, Wilson PJ, Markham E, Cloonan N, Anderson MJ, Fink JL, Holmes O, Kazakoff SH, Leonard C, Newell F, Poudel B, Song S, Taylor D, Waddell N, Wood S, Xu Q, Wu J, Pinese M, Cowley MJ, Lee HC, Jones MD, Nagrial AM, Humphris J, Chantrill LA, Chin V, Steinmann AM, Mawson A, Humphrey ES, Colvin EK, Chou A, Scarlett CJ, Pinho AV, Giry-Laterriere M, Rooman I, Samra JS, Kench JG, Pettitt JA, Merrett ND, Toon C, Epari K, Nguyen NQ, Barbour A, Zeps N, Jamieson NB, Graham JS, Niclou SP, Bjerkvig R, Gr?tzmann R, Aust D, Hruban RH, Maitra A, Iacobuzio-Donahue CA, Wolfgang CL, Morgan RA, Lawlor RT, Corbo V, Bassi C, Falconi M, Zamboni G, Tortora G, Tempero MA, Australian Pancreatic Cancer Genome Initiative, Gill AJ, Eshleman JR, Pilarsky C, Scarpa A, Musgrove EA, Pearson JV, Biankin AV, Grimmond SMNatureWhole genomes redefine the mutational landscape of pancreatic cancer. Nature. 2015 Feb 26; 518(7540):495-501.Nature2015-02-26T00:00:002015Whole genomes redefine the mutational landscape of pancreatic cancer.25931254Chari ST, Kelly K, Hollingsworth MA, Thayer SP, Ahlquist DA, Andersen DK, Batra SK, Brentnall TA, Canto M, Cleeter DF, Firpo MA, Gambhir SS, Go VL, Hines OJ, Kenner BJ, Klimstra DS, Lerch MM, Levy MJ, Maitra A, Mulvihill SJ, Petersen GM, Rhim AD, Simeone DM, Srivastava S, Tanaka M, Vinik AI, Wong DPancreasEarly detection of sporadic pancreatic cancer: summative review. Pancreas. 2015 Jul; 44(5):693-712.Pancreas2015-07-01T00:00:002015Early detection of sporadic pancreatic cancer: summative review.25931518Hu C, Dadon T, Chenna V, Yabuuchi S, Bannerji R, Booher R, Strack P, Azad N, Nelkin BD, Maitra AMolecular cancer therapeuticsCombined Inhibition of Cyclin-Dependent Kinases (Dinaciclib) and AKT (MK-2206) Blocks Pancreatic Tumor Growth and Metastases in Patient-Derived Xenograft Models. Mol Cancer Ther. 2015 Jul; 14(7):1532-9.Mol Cancer Ther2015-04-30T00:00:002015Combined Inhibition of Cyclin-Dependent Kinases (Dinaciclib) and AKT (MK-2206) Blocks Pancreatic Tumor Growth and Metastases in Patient-Derived Xenograft Models.25945396Fischer LK, Katz MH, Lee SM, Liu L, Wang H, Varadhachary GR, Wolff RA, Lee JE, Maitra A, Roland CL, Fleming JB, Estrella J, Rashid A, Wang HHistopathologyThe number and ratio of positive lymph nodes affect pancreatic cancer patient survival after neoadjuvant therapy and pancreaticoduodenectomy. Histopathology. 2016 Jan; 68(2):210-20.Histopathology2015-06-19T00:00:002015The number and ratio of positive lymph nodes affect pancreatic cancer patient survival after neoadjuvant therapy and pancreaticoduodenectomy.25989273Schueneman A, Goggins M, Ensor J, Saka B, Neishaboori N, Lee S, Maitra A, Varadhachary G, Rezaee N, Wolfgang C, Adsay V, Wang H, Overman MJBritish journal of cancerValidation of histomolecular classification utilizing histological subtype, MUC1, and CDX2 for prognostication of resected ampullary adenocarcinoma. Br J Cancer. 2015 Jun 30; 113(1):64-8.Br J Cancer2015-05-19T00:00:002015Validation of histomolecular classification utilizing histological subtype, MUC1, and CDX2 for prognostication of resected ampullary adenocarcinoma.25995340Wang H, Maitra A, Wang HClinical cancer research : an official journal of the American Association for Cancer ResearchObesity, Intrapancreatic Fatty Infiltration, and Pancreatic Cancer. Clin Cancer Res. 2015 Aug 01; 21(15):3369-71.Clin Cancer Res2015-05-20T00:00:002015Obesity, Intrapancreatic Fatty Infiltration, and Pancreatic Cancer.26025324Capello M, Lee M, Wang H, Babel I, Katz MH, Fleming JB, Maitra A, Wang H, Tian W, Taguchi A, Hanash SMJournal of the National Cancer InstituteCarboxylesterase 2 as a Determinant of Response to Irinotecan and Neoadjuvant FOLFIRINOX Therapy in Pancreatic Ductal Adenocarcinoma. J Natl Cancer Inst. 2015 Aug; 107(8).J Natl Cancer Inst2015-05-29T00:00:002015Carboxylesterase 2 as a Determinant of Response to Irinotecan and Neoadjuvant FOLFIRINOX Therapy in Pancreatic Ductal Adenocarcinoma.26046433Taniguchi C, Maitra ACellIt's a SMAD/SMAD World. Cell. 2015 Jun 04; 161(6):1245-6.Cell2015-06-04T00:00:002015It's a SMAD/SMAD World.26061556Bailey JM, Hendley AM, Maitra APancreasNew insights into plasticity of pancreatic cancer: cancer to acinar cell reprogramming by the basic helix-loop-helix transcription factor E47. Pancreas. 2015 Jul; 44(5):683-5.Pancreas2015-07-01T00:00:002015New insights into plasticity of pancreatic cancer: cancer to acinar cell reprogramming by the basic helix-loop-helix transcription factor E47.26113084Rajeshkumar NV, Dutta P, Yabuuchi S, de Wilde RF, Martinez GV, Le A, Kamphorst JJ, Rabinowitz JD, Jain SK, Hidalgo M, Dang CV, Gillies RJ, Maitra ACancer researchTherapeutic Targeting of the Warburg Effect in Pancreatic Cancer Relies on an Absence of p53 Function. Cancer Res. 2015 Aug 15; 75(16):3355-64.Cancer Res2015-06-25T00:00:002015Therapeutic Targeting of the Warburg Effect in Pancreatic Cancer Relies on an Absence of p53 Function.26154128Sausen M, Phallen J, Adleff V, Jones S, Leary RJ, Barrett MT, Anagnostou V, Parpart-Li S, Murphy D, Kay Li Q, Hruban CA, Scharpf R, White JR, O'Dwyer PJ, Allen PJ, Eshleman JR, Thompson CB, Klimstra DS, Linehan DC, Maitra A, Hruban RH, Diaz LA, Von Hoff DD, Johansen JS, Drebin JA, Velculescu VENature communicationsClinical implications of genomic alterations in the tumour and circulation of pancreatic cancer patients. Nat Commun. 2015 Jul 07; 6:7686.Nat Commun2015-07-07T00:00:002015Clinical implications of genomic alterations in the tumour and circulation of pancreatic cancer patients.26193883Cai J, Maitra A, Anders RA, Taketo MM, Pan DGenes & development?-Catenin destruction complex-independent regulation of Hippo-YAP signaling by APC in intestinal tumorigenesis. Genes Dev. 2015 Jul 15; 29(14):1493-506.Genes Dev2015-07-15T00:00:002015?-Catenin destruction complex-independent regulation of Hippo-YAP signaling by APC in intestinal tumorigenesis.26200098Liu L, Katz MH, Lee SM, Fischer LK, Prakash L, Parker N, Wang H, Varadhachary GR, Wolff RA, Lee JE, Pisters PW, Maitra A, Fleming JB, Estrella J, Rashid A, Wang HThe American journal of surgical pathologySuperior Mesenteric Artery Margin of Posttherapy Pancreaticoduodenectomy and Prognosis in Patients With Pancreatic Ductal Adenocarcinoma. Am J Surg Pathol. 2015 Oct; 39(10):1395-403.Am J Surg Pathol2015-10-01T00:00:002015Superior Mesenteric Artery Margin of Posttherapy Pancreaticoduodenectomy and Prognosis in Patients With Pancreatic Ductal Adenocarcinoma.26243191Foley K, Rucki AA, Xiao Q, Zhou D, Leubner A, Mo G, Kleponis J, Wu AA, Sharma R, Jiang Q, Anders RA, Iacobuzio-Donahue CA, Hajjar KA, Maitra A, Jaffee EM, Zheng LScience signalingSemaphorin 3D autocrine signaling mediates the metastatic role of annexin A2 in pancreatic cancer. Sci Signal. 2015 Aug 04; 8(388):ra77.Sci Signal2015-08-04T00:00:002015Semaphorin 3D autocrine signaling mediates the metastatic role of annexin A2 in pancreatic cancer.26461089Biankin AV, Maitra ACancer cellSubtyping Pancreatic Cancer. Cancer Cell. 2015 Oct 12; 28(4):411-413.Cancer Cell2015-10-12T00:00:002015Subtyping Pancreatic Cancer.26465942Maitra APancreas2015 American Pancreatic Association Presidential Address: Building Relationships, Impacting Lives. Pancreas. 2015 Nov; 44(8):1167-8.Pancreas2015-11-01T00:00:0020152015 American Pancreatic Association Presidential Address: Building Relationships, Impacting Lives.26482853Hu B, Sun D, Sun C, Sun YF, Sun HX, Zhu QF, Yang XR, Gao YB, Tang WG, Fan J, Maitra A, Anders RA, Xu YBiochemical and biophysical research communicationsA polymeric nanoparticle formulation of curcumin in combination with sorafenib synergistically inhibits tumor growth and metastasis in an orthotopic model of human hepatocellular carcinoma. Biochem Biophys Res Commun. 2015 Dec 25; 468(4):525-32.Biochem Biophys Res Commun2015-10-19T00:00:002015A polymeric nanoparticle formulation of curcumin in combination with sorafenib synergistically inhibits tumor growth and metastasis in an orthotopic model of human hepatocellular carcinoma.26526714Cowan RW, Maitra A, Rhim ADGastroenterologyA New Scalpel for the Treatment of Pancreatic Cancer: Targeting Stromal-Derived STAT3 Signaling. Gastroenterology. 2015 Dec; 149(7):1685-8.Gastroenterology2015-10-23T00:00:002015A New Scalpel for the Treatment of Pancreatic Cancer: Targeting Stromal-Derived STAT3 Signaling.26675084Wu PH, Phillip JM, Khatau SB, Chen WC, Stirman J, Rosseel S, Tschudi K, Van Patten J, Wong M, Gupta S, Baras AS, Leek JT, Maitra A, Wirtz DScientific reportsEvolution of cellular morpho-phenotypes in cancer metastasis. Sci Rep. 2015 Dec 17; 5:18437.Sci Rep2015-12-17T00:00:002015Evolution of cellular morpho-phenotypes in cancer metastasis.26725216Hayes TK, Neel NF, Hu C, Gautam P, Chenard M, Long B, Aziz M, Kassner M, Bryant KL, Pierobon M, Marayati R, Kher S, George SD, Xu M, Wang-Gillam A, Samatar AA, Maitra A, Wennerberg K, Petricoin EF, Yin HH, Nelkin B, Cox AD, Yeh JJ, Der CJCancer cellLong-Term ERK Inhibition in KRAS-Mutant Pancreatic Cancer Is Associated with MYC Degradation and Senescence-like Growth Suppression. Cancer Cell. 2016 Jan 11; 29(1):75-89.Cancer Cell2015-12-24T00:00:002015Long-Term ERK Inhibition in KRAS-Mutant Pancreatic Cancer Is Associated with MYC Degradation and Senescence-like Growth Suppression.26773005Takano S, Reichert M, Bakir B, Das KK, Nishida T, Miyazaki M, Heeg S, Collins MA, Marchand B, Hicks PD, Maitra A, Rustgi AKGenes & developmentPrrx1 isoform switching regulates pancreatic cancer invasion and metastatic colonization. Genes Dev. 2016 Jan 15; 30(2):233-47.Genes Dev2016-01-15T00:00:002016Prrx1 isoform switching regulates pancreatic cancer invasion and metastatic colonization.26920219Zhao H, Yang L, Baddour J, Achreja A, Bernard V, Moss T, Marini JC, Tudawe T, Seviour EG, San Lucas FA, Alvarez H, Gupta S, Maiti SN, Cooper L, Peehl D, Ram PT, Maitra A, Nagrath DeLifeTumor microenvironment derived exosomes pleiotropically modulate cancer cell metabolism. Elife. 2016 Feb 27; 5:e10250.Elife2016-02-27T00:00:002016Tumor microenvironment derived exosomes pleiotropically modulate cancer cell metabolism.74Professor10Assistant Professor14Associate Professor26909576Bailey P, Chang DK, Nones K, Johns AL, Patch AM, Gingras MC, Miller DK, Christ AN, Bruxner TJ, Quinn MC, Nourse C, Murtaugh LC, Harliwong I, Idrisoglu S, Manning S, Nourbakhsh E, Wani S, Fink L, Holmes O, Chin V, Anderson MJ, Kazakoff S, Leonard C, Newell F, Waddell N, Wood S, Xu Q, Wilson PJ, Cloonan N, Kassahn KS, Taylor D, Quek K, Robertson A, Pantano L, Mincarelli L, Sanchez LN, Evers L, Wu J, Pinese M, Cowley MJ, Jones MD, Colvin EK, Nagrial AM, Humphrey ES, Chantrill LA, Mawson A, Humphris J, Chou A, Pajic M, Scarlett CJ, Pinho AV, Giry-Laterriere M, Rooman I, Samra JS, Kench JG, Lovell JA, Merrett ND, Toon CW, Epari K, Nguyen NQ, Barbour A, Zeps N, Moran-Jones K, Jamieson NB, Graham JS, Duthie F, Oien K, Hair J, Gr?tzmann R, Maitra A, Iacobuzio-Donahue CA, Wolfgang CL, Morgan RA, Lawlor RT, Corbo V, Bassi C, Rusev B, Capelli P, Salvia R, Tortora G, Mukhopadhyay D, Petersen GM, Australian Pancreatic Cancer Genome Initiative, Munzy DM, Fisher WE, Karim SA, Eshleman JR, Hruban RH, Pilarsky C, Morton JP, Sansom OJ, Scarpa A, Musgrove EA, Bailey UM, Hofmann O, Sutherland RL, Wheeler DA, Gill AJ, Gibbs RA, Pearson JV, Waddell N, Biankin AV, Grimmond SMNatureGenomic analyses identify molecular subtypes of pancreatic cancer. Nature. 2016 Mar 03; 531(7592):47-52.Nature2016-02-24T00:00:002016Genomic analyses identify molecular subtypes of pancreatic cancer.27320920Carugo A, Genovese G, Seth S, Nezi L, Rose JL, Bossi D, Cicalese A, Shah PK, Viale A, Pettazzoni PF, Akdemir KC, Bristow CA, Robinson FS, Tepper J, Sanchez N, Gupta S, Estecio MR, Giuliani V, Dellino GI, Riva L, Yao W, Di Francesco ME, Green T, D'Alesio C, Corti D, Kang Y, Jones P, Wang H, Fleming JB, Maitra A, Pelicci PG, Chin L, DePinho RA, Lanfrancone L, Heffernan TP, Draetta GFCell reportsIn?Vivo Functional Platform Targeting Patient-Derived Xenografts Identifies WDR5-Myc Association as a Critical Determinant of Pancreatic Cancer. Cell Rep. 2016 06 28; 16(1):133-147.Cell Rep2016-06-16T00:00:002016In?Vivo Functional Platform Targeting Patient-Derived Xenografts Identifies WDR5-Myc Association as a Critical Determinant of Pancreatic Cancer.19351817Blackford A, Parmigiani G, Kensler TW, Wolfgang C, Jones S, Zhang X, Parsons DW, Lin JC, Leary RJ, Eshleman JR, Goggins M, Jaffee EM, Iacobuzio-Donahue CA, Maitra A, Klein A, Cameron JL, Olino K, Schulick R, Winter J, Vogelstein B, Velculescu VE, Kinzler KW, Hruban RHCancer researchGenetic mutations associated with cigarette smoking in pancreatic cancer. Cancer Res. 2009 Apr 15; 69(8):3681-8.Cancer Res2009-04-07T00:00:002009Genetic mutations associated with cigarette smoking in pancreatic cancer.Authorship 3733006918772397Jones S, Zhang X, Parsons DW, Lin JC, Leary RJ, Angenendt P, Mankoo P, Carter H, Kamiyama H, Jimeno A, Hong SM, Fu B, Lin MT, Calhoun ES, Kamiyama M, Walter K, Nikolskaya T, Nikolsky Y, Hartigan J, Smith DR, Hidalgo M, Leach SD, Klein AP, Jaffee EM, Goggins M, Maitra A, Iacobuzio-Donahue C, Eshleman JR, Kern SE, Hruban RH, Karchin R, Papadopoulos N, Parmigiani G, Vogelstein B, Velculescu VE, Kinzler KWScience (New York, N.Y.)Core signaling pathways in human pancreatic cancers revealed by global genomic analyses. Science. 2008 Sep 26; 321(5897):1801-6.Science2008-09-04T00:00:002008Core signaling pathways in human pancreatic cancers revealed by global genomic analyses.19584151Blackford A, Serrano OK, Wolfgang CL, Parmigiani G, Jones S, Zhang X, Parsons DW, Lin JC, Leary RJ, Eshleman JR, Goggins M, Jaffee EM, Iacobuzio-Donahue CA, Maitra A, Cameron JL, Olino K, Schulick R, Winter J, Herman JM, Laheru D, Klein AP, Vogelstein B, Kinzler KW, Velculescu VE, Hruban RHClinical cancer research : an official journal of the American Association for Cancer ResearchSMAD4 gene mutations are associated with poor prognosis in pancreatic cancer. Clin Cancer Res. 2009 Jul 15; 15(14):4674-9.Clin Cancer Res2009-07-07T00:00:002009SMAD4 gene mutations are associated with poor prognosis in pancreatic cancer.CHING-WEI DAVIDTZENGCHING-WEI DAVID TZENG12722TZENG, CHING-WEI DAVIDAssistant Professor22009941Jones S, Li M, Parsons DW, Zhang X, Wesseling J, Kristel P, Schmidt MK, Markowitz S, Yan H, Bigner D, Hruban RH, Eshleman JR, Iacobuzio-Donahue CA, Goggins M, Maitra A, Malek SN, Powell S, Vogelstein B, Kinzler KW, Velculescu VE, Papadopoulos NHuman mutationSomatic mutations in the chromatin remodeling gene ARID1A occur in several tumor types. Hum Mutat. 2012 Jan; 33(1):100-3.Hum Mutat2011-11-23T00:00:002011Somatic mutations in the chromatin remodeling gene ARID1A occur in several tumor types.Authorship 841437Authorship 841449Authorship 841943Authorship 842407Authorship 842706Authorship 843059Authorship 843389Authorship 843773Authorship 843835Authorship 845052Authorship 845056Authorship 845064Authorship 845071Authorship 845430Authorship 846665Authorship 847050Authorship 847533Authorship 848207Authorship 848840Authorship 849362Authorship 849659Authorship 850217Authorship 850599Authorship 851106Authorship 851229Authorship 851285Authorship 851758Authorship 851786Authorship 854153Authorship 854913Authorship 855357Authorship 855461Authorship 856343Authorship 856711Authorship 856832Authorship 857283Authorship 857286Authorship 857418Authorship 857851Authorship 857950Authorship 858728Authorship 859556Authorship 859799Authorship 860478Authorship 860537Authorship 860567Authorship 860662Authorship 860927Authorship 861115Authorship 861351Authorship 862086Authorship 862515Authorship 863653Authorship 864298Authorship 865355Authorship 865439Authorship 866673Authorship 866974Authorship 867159Authorship 867274Authorship 867625Authorship 867990Authorship 868133Cancer CellErratum. Cancer Cell. 5:103.ErratumScientific ReportsEvolution of cellular morpho-phenotypes in cancer metastasis. Scientific Reports. 5.Evolution of cellular morpho-phenotypes in cancer metastasisCurrent Molecular MedicineEditorial. Current Molecular Medicine. 8:1.EditorialGastroenterologyDCLK1 marks a morphologically distinct subpopulation of cells with stem cell properties in preinvasive pancreatic cancer. Gastroenterology. 146:245-256.DCLK1 marks a morphologically distinct subpopulation of cells with stem cell properties in preinvasive pancreatic cancereLifeTumor microenvironment derived exosomes pleiotropically modulate cancer cell metabolism. eLife. 5.Tumor microenvironment derived exosomes pleiotropically modulate cancer cell metabolismOncotargetQuantitative imaging to evaluate malignant potential of IPMNs. Oncotarget. 7:85776-85784.Quantitative imaging to evaluate malignant potential of IPMNsExpert Opinion on Drug DiscoveryIn vitro models of pancreatic cancer for translational oncology research. Expert Opinion on Drug Discovery. 4:429-443.In vitro models of pancreatic cancer for translational oncology researchPancreasEarly Detection of Pancreatic Cancer - A Defined Future Using Lessons from Other Cancers. Pancreas. 45:1073-1079.Early Detection of Pancreatic Cancer - A Defined Future Using Lessons from Other CancersMethylation detection and epigenomics in pancreatic cancer. 181-204.Methylation detection and epigenomics in pancreatic cancerPancreasEarly Detection of Sporadic Pancreatic Cancer. Pancreas. 44:693-712.Early Detection of Sporadic Pancreatic CancerJournal of Clinical OncologyPotentially curable pancreatic cancer. Journal of Clinical Oncology. 34:2541-2556.Potentially curable pancreatic cancerSeminars in Cancer BiologyThe emerging roles of F-box proteins in pancreatic tumorigenesis. Seminars in Cancer Biology. 36:88-94.The emerging roles of F-box proteins in pancreatic tumorigenesisBritish Journal of CancerSuperior therapeutic efficacy of nab-paclitaxel over cremophor-based paclitaxel in locally advanced and metastatic models of human pancreatic cancer. British Journal of Cancer. 115:442-453.Superior therapeutic efficacy of nab-paclitaxel over cremophor-based paclitaxel in locally advanced and metastatic models of human pancreatic cancerPrecursor lesions of pancreatic cancer. 395-420.Precursor lesions of pancreatic cancerPathology of pancreatic cancer. 497-511.Pathology of pancreatic cancerMolecular diagnostics of pancreatic cancer. 399-416.Molecular diagnostics of pancreatic cancerCurrent Problems in CancerGene expression profiling. Current Problems in Cancer. 26:199-202.Gene expression profilingOncogeneChronic inflammation initiates multiple forms of K-Ras-independent mouse pancreatic cancer in the absence of TP53. Oncogene. Chronic inflammation initiates multiple forms of K-Ras-independent mouse pancreatic cancer in the absence of TP53Genes and DevelopmentPrrx1 isoform switching regulates pancreatic cancer invasion and metastatic colonization. Genes and Development. 30:233-247.Prrx1 isoform switching regulates pancreatic cancer invasion and metastatic colonizationContemporary Ob-GynMolecular changes in cervical endocrine tumors. Contemporary Ob-Gyn. 45:25-36.Molecular changes in cervical endocrine tumorsClinical Cancer ResearchVery long-term survival following resection for pancreatic cancer is not explained by commonly mutated genes. Clinical Cancer Research. 21:1944-1950.Very long-term survival following resection for pancreatic cancer is not explained by commonly mutated genesPancreasMinutes of the business meeting of the American Pancreatic Association, Friday, November 1, 2013, Miami, Florida. Pancreas. 43:1141-1142.Minutes of the business meeting of the American Pancreatic Association, Friday, November 1, 2013, Miami, FloridaPancreasMinutes of the Business Meeting of the American Pancreatic Association, Friday, November 6, 2015, San Diego, California. Pancreas. 45:1376-1377.Minutes of the Business Meeting of the American Pancreatic Association, Friday, November 6, 2015, San Diego, CaliforniaCancer CellLong-Term ERK Inhibition in KRAS-Mutant Pancreatic Cancer Is Associated with MYC Degradation and Senescence-like Growth Suppression. Cancer Cell. 29:75-89.Long-Term ERK Inhibition in KRAS-Mutant Pancreatic Cancer Is Associated with MYC Degradation and Senescence-like Growth SuppressionEmergency MedicineMolecular changes in cervical endocrine tumors. Emergency Medicine. 45:25-36.Molecular changes in cervical endocrine tumorsGenes and DevelopmentGenetics and biology of pancreatic ductal adenocarcinoma. Genes and Development. 30:355-385.Genetics and biology of pancreatic ductal adenocarcinoma8 Direct, in situ assessment of telomere length variation in human cancers and preneoplastic lesions. 83-87.8 Direct, in situ assessment of telomere length variation in human cancers and preneoplastic lesionsMolecular Cancer TherapeuticsCombined inhibition of cyclin-dependent kinases (dinaciclib) and AKT(MK-2206) blocks pancreatic tumor growth and metastases in patient-derived xenograft models. Molecular Cancer Therapeutics. 14:1532-1539.Combined inhibition of cyclin-dependent kinases (dinaciclib) and AKT(MK-2206) blocks pancreatic tumor growth and metastases in patient-derived xenograft modelsOncogeneP53 mutations cooperate with oncogenic Kras to promote adenocarcinoma from pancreatic ductal cells. Oncogene. 35:4282-4288.P53 mutations cooperate with oncogenic Kras to promote adenocarcinoma from pancreatic ductal cellsMolecular genetics of pancreatic cancer. Molecular genetics of pancreatic cancerCell ReportsIn Vivo Functional Platform Targeting Patient-Derived Xenografts Identifies WDR5-Myc Association as a Critical Determinant of Pancreatic Cancer. Cell Reports. 16:133-147.In Vivo Functional Platform Targeting Patient-Derived Xenografts Identifies WDR5-Myc Association as a Critical Determinant of Pancreatic CancerCancer ResearchErratum. Cancer Research. 67:7937.ErratumGastroenterologyETS-Transcription Factor ETV1 Regulates Stromal Expansion and Metastasis in Pancreatic Cancer. Gastroenterology. 151:540-553.e14.ETS-Transcription Factor ETV1 Regulates Stromal Expansion and Metastasis in Pancreatic CancerGlobal characterization and genomic stability of human multistem, a multipotent adult progenitor cell. 119-134.Global characterization and genomic stability of human multistem, a multipotent adult progenitor cellCancer Biology and TherapyAllele-specific expression in the germline of patients with familial pancreatic cancer. Cancer Biology and Therapy. 7:137-146.Allele-specific expression in the germline of patients with familial pancreatic cancerCancer ResearchDetection of pancreatic cancer-induced cachexia using a fluorescent myoblast reporter system and analysis of metabolite abundance. Cancer Research. 76:1441-1450.Detection of pancreatic cancer-induced cachexia using a fluorescent myoblast reporter system and analysis of metabolite abundanceOncotargetOverexpression of ankyrin1 promotes pancreatic cancer cell growth. Oncotarget. 7:34977-34987.Overexpression of ankyrin1 promotes pancreatic cancer cell growthScience SignalingSemaphorin 3D autocrine signaling mediates the metastatic role of annexin A2 in pancreatic cancer. Science Signaling. 8.Semaphorin 3D autocrine signaling mediates the metastatic role of annexin A2 in pancreatic cancerCancer Researchp120 catenin suppresses basal epithelial cell extrusion in invasive pancreatic neoplasia. Cancer Research. 76:3351-3363.p120 catenin suppresses basal epithelial cell extrusion in invasive pancreatic neoplasiaDiagnostic HistopathologyReporting precursors to invasive pancreatic cancer. Diagnostic Histopathology. 18:17-30.Reporting precursors to invasive pancreatic cancerSurgical Oncology Clinics of North AmericaMolecular and Genetic Basis of Pancreatic Carcinogenesis. Surgical Oncology Clinics of North America. 25:227-238.Molecular and Genetic Basis of Pancreatic CarcinogenesisProteomics of human bile. 399-414.Proteomics of human bileNature CommunicationsClinical implications of genomic alterations in the tumour and circulation of pancreatic cancer patients. Nature Communications. 6.Clinical implications of genomic alterations in the tumour and circulation of pancreatic cancer patientsCancer Biology and TherapySonic Hedgehog signaling involved in prostate cancer metastasis and can be blocked by cyclopamine. Cancer Biology and Therapy. 3:926.Sonic Hedgehog signaling involved in prostate cancer metastasis and can be blocked by cyclopamineCurrent Diagnostic PathologyPathology of the gallbladder. Current Diagnostic Pathology. 10:304-317.Pathology of the gallbladderJournal of Gastrointestinal SurgeryPreoperative Therapy and Pancreatoduodenectomy for Pancreatic Ductal Adenocarcinoma. Journal of Gastrointestinal Surgery. 1-11.Preoperative Therapy and Pancreatoduodenectomy for Pancreatic Ductal AdenocarcinomaPancreasMinutes of the business meeting of the American pancreatic association, Friday, November 7, 2014, Kohala Coast, Hawaii. Pancreas. 44:1176-1177.Minutes of the business meeting of the American pancreatic association, Friday, November 7, 2014, Kohala Coast, HawaiiLaboratory InvestigationBringing pathobiology into focus. Laboratory Investigation. 86:632.Bringing pathobiology into focusClinical Cancer ResearchIncreased prevalence of precursor lesions in familial pancreatic cancer patients. Clinical Cancer Research. 15:7737-7743.Increased prevalence of precursor lesions in familial pancreatic cancer patientsGastroenterologyHypermutation In Pancreatic Cancer. Gastroenterology. 152:68-74.e2.Hypermutation In Pancreatic CancerCancer CellErratum to Depletion of Carcinoma-Associated Fibroblasts and Fibrosis Induces Immunosuppression and Accelerates Pancreas Cancer with Reduced Survival [Cancer Cell 25, 719-734; (2014)]. Cancer Cell. 28:831-833.Erratum to Depletion of Carcinoma-Associated Fibroblasts and Fibrosis Induces Immunosuppression and Accelerates Pancreas Cancer with Reduced Survival [Cancer Cell 25, 719-734; (2014)]Scientific ReportsExploiting the neoantigen landscape for immunotherapy of pancreatic ductal adenocarcinoma. Scientific Reports. 6.Exploiting the neoantigen landscape for immunotherapy of pancreatic ductal adenocarcinomaPLoS OnePrognostic and functional significance of MAP4K5 in pancreatic cancer. PLoS One. 11.Prognostic and functional significance of MAP4K5 in pancreatic cancerProteomics of human pancreatic juice. 377-397.Proteomics of human pancreatic juiceCell ReportsAmpullary Cancers Harbor ELF3 Tumor Suppressor Gene Mutations and Exhibit Frequent WNT Dysregulation. Cell Reports. 14:907-919.Ampullary Cancers Harbor ELF3 Tumor Suppressor Gene Mutations and Exhibit Frequent WNT DysregulationGenomic alterations in sporadic pancreatic cancer. 1-26.Genomic alterations in sporadic pancreatic cancerJournal of Surgical OncologyReview of the clinical, histological, and molecular aspects of pancreatic endocrine neoplasms. Journal of Surgical Oncology. 81:54.Review of the clinical, histological, and molecular aspects of pancreatic endocrine neoplasmsJournal of UrologyUrological oncology. Journal of Urology. 173:1169-1171.Urological oncologyNeoplasia (United States)Prox1-Heterozygosis Sensitizes the Pancreas to Oncogenic Kras-Induced Neoplastic Transformation. Neoplasia (United States). 18:172-184.Prox1-Heterozygosis Sensitizes the Pancreas to Oncogenic Kras-Induced Neoplastic TransformationAnnals of OncologyMinimally invasive genomic and transcriptomic profiling of visceral cancers by next-generation sequencing of circulating exosomes. Annals of Oncology. 27:635-641.Minimally invasive genomic and transcriptomic profiling of visceral cancers by next-generation sequencing of circulating exosomesJournal of NanobiotechnologyPolymeric nanoparticle-encapsulated curcumin ("nanocurcumin"). Journal of Nanobiotechnology. 5.Polymeric nanoparticle-encapsulated curcumin ("nanocurcumin")American Journal of Surgical PathologyValidation of a Proposed Tumor Regression Grading Scheme for Pancreatic Ductal Adenocarcinoma After Neoadjuvant Therapy as a Prognostic Indicator for Survival. American Journal of Surgical Pathology. Validation of a Proposed Tumor Regression Grading Scheme for Pancreatic Ductal Adenocarcinoma After Neoadjuvant Therapy as a Prognostic Indicator for SurvivalHistopathologyThe number and ratio of positive lymph nodes affect pancreatic cancer patient survival after neoadjuvant therapy and pancreaticoduodenectomy. Histopathology. The number and ratio of positive lymph nodes affect pancreatic cancer patient survival after neoadjuvant therapy and pancreaticoduodenectomy28376157Capello M, Bantis LE, Scelo G, Zhao Y, Li P, Dhillon DS, Patel NJ, Kundnani DL, Wang H, Abbruzzese JL, Maitra A, Tempero MA, Brand R, Firpo MA, Mulvihill SJ, Katz MH, Brennan P, Feng Z, Taguchi A, Hanash SMJournal of the National Cancer InstituteSequential Validation of Blood-Based Protein Biomarker Candidates for Early-Stage Pancreatic Cancer. J Natl Cancer Inst. 2017 04 01; 109(4).J Natl Cancer Inst2017-04-01T00:00:002017Sequential Validation of Blood-Based Protein Biomarker Candidates for Early-Stage Pancreatic Cancer.19264984Jones S, Hruban RH, Kamiyama M, Borges M, Zhang X, Parsons DW, Lin JC, Palmisano E, Brune K, Jaffee EM, Iacobuzio-Donahue CA, Maitra A, Parmigiani G, Kern SE, Velculescu VE, Kinzler KW, Vogelstein B, Eshleman JR, Goggins M, Klein APScience (New York, N.Y.)Exomic sequencing identifies PALB2 as a pancreatic cancer susceptibility gene. Science. 2009 Apr 10; 324(5924):217.Science2009-03-05T00:00:002009Exomic sequencing identifies PALB2 as a pancreatic cancer susceptibility gene.23103869Biankin AV, Waddell N, Kassahn KS, Gingras MC, Muthuswamy LB, Johns AL, Miller DK, Wilson PJ, Patch AM, Wu J, Chang DK, Cowley MJ, Gardiner BB, Song S, Harliwong I, Idrisoglu S, Nourse C, Nourbakhsh E, Manning S, Wani S, Gongora M, Pajic M, Scarlett CJ, Gill AJ, Pinho AV, Rooman I, Anderson M, Holmes O, Leonard C, Taylor D, Wood S, Xu Q, Nones K, Fink JL, Christ A, Bruxner T, Cloonan N, Kolle G, Newell F, Pinese M, Mead RS, Humphris JL, Kaplan W, Jones MD, Colvin EK, Nagrial AM, Humphrey ES, Chou A, Chin VT, Chantrill LA, Mawson A, Samra JS, Kench JG, Lovell JA, Daly RJ, Merrett ND, Toon C, Epari K, Nguyen NQ, Barbour A, Zeps N, Australian Pancreatic Cancer Genome Initiative, Kakkar N, Zhao F, Wu YQ, Wang M, Muzny DM, Fisher WE, Brunicardi FC, Hodges SE, Reid JG, Drummond J, Chang K, Han Y, Lewis LR, Dinh H, Buhay CJ, Beck T, Timms L, Sam M, Begley K, Brown A, Pai D, Panchal A, Buchner N, De Borja R, Denroche RE, Yung CK, Serra S, Onetto N, Mukhopadhyay D, Tsao MS, Shaw PA, Petersen GM, Gallinger S, Hruban RH, Maitra A, Iacobuzio-Donahue CA, Schulick RD, Wolfgang CL, Morgan RA, Lawlor RT, Capelli P, Corbo V, Scardoni M, Tortora G, Tempero MA, Mann KM, Jenkins NA, Perez-Mancera PA, Adams DJ, Largaespada DA, Wessels LF, Rust AG, Stein LD, Tuveson DA, Copeland NG, Musgrove EA, Scarpa A, Eshleman JR, Hudson TJ, Sutherland RL, Wheeler DA, Pearson JV, McPherson JD, Gibbs RA, Grimmond SMNaturePancreatic cancer genomes reveal aberrations in axon guidance pathway genes. Nature. 2012 Nov 15; 491(7424):399-405.Nature2012-10-24T00:00:002012Pancreatic cancer genomes reveal aberrations in axon guidance pathway genes.29331808Zhao J, Wang H, Hsiao CH, Chow DS, Koay EJ, Kang Y, Wen X, Huang Q, Ma Y, Bankson JA, Ullrich SE, Overwijk W, Maitra A, Piwnica-Worms D, Fleming JB, Li CBiomaterialsSimultaneous inhibition of hedgehog signaling and tumor proliferation remodels stroma and enhances pancreatic cancer therapy. Biomaterials. 2018 03; 159:215-228.Biomaterials2018-01-09T00:00:002018Simultaneous inhibition of hedgehog signaling and tumor proliferation remodels stroma and enhances pancreatic cancer therapy.29606349Wang YN, Lee HH, Chou CK, Yang WH, Wei Y, Chen CT, Yao J, Hsu JL, Zhu C, Ying H, Ye Y, Wang WJ, Lim SO, Xia W, Ko HW, Liu X, Liu CG, Wu X, Wang H, Li D, Prakash LR, Katz MH, Kang Y, Kim M, Fleming JB, Fogelman D, Javle M, Maitra A, Hung MCCancer cellAngiogenin/Ribonuclease 5 Is an EGFR Ligand and a Serum Biomarker for Erlotinib Sensitivity in Pancreatic Cancer. Cancer Cell. 2018 04 09; 33(4):752-769.e8.Cancer Cell2018-03-29T00:00:002018Angiogenin/Ribonuclease 5 Is an EGFR Ligand and a Serum Biomarker for Erlotinib Sensitivity in Pancreatic Cancer.Authorship 88829611Authorship 88941830Authorship 88961417Authorship 88970213Authorship 89005228D002278Disorders1914950.738397Carcinoma in SituD010190Disorders69850490.284554Pancreatic NeoplasmsD021441Disorders30517220.439946Carcinoma, Pancreatic DuctalD000230Disorders102777770.261801AdenocarcinomaD011230Concepts & IdeasDisorders34310480.596064Precancerous ConditionsAuthorship 8923312Authorship 8924311Authorship 8926601Authorship 8929081Authorship 8954063Authorship 8971561Authorship 8991674Authorship 8992503Authorship 8995776Authorship 90205216Authorship 9028346Authorship 9040872Authorship 9042716Authorship 9050778Authorship 9052686Authorship 9064647Authorship 90699710Authorship 90755610Authorship 90767215Authorship 90887511Authorship 9089403Authorship 90910012Authorship 9095132Authorship 91006522Authorship 9105512Authorship 9109683Authorship 9110056Authorship 91104614Authorship 9118447Authorship 91197812Authorship 91243663Authorship 9130371Authorship 91328315Authorship 91335836Authorship 9136898Authorship 9136968Authorship 9140082Authorship 91487028Authorship 9150014Authorship 91509512Authorship 91573038Authorship 9158769Authorship 91643912Authorship 91782822Authorship 9179215Authorship 9187815Authorship 9201582Authorship 9202689Authorship 92045212Authorship 9213144Authorship 9214492Authorship 9225181Authorship 92280116Authorship 92297520Authorship 92342317Authorship 92382510Authorship 92560122Authorship 9259836Authorship 9263659Authorship 92670920Authorship 92715410Authorship 9271806Authorship 92770122Authorship 92774512Authorship 92838218Authorship 92856924Authorship 9285912Authorship 93034519Authorship 9312446Authorship 93137424Authorship 93139311Authorship 93249530Authorship 93285521Authorship 93382815Authorship 93406418Authorship 93503116Authorship 93596612Authorship 9360961Authorship 93625915Authorship 9373534Authorship 9380019Authorship 9385683Authorship 9392579Authorship 9400707Authorship 94018014Authorship 9403116Authorship 94032524526412Maitra AKThe British journal of clinical practiceSkateboard injuries. Br J Clin Pract. 1979 Oct; 33(10):281-2, 288.Br J Clin Pract1979-10-01T00:00:001979Skateboard injuries.2696483Han KH, Maitra AKBurns : journal of the International Society for Burn InjuriesManagement of partial skin thickness burn wounds with Inadine dressings. Burns. 1989 Dec; 15(6):399-402.Burns1989-12-01T00:00:001989Management of partial skin thickness burn wounds with Inadine dressings.3334236Maitra AKInjuryTreatment of fractures of the hallux with a simple splint. Injury. 1987 Sep; 18(5):344-6.Injury1987-09-01T00:00:001987Treatment of fractures of the hallux with a simple splint.7306446Maitra AKThe British journal of clinical practicePattern of care for mild head injuries in accident and emergency department. Br J Clin Pract. 1981 Nov-Dec; 35(11-12):385-9.Br J Clin Pract1981-11-01T00:00:001981Pattern of care for mild head injuries in accident and emergency department.9475221Choyce MQ, Potts M, Maitra AKJournal of accident & emergency medicineA profile of sports hand injuries in an accident and emergency department. J Accid Emerg Med. 1998 Jan; 15(1):35-8.J Accid Emerg Med1998-01-01T00:00:001998A profile of sports hand injuries in an accident and emergency department.15033878Maitra A, Sherriff A, Griffiths M, Henderson J, Avon Longitudinal Study of Parents and Children Study TeamBMJ (Clinical research ed.)Pertussis vaccination in infancy and asthma or allergy in later childhood: birth cohort study. BMJ. 2004 Apr 17; 328(7445):925-6.BMJ2004-03-19T00:00:002004Pertussis vaccination in infancy and asthma or allergy in later childhood: birth cohort study.19996207Shi C, Klein AP, Goggins M, Maitra A, Canto M, Ali S, Schulick R, Palmisano E, Hruban RHClinical cancer research : an official journal of the American Association for Cancer ResearchIncreased Prevalence of Precursor Lesions in Familial Pancreatic Cancer Patients. Clin Cancer Res. 2009 Dec 15; 15(24):7737-7743.Clin Cancer Res2009-12-15T00:00:002009Increased Prevalence of Precursor Lesions in Familial Pancreatic Cancer Patients.20498688Boozer S, Lehman N, Lakshmipathy U, Love B, Raber A, Maitra A, Deans R, Rao MS, Ting AEJournal of stem cellsGlobal Characterization and Genomic Stability of Human MultiStem, A Multipotent Adult Progenitor Cell. J Stem Cells. 2009; 4(1):17-28.J Stem Cells2009-01-01T00:00:002009Global Characterization and Genomic Stability of Human MultiStem, A Multipotent Adult Progenitor Cell.20160967Feldmann G, Rauenzahn S, Maitra AExpert opinion on drug discoveryIn vitro models of pancreatic cancer for translational oncology research. Expert Opin Drug Discov. 2009 Apr 01; 4(4):429-443.Expert Opin Drug Discov2009-04-01T00:00:002009In vitro models of pancreatic cancer for translational oncology research.24839966Thomas JK, Kim MS, Balakrishnan L, Nanjappa V, Raju R, Marimuthu A, Radhakrishnan A, Muthusamy B, Khan AA, Sakamuri S, Tankala SG, Singal M, Nair B, Sirdeshmukh R, Chatterjee A, Prasad TS, Maitra A, Gowda H, Hruban RH, Pandey ACancer biology & therapyPancreatic Cancer Database: an integrative resource for pancreatic cancer. Cancer Biol Ther. 2014 Aug; 15(8):963-7.Cancer Biol Ther2014-05-19T00:00:002014Pancreatic Cancer Database: an integrative resource for pancreatic cancer.25485576Shrivastava MS, Hussain Z, Giricz O, Shenoy N, Polineni R, Maitra A, Verma ACell cycle (Georgetown, Tex.)Targeting chemokine pathways in esophageal adenocarcinoma. Cell Cycle. 2014; 13(21):3320-7.Cell Cycle2014-01-01T00:00:002014Targeting chemokine pathways in esophageal adenocarcinoma.26384530Wang H, Maitra A, Wang HSeminars in cancer biologyThe emerging roles of F-box proteins in pancreatic tumorigenesis. Semin Cancer Biol. 2016 Feb; 36:88-94.Semin Cancer Biol2015-09-16T00:00:002015The emerging roles of F-box proteins in pancreatic tumorigenesis.26883357Ying H, Dey P, Yao W, Kimmelman AC, Draetta GF, Maitra A, DePinho RAGenes & developmentGenetics and biology of pancreatic ductal adenocarcinoma. Genes Dev. 2016 Feb 15; 30(4):355-85.Genes Dev2016-02-15T00:00:002016Genetics and biology of pancreatic ductal adenocarcinoma.27023625Wang OH, Azizian N, Guo M, Capello M, Deng D, Zang F, Fry J, Katz MH, Fleming JB, Lee JE, Wolff RA, Hanash S, Wang H, Maitra APloS onePrognostic and Functional Significance of MAP4K5 in Pancreatic Cancer. PLoS One. 2016; 11(3):e0152300.PLoS One2016-03-29T00:00:002016Prognostic and Functional Significance of MAP4K5 in Pancreatic Cancer.27013361Bernard V, Fleming J, Maitra ASurgical oncology clinics of North AmericaMolecular and Genetic Basis of Pancreatic Carcinogenesis: Which Concepts May be Clinically Relevant? Surg Oncol Clin N Am. 2016 Apr; 25(2):227-38.Surg Oncol Clin N Am2016-04-01T00:00:002016Molecular and Genetic Basis of Pancreatic Carcinogenesis: Which Concepts May be Clinically Relevant?26719527Winnard PT, Bharti SK, Penet MF, Marik R, Mironchik Y, Wildes F, Maitra A, Bhujwalla ZMCancer researchDetection of Pancreatic Cancer-Induced Cachexia Using a Fluorescent Myoblast Reporter System and Analysis of Metabolite Abundance. Cancer Res. 2016 Mar 15; 76(6):1441-50.Cancer Res2015-12-30T00:00:002015Detection of Pancreatic Cancer-Induced Cachexia Using a Fluorescent Myoblast Reporter System and Analysis of Metabolite Abundance.26919422Gupta S, Maitra ACellEMT: Matter of Life or Death? Cell. 2016 Feb 25; 164(5):840-2.Cell2016-02-25T00:00:002016EMT: Matter of Life or Death?26924195Javle M, Golan T, Maitra ACancer treatment reviewsChanging the course of pancreatic cancer--Focus on recent translational advances. Cancer Treat Rev. 2016 Mar; 44:17-25.Cancer Treat Rev2016-01-25T00:00:002016Changing the course of pancreatic cancer--Focus on recent translational advances.27032419Hendley AM, Wang YJ, Polireddy K, Alsina J, Ahmed I, Lafaro KJ, Zhang H, Roy N, Savidge SG, Cao Y, Hebrok M, Maitra A, Reynolds AB, Goggins M, Younes M, Iacobuzio-Donahue CA, Leach SD, Bailey JMCancer researchp120 Catenin Suppresses Basal Epithelial Cell Extrusion in Invasive Pancreatic Neoplasia. Cancer Res. 2016 06 01; 76(11):3351-63.Cancer Res2016-03-31T00:00:002016p120 Catenin Suppresses Basal Epithelial Cell Extrusion in Invasive Pancreatic Neoplasia.27518362Kenner BJ, Chari ST, Maitra A, Srivastava S, Cleeter DF, Go VL, Rothschild LJ, Goldberg AEPancreasEarly Detection of Pancreatic Cancer-a Defined Future Using Lessons From Other Cancers: A White Paper. Pancreas. 2016 09; 45(8):1073-9.Pancreas2016-09-01T00:00:002016Early Detection of Pancreatic Cancer-a Defined Future Using Lessons From Other Cancers: A White Paper.27144336Omura N, Mizuma M, MacGregor A, Hong SM, Ayars M, Almario JA, Borges M, Kanda M, Li A, Vincent A, Maitra A, Goggins MOncotargetOverexpression of ankyrin1 promotes pancreatic cancer cell growth. Oncotarget. 2016 Jun 07; 7(23):34977-87.Oncotarget2016-06-07T00:00:002016Overexpression of ankyrin1 promotes pancreatic cancer cell growth.27441498Rajeshkumar NV, Yabuuchi S, Pai SG, Tong Z, Hou S, Bateman S, Pierce DW, Heise C, Von Hoff DD, Maitra A, Hidalgo MBritish journal of cancerSuperior therapeutic efficacy of nab-paclitaxel over cremophor-based paclitaxel in locally advanced and metastatic models of human pancreatic cancer. Br J Cancer. 2016 08 09; 115(4):442-53.Br J Cancer2016-07-21T00:00:002016Superior therapeutic efficacy of nab-paclitaxel over cremophor-based paclitaxel in locally advanced and metastatic models of human pancreatic cancer.26992918Drosos Y, Neale G, Ye J, Paul L, Kuliyev E, Maitra A, Means AL, Washington MK, Rehg J, Finkelstein DB, Sosa-Pineda BNeoplasia (New York, N.Y.)Prox1-Heterozygosis Sensitizes the Pancreas to Oncogenic Kras-Induced Neoplastic Transformation. Neoplasia. 2016 Mar; 18(3):172-84.Neoplasia2016-03-01T00:00:002016Prox1-Heterozygosis Sensitizes the Pancreas to Oncogenic Kras-Induced Neoplastic Transformation.27243381Cloyd JM, Crane CH, Koay EJ, Das P, Krishnan S, Prakash L, Snyder RA, Varadhachary GR, Wolff RA, Javle M, Shroff RT, Fogelman D, Overman M, Wang H, Maitra A, Lee JE, Fleming JB, Katz MHCancerImpact of hypofractionated and standard fractionated chemoradiation before pancreatoduodenectomy for pancreatic ductal adenocarcinoma. Cancer. 2016 09 01; 122(17):2671-9.Cancer2016-05-31T00:00:002016Impact of hypofractionated and standard fractionated chemoradiation before pancreatoduodenectomy for pancreatic ductal adenocarcinoma.27247221Khorana AA, Mangu PB, Berlin J, Engebretson A, Hong TS, Maitra A, Mohile SG, Mumber M, Schulick R, Shapiro M, Urba S, Zeh HJ, Katz MHJournal of clinical oncology : official journal of the American Society of Clinical OncologyPotentially Curable Pancreatic Cancer: American Society of Clinical Oncology Clinical Practice Guideline. J Clin Oncol. 2016 07 20; 34(21):2541-56.J Clin Oncol2016-05-31T00:00:002016Potentially Curable Pancreatic Cancer: American Society of Clinical Oncology Clinical Practice Guideline.27318148Heeg S, Das KK, Reichert M, Bakir B, Takano S, Caspers J, Aiello NM, Wu K, Neesse A, Maitra A, Iacobuzio-Donahue CA, Hicks P, Rustgi AKGastroenterologyETS-Transcription Factor ETV1 Regulates Stromal Expansion and?Metastasis in Pancreatic Cancer. Gastroenterology. 2016 09; 151(3):540-553.e14.Gastroenterology2016-06-16T00:00:002016ETS-Transcription Factor ETV1 Regulates Stromal Expansion and?Metastasis in Pancreatic Cancer.27588410Hanania AN, Bantis LE, Feng Z, Wang H, Tamm EP, Katz MH, Maitra A, Koay EJOncotargetQuantitative imaging to evaluate malignant potential of IPMNs. Oncotarget. 2016 Dec 27; 7(52):85776-85784.Oncotarget2016-12-27T00:00:002016Quantitative imaging to evaluate malignant potential of IPMNs.28124275Cloyd JM, Wang H, Overman M, Zhao J, Denbo J, Prakash L, Kim MP, Shroff R, Javle M, Varadhachary GR, Fogelman D, Wolff RA, Koay EJ, Das P, Maitra A, Aloia TA, Vauthey JN, Fleming JB, Lee JE, Katz MHGAnnals of surgical oncologyInfluence of Preoperative Therapy on Short- and Long-Term Outcomes of Patients with Adenocarcinoma of the Ampulla of Vater. Ann Surg Oncol. 2017 Jul; 24(7):2031-2039.Ann Surg Oncol2017-01-25T00:00:002017Influence of Preoperative Therapy on Short- and Long-Term Outcomes of Patients with Adenocarcinoma of the Ampulla of Vater.27631521Lee SM, Katz MH, Liu L, Sundar M, Wang H, Varadhachary GR, Wolff RA, Lee JE, Maitra A, Fleming JB, Rashid A, Wang HThe American journal of surgical pathologyValidation of a Proposed Tumor Regression Grading Scheme for Pancreatic Ductal Adenocarcinoma After Neoadjuvant Therapy as a Prognostic Indicator for Survival. Am J Surg Pathol. 2016 12; 40(12):1653-1660.Am J Surg Pathol2016-12-01T00:00:002016Validation of a Proposed Tumor Regression Grading Scheme for Pancreatic Ductal Adenocarcinoma After Neoadjuvant Therapy as a Prognostic Indicator for Survival.27778257Cloyd JM, Katz MH, Prakash L, Varadhachary GR, Wolff RA, Shroff RT, Javle M, Fogelman D, Overman M, Crane CH, Koay EJ, Das P, Krishnan S, Minsky BD, Lee JH, Bhutani MS, Weston B, Ross W, Bhosale P, Tamm EP, Wang H, Maitra A, Kim MP, Aloia TA, Vauthey JN, Fleming JB, Abbruzzese JL, Pisters PW, Evans DB, Lee JEJournal of gastrointestinal surgery : official journal of the Society for Surgery of the Alimentary TractPreoperative Therapy and Pancreatoduodenectomy for Pancreatic Ductal Adenocarcinoma: a 25-Year Single-Institution Experience. J Gastrointest Surg. 2017 01; 21(1):164-174.J Gastrointest Surg2016-10-24T00:00:002016Preoperative Therapy and Pancreatoduodenectomy for Pancreatic Ductal Adenocarcinoma: a 25-Year Single-Institution Experience.27856273Humphris JL, Patch AM, Nones K, Bailey PJ, Johns AL, McKay S, Chang DK, Miller DK, Pajic M, Kassahn KS, Quinn MC, Bruxner TJ, Christ AN, Harliwong I, Idrisoglu S, Manning S, Nourse C, Nourbakhsh E, Stone A, Wilson PJ, Anderson M, Fink JL, Holmes O, Kazakoff S, Leonard C, Newell F, Waddell N, Wood S, Mead RS, Xu Q, Wu J, Pinese M, Cowley MJ, Jones MD, Nagrial AM, Chin VT, Chantrill LA, Mawson A, Chou A, Scarlett CJ, Pinho AV, Rooman I, Giry-Laterriere M, Samra JS, Kench JG, Merrett ND, Toon CW, Epari K, Nguyen NQ, Barbour A, Zeps N, Jamieson NB, McKay CJ, Carter CR, Dickson EJ, Graham JS, Duthie F, Oien K, Hair J, Morton JP, Sansom OJ, Gr?tzmann R, Hruban RH, Maitra A, Iacobuzio-Donahue CA, Schulick RD, Wolfgang CL, Morgan RA, Lawlor RT, Rusev B, Corbo V, Salvia R, Cataldo I, Tortora G, Tempero MA, Australian Pancreatic Cancer Genome Initiative, Hofmann O, Eshleman JR, Pilarsky C, Scarpa A, Musgrove EA, Gill AJ, Pearson JV, Grimmond SM, Waddell N, Biankin AVGastroenterologyHypermutation In Pancreatic Cancer. Gastroenterology. 2017 01; 152(1):68-74.e2.Gastroenterology2016-11-15T00:00:002016Hypermutation In Pancreatic Cancer.28104621Allenson K, Castillo J, San Lucas FA, Scelo G, Kim DU, Bernard V, Davis G, Kumar T, Katz M, Overman MJ, Foretova L, Fabianova E, Holcatova I, Janout V, Meric-Bernstam F, Gascoyne P, Wistuba I, Varadhachary G, Brennan P, Hanash S, Li D, Maitra A, Alvarez HAnnals of oncology : official journal of the European Society for Medical OncologyHigh prevalence of mutant KRAS in circulating exosome-derived DNA from early-stage pancreatic cancer patients. Ann Oncol. 2017 04 01; 28(4):741-747.Ann Oncol2017-04-01T00:00:002017High prevalence of mutant KRAS in circulating exosome-derived DNA from early-stage pancreatic cancer patients.28108630Cullis J, Siolas D, Avanzi A, Barui S, Maitra A, Bar-Sagi DCancer immunology researchMacropinocytosis of Nab-paclitaxel Drives Macrophage Activation in Pancreatic Cancer. Cancer Immunol Res. 2017 03; 5(3):182-190.Cancer Immunol Res2017-01-20T00:00:002017Macropinocytosis of Nab-paclitaxel Drives Macrophage Activation in Pancreatic Cancer.28178232Genovese G, Carugo A, Tepper J, Robinson FS, Li L, Svelto M, Nezi L, Corti D, Minelli R, Pettazzoni P, Gutschner T, Wu CC, Seth S, Akdemir KC, Leo E, Amin S, Molin MD, Ying H, Kwong LN, Colla S, Takahashi K, Ghosh P, Giuliani V, Muller F, Dey P, Jiang S, Garvey J, Liu CG, Zhang J, Heffernan TP, Toniatti C, Fleming JB, Goggins MG, Wood LD, Sgambato A, Agaimy A, Maitra A, Roberts CW, Wang H, Viale A, DePinho RA, Draetta GF, Chin LNatureSynthetic vulnerabilities of mesenchymal subpopulations in pancreatic cancer. Nature. 2017 02 16; 542(7641):362-366.Nature2017-02-08T00:00:002017Synthetic vulnerabilities of mesenchymal subpopulations in pancreatic cancer.28187218Liu Q, Stewart J, Wang H, Rashid A, Zhao J, Katz MH, Lee JE, Fleming JB, Maitra A, Wolff RA, Varadhachary GR, Krishnan S, Wang HPloS oneReduced expression of argininosuccinate synthetase 1 has a negative prognostic impact in patients with pancreatic ductal adenocarcinoma. PLoS One. 2017; 12(2):e0171985.PLoS One2017-02-10T00:00:002017Reduced expression of argininosuccinate synthetase 1 has a negative prognostic impact in patients with pancreatic ductal adenocarcinoma.27762323Bailey P, Chang DK, Forget MA, Lucas FA, Alvarez HA, Haymaker C, Chattopadhyay C, Kim SH, Ekmekcioglu S, Grimm EA, Biankin AV, Hwu P, Maitra A, Roszik JScientific reportsExploiting the neoantigen landscape for immunotherapy of pancreatic ductal adenocarcinoma. Sci Rep. 2016 10 20; 6:35848.Sci Rep2016-10-20T00:00:002016Exploiting the neoantigen landscape for immunotherapy of pancreatic ductal adenocarcinoma.28085752Xie VK, Maitra APancreasKr?ppel-Like Factor 4 Promotes Pancreatic Acinar-to-Ductal Metaplasia and Tumor Initiation. Pancreas. 2017 02; 46(2):139-142.Pancreas2017-02-01T00:00:002017Kr?ppel-Like Factor 4 Promotes Pancreatic Acinar-to-Ductal Metaplasia and Tumor Initiation.28085753Thota R, Maitra A, Berlin JDPancreasPreclinical Rationale for the Phase III Trials in Metastatic Pancreatic Cancer: Is Wishful Thinking Clouding Successful Drug Development for Pancreatic Cancer? Pancreas. 2017 02; 46(2):143-150.Pancreas2017-02-01T00:00:002017Preclinical Rationale for the Phase III Trials in Metastatic Pancreatic Cancer: Is Wishful Thinking Clouding Successful Drug Development for Pancreatic Cancer?28099419Dey P, Baddour J, Muller F, Wu CC, Wang H, Liao WT, Lan Z, Chen A, Gutschner T, Kang Y, Fleming J, Satani N, Zhao D, Achreja A, Yang L, Lee J, Chang E, Genovese G, Viale A, Ying H, Draetta G, Maitra A, Wang YA, Nagrath D, DePinho RANatureGenomic deletion of malic enzyme 2 confers collateral lethality in pancreatic cancer. Nature. 2017 02 02; 542(7639):119-123.Nature2017-01-18T00:00:002017Genomic deletion of malic enzyme 2 confers collateral lethality in pancreatic cancer.28292434Collisson EA, Maitra ACancer cellPancreatic Cancer Genomics 2.0: Profiling Metastases. Cancer Cell. 2017 03 13; 31(3):309-310.Cancer Cell2017-03-13T00:00:002017Pancreatic Cancer Genomics 2.0: Profiling Metastases.28947567Sakellariou-Thompson D, Forget MA, Creasy C, Bernard V, Zhao L, Kim YU, Hurd MW, Uraoka N, Parra ER, Kang Y, Bristow CA, Rodriguez-Canales J, Fleming JB, Varadhachary G, Javle M, Overman MJ, Alvarez HA, Heffernan TP, Zhang J, Hwu P, Maitra A, Haymaker C, Bernatchez CClinical cancer research : an official journal of the American Association for Cancer Research4-1BB Agonist Focuses CD8+ Tumor-Infiltrating T-Cell Growth into a Distinct Repertoire Capable of Tumor Recognition in Pancreatic Cancer. Clin Cancer Res. 2017 Dec 01; 23(23):7263-7275.Clin Cancer Res2017-09-25T00:00:0020174-1BB Agonist Focuses CD8+ Tumor-Infiltrating T-Cell Growth into a Distinct Repertoire Capable of Tumor Recognition in Pancreatic Cancer.28611197Rajeshkumar NV, Yabuuchi S, Pai SG, De Oliveira E, Kamphorst JJ, Rabinowitz JD, Tejero H, Al-Shahrour F, Hidalgo M, Maitra A, Dang CVClinical cancer research : an official journal of the American Association for Cancer ResearchTreatment of Pancreatic Cancer Patient-Derived Xenograft Panel with Metabolic Inhibitors Reveals Efficacy of Phenformin. Clin Cancer Res. 2017 Sep 15; 23(18):5639-5647.Clin Cancer Res2017-06-13T00:00:002017Treatment of Pancreatic Cancer Patient-Derived Xenograft Panel with Metabolic Inhibitors Reveals Efficacy of Phenformin.28614206Chatterjee D, Katz MH, Foo WC, Sundar M, Wang H, Varadhachary GR, Wolff RA, Lee JE, Maitra A, Fleming JB, Rashid A, Wang HThe American journal of surgical pathologyPrognostic Significance of New AJCC Tumor Stage in Patients With Pancreatic Ductal Adenocarcinoma Treated With Neoadjuvant Therapy. Am J Surg Pathol. 2017 Aug; 41(8):1097-1104.Am J Surg Pathol2017-08-01T00:00:002017Prognostic Significance of New AJCC Tumor Stage in Patients With Pancreatic Ductal Adenocarcinoma Treated With Neoadjuvant Therapy.28351381von Ahrens D, Bhagat TD, Nagrath D, Maitra A, Verma AJournal of hematology & oncologyThe role of stromal cancer-associated fibroblasts in pancreatic cancer. J Hematol Oncol. 2017 03 28; 10(1):76.J Hematol Oncol2017-03-28T00:00:002017The role of stromal cancer-associated fibroblasts in pancreatic cancer.28656024McAllister F, Montiel MF, Uberoi GS, Uberoi AS, Maitra A, Bhutani MSGastroenterology & hepatologyCurrent Status and Future Directions for Screening Patients at High Risk for Pancreatic Cancer. Gastroenterol Hepatol (N Y). 2017 May; 13(5):268-275.Gastroenterol Hepatol (N Y)2017-05-01T00:00:002017Current Status and Future Directions for Screening Patients at High Risk for Pancreatic Cancer.28398845Khorana AA, Mangu PB, Berlin J, Engebretson A, Hong TS, Maitra A, Mohile SG, Mumber M, Schulick R, Shapiro M, Urba S, Zeh HJ, Katz MHGJournal of clinical oncology : official journal of the American Society of Clinical OncologyPotentially Curable Pancreatic Cancer: American Society of Clinical Oncology Clinical Practice Guideline Update. J Clin Oncol. 2017 Jul 10; 35(20):2324-2328.J Clin Oncol2017-04-11T00:00:002017Potentially Curable Pancreatic Cancer: American Society of Clinical Oncology Clinical Practice Guideline Update.28986391Bhattacharyya S, Pradhan K, Campbell N, Mazdo J, Vasantkumar A, Maqbool S, Bhagat TD, Gupta S, Suzuki M, Yu Y, Greally JM, Steidl U, Bradner J, Dawlaty M, Godley L, Maitra A, Verma AGenome researchAltered hydroxymethylation is seen at regulatory regions in pancreatic cancer and regulates oncogenic pathways. Genome Res. 2017 11; 27(11):1830-1842.Genome Res2017-10-06T00:00:002017Altered hydroxymethylation is seen at regulatory regions in pancreatic cancer and regulates oncogenic pathways.28843279?zdemir BC, Pentcheva-Hoang T, Carstens JL, Zheng X, Wu CC, Simpson TR, Laklai H, Sugimoto H, Kahlert C, Novitskiy SV, De Jesus-Acosta A, Sharma P, Heidari P, Mahmood U, Chin L, Moses HL, Weaver VM, Maitra A, Allison JP, LeBleu VS, Kalluri RCancer cellDepletion of Carcinoma-Associated Fibroblasts and Fibrosis Induces Immunosuppression and Accelerates Pancreas Cancer with Reduced Survival. Cancer Cell. 2015 Dec 14; 28(6):831-833.Cancer Cell2015-12-14T00:00:002015Depletion of Carcinoma-Associated Fibroblasts and Fibrosis Induces Immunosuppression and Accelerates Pancreas Cancer with Reduced Survival.29180468Ludwig KF, Du W, Sorrelle NB, Wnuk-Lipinska K, Topalovski M, Toombs JE, Cruz VH, Yabuuchi S, Rajeshkumar NV, Maitra A, Lorens JB, Brekken RACancer researchSmall-Molecule Inhibition of Axl Targets Tumor Immune Suppression and Enhances Chemotherapy in Pancreatic Cancer. Cancer Res. 2018 01 01; 78(1):246-255.Cancer Res2017-11-27T00:00:002017Small-Molecule Inhibition of Axl Targets Tumor Immune Suppression and Enhances Chemotherapy in Pancreatic Cancer.28700784Cloyd JM, Wang H, Egger ME, Tzeng CD, Prakash LR, Maitra A, Varadhachary GR, Shroff R, Javle M, Fogelman D, Wolff RA, Overman MJ, Koay EJ, Das P, Herman JM, Kim MP, Vauthey JN, Aloia TA, Fleming JB, Lee JE, Katz MHGJAMA surgeryAssociation of Clinical Factors With a Major Pathologic Response Following Preoperative Therapy for Pancreatic Ductal Adenocarcinoma. JAMA Surg. 2017 Nov 01; 152(11):1048-1056.JAMA Surg2017-11-01T00:00:002017Association of Clinical Factors With a Major Pathologic Response Following Preoperative Therapy for Pancreatic Ductal Adenocarcinoma.28902789Nejati R, Goldstein JB, Halperin DM, Wang H, Hejazi N, Rashid A, Katz MH, Lee JE, Fleming JB, Rodriguez-Canales J, Blando J, Wistuba II, Maitra A, Wolff RA, Varadhachary GR, Wang HPancreasPrognostic Significance of Tumor-Infiltrating Lymphocytes in Patients With Pancreatic Ductal Adenocarcinoma Treated With Neoadjuvant Chemotherapy. Pancreas. 2017 10; 46(9):1180-1187.Pancreas2017-10-01T00:00:002017Prognostic Significance of Tumor-Infiltrating Lymphocytes in Patients With Pancreatic Ductal Adenocarcinoma Treated With Neoadjuvant Chemotherapy.28912244Geller LT, Barzily-Rokni M, Danino T, Jonas OH, Shental N, Nejman D, Gavert N, Zwang Y, Cooper ZA, Shee K, Thaiss CA, Reuben A, Livny J, Avraham R, Frederick DT, Ligorio M, Chatman K, Johnston SE, Mosher CM, Brandis A, Fuks G, Gurbatri C, Gopalakrishnan V, Kim M, Hurd MW, Katz M, Fleming J, Maitra A, Smith DA, Skalak M, Bu J, Michaud M, Trauger SA, Barshack I, Golan T, Sandbank J, Flaherty KT, Mandinova A, Garrett WS, Thayer SP, Ferrone CR, Huttenhower C, Bhatia SN, Gevers D, Wargo JA, Golub TR, Straussman RScience (New York, N.Y.)Potential role of intratumor bacteria in mediating tumor resistance to the chemotherapeutic drug gemcitabine. Science. 2017 09 15; 357(6356):1156-1160.Science2017-09-15T00:00:002017Potential role of intratumor bacteria in mediating tumor resistance to the chemotherapeutic drug gemcitabine.29045505Castillo J, Bernard V, San Lucas FA, Allenson K, Capello M, Kim DU, Gascoyne P, Mulu FC, Stephens BM, Huang J, Wang H, Momin AA, Jacamo RO, Katz M, Wolff R, Javle M, Varadhachary G, Wistuba II, Hanash S, Maitra A, Alvarez HAnnals of oncology : official journal of the European Society for Medical OncologySurfaceome profiling enables isolation of cancer-specific exosomal cargo in liquid biopsies from pancreatic cancer patients. Ann Oncol. 2018 01 01; 29(1):223-229.Ann Oncol2018-01-01T00:00:002018Surfaceome profiling enables isolation of cancer-specific exosomal cargo in liquid biopsies from pancreatic cancer patients.28692661Begum A, Ewachiw T, Jung C, Huang A, Norberg KJ, Marchionni L, McMillan R, Penchev V, Rajeshkumar NV, Maitra A, Wood L, Wang C, Wolfgang C, DeJesus-Acosta A, Laheru D, Shapiro IM, Padval M, Pachter JA, Weaver DT, Rasheed ZA, Matsui WPloS oneThe extracellular matrix and focal adhesion kinase signaling regulate cancer stem cell function in pancreatic ductal adenocarcinoma. PLoS One. 2017; 12(7):e0180181.PLoS One2017-07-10T00:00:002017The extracellular matrix and focal adhesion kinase signaling regulate cancer stem cell function in pancreatic ductal adenocarcinoma.28816351Marcus R, Maitra A, Roszik JThe Journal of pathologyRecent advances in genomic profiling of adenosquamous carcinoma of the pancreas. J Pathol. 2017 11; 243(3):271-272.J Pathol2017-09-25T00:00:002017Recent advances in genomic profiling of adenosquamous carcinoma of the pancreas.28874546Cohen JD, Javed AA, Thoburn C, Wong F, Tie J, Gibbs P, Schmidt CM, Yip-Schneider MT, Allen PJ, Schattner M, Brand RE, Singhi AD, Petersen GM, Hong SM, Kim SC, Falconi M, Doglioni C, Weiss MJ, Ahuja N, He J, Makary MA, Maitra A, Hanash SM, Dal Molin M, Wang Y, Li L, Ptak J, Dobbyn L, Schaefer J, Silliman N, Popoli M, Goggins MG, Hruban RH, Wolfgang CL, Klein AP, Tomasetti C, Papadopoulos N, Kinzler KW, Vogelstein B, Lennon AMProceedings of the National Academy of Sciences of the United States of AmericaCombined circulating tumor DNA and protein biomarker-based liquid biopsy for the earlier detection of pancreatic cancers. Proc Natl Acad Sci U S A. 2017 09 19; 114(38):10202-10207.Proc Natl Acad Sci U S A2017-09-05T00:00:002017Combined circulating tumor DNA and protein biomarker-based liquid biopsy for the earlier detection of pancreatic cancers.29317774Semaan A, Maitra ANature reviews. Gastroenterology & hepatologyPancreatic cancer in 2017: Rebooting pancreatic cancer knowledge and treatment options. Nat Rev Gastroenterol Hepatol. 2018 02; 15(2):76-78.Nat Rev Gastroenterol Hepatol2018-01-10T00:00:002018Pancreatic cancer in 2017: Rebooting pancreatic cancer knowledge and treatment options.29299351Ramanathan RK, Weiss GJ, Posner RG, Rajeshkumar NV, Jameson G, Aziz M, Hoering A, Bolejack V, Maitra A, Fulk M, Stites EC, Hlavacek WS, Gatalica Z, Xiu J, Hidalgo M, Von Hoff DD, Barrett MTJournal of gastrointestinal oncologyA phase 2 trial of personalized cytotoxic therapy based on tumor immunohistochemistry in previously treated metastatic pancreatic cancer patients. J Gastrointest Oncol. 2017 Dec; 8(6):925-935.J Gastrointest Oncol2017-12-01T00:00:002017A phase 2 trial of personalized cytotoxic therapy based on tumor immunohistochemistry in previously treated metastatic pancreatic cancer patients.29599906Wolff RA, Wang-Gillam A, Alvarez H, Tiriac H, Engle D, Hou S, Groff AF, San Lucas A, Bernard V, Allenson K, Castillo J, Kim D, Mulu F, Huang J, Stephens B, Wistuba II, Katz M, Varadhachary G, Park Y, Hicks J, Chinnaiyan A, Scampavia L, Spicer T, Gerhardinger C, Maitra A, Tuveson D, Rinn J, Lizee G, Yee C, Levine AJOncotargetDynamic changes during the treatment of pancreatic cancer. Oncotarget. 2018 Mar 13; 9(19):14764-14790.Oncotarget2018-02-13T00:00:002018Dynamic changes during the treatment of pancreatic cancer.29604293Zhang Y, Zoltan M, Riquelme E, Xu H, Sahin I, Castro-Pando S, Montiel MF, Chang K, Jiang Z, Ling J, Gupta S, Horne W, Pruski M, Wang H, Sun SC, Lozano G, Chiao P, Maitra A, Leach SD, Kolls JK, Vilar E, Wang TC, Bailey JM, McAllister FGastroenterologyImmune Cell Production of Interleukin 17 Induces Stem Cell Features of Pancreatic Intraepithelial Neoplasia Cells. Gastroenterology. 2018 07; 155(1):210-223.e3.Gastroenterology2018-03-29T00:00:002018Immune Cell Production of Interleukin 17 Induces Stem Cell Features of Pancreatic Intraepithelial Neoplasia Cells.29610286Riquelme E, Maitra A, McAllister FCancer discoveryImmunotherapy for Pancreatic Cancer: More Than Just a Gut Feeling. Cancer Discov. 2018 04; 8(4):386-388.Cancer Discov2018-04-01T00:00:002018Immunotherapy for Pancreatic Cancer: More Than Just a Gut Feeling.29669940Mendt M, Kamerkar S, Sugimoto H, McAndrews KM, Wu CC, Gagea M, Yang S, Blanko EVR, Peng Q, Ma X, Marszalek JR, Maitra A, Yee C, Rezvani K, Shpall E, LeBleu VS, Kalluri RJCI insightGeneration and testing of clinical-grade exosomes for pancreatic cancer. JCI Insight. 2018 04 19; 3(8).JCI Insight2018-04-19T00:00:002018Generation and testing of clinical-grade exosomes for pancreatic cancer.29370450Amer AM, Zaid M, Chaudhury B, Elganainy D, Lee Y, Wilke CT, Cloyd J, Wang H, Maitra A, Wolff RA, Varadhachary G, Overman MJ, Lee JE, Fleming JB, Tzeng CW, Katz MH, Holliday EB, Krishnan S, Minsky BD, Herman JM, Taniguchi CM, Das P, Crane CH, Le O, Bhosale P, Tamm EP, Koay EJCancerImaging-based biomarkers: Changes in the tumor interface of pancreatic ductal adenocarcinoma on computed tomography scans indicate response to cytotoxic therapy. Cancer. 2018 04 15; 124(8):1701-1709.Cancer2018-01-25T00:00:002018Imaging-based biomarkers: Changes in the tumor interface of pancreatic ductal adenocarcinoma on computed tomography scans indicate response to cytotoxic therapy.29567676Shah MY, Ferracin M, Pileczki V, Chen B, Redis R, Fabris L, Zhang X, Ivan C, Shimizu M, Rodriguez-Aguayo C, Dragomir M, Van Roosbroeck K, Almeida MI, Ciccone M, Nedelcu D, Cortez MA, Manshouri T, Calin S, Muftuoglu M, Banerjee PP, Badiwi MH, Parker-Thornburg J, Multani A, Welsh JW, Estecio MR, Ling H, Tomuleasa C, Dima D, Yang H, Alvarez H, You MJ, Radovich M, Shpall E, Fabbri M, Rezvani K, Girnita L, Berindan-Neagoe I, Maitra A, Verstovsek S, Fodde R, Bueso-Ramos C, Gagea M, Manero GG, Calin GAGenome researchCancer-associated rs6983267 SNP and its accompanying long noncoding RNA CCAT2 induce myeloid malignancies via unique SNP-specific RNA mutations. Genome Res. 2018 04; 28(4):432-447.Genome Res2018-03-22T00:00:002018Cancer-associated rs6983267 SNP and its accompanying long noncoding RNA CCAT2 induce myeloid malignancies via unique SNP-specific RNA mutations.29424809Fonseca AL, Kirkwood K, Kim MP, Maitra A, Koay EJPancreasIntraductal Papillary Mucinous Neoplasms of the Pancreas: Current Understanding and Future Directions for Stratification of Malignancy Risk. Pancreas. 2018 03; 47(3):272-279.Pancreas2018-03-01T00:00:002018Intraductal Papillary Mucinous Neoplasms of the Pancreas: Current Understanding and Future Directions for Stratification of Malignancy Risk.30013304Barua S, Solis L, Parra ER, Uraoka N, Jiang M, Wang H, Rodriguez-Canales J, Wistuba I, Maitra A, Sen S, Rao ACancer informaticsA Functional Spatial Analysis Platform for Discovery of Immunological Interactions Predictive of Low-Grade to High-Grade Transition of Pancreatic Intraductal Papillary Mucinous Neoplasms. Cancer Inform. 2018; 17:1176935118782880.Cancer Inform2018-06-28T00:00:002018A Functional Spatial Analysis Platform for Discovery of Immunological Interactions Predictive of Low-Grade to High-Grade Transition of Pancreatic Intraductal Papillary Mucinous Neoplasms.30082477Koay EJ, Lee Y, Cristini V, Lowengrub JS, Kang Y, Lucas FAS, Hobbs BP, Ye R, Elganainy D, Almahariq M, Amer AM, Chatterjee D, Yan H, Park PC, Rios Perez MV, Li D, Garg N, Reiss KA, Yu S, Chauhan A, Zaid M, Nikzad N, Wolff RA, Javle M, Varadhachary GR, Shroff RT, Das P, Lee JE, Ferrari M, Maitra A, Taniguchi CM, Kim MP, Crane CH, Katz MH, Wang H, Bhosale P, Tamm EP, Fleming JBClinical cancer research : an official journal of the American Association for Cancer ResearchA Visually Apparent and Quantifiable CT Imaging Feature Identifies Biophysical Subtypes of Pancreatic Ductal Adenocarcinoma. Clin Cancer Res. 2018 12 01; 24(23):5883-5894.Clin Cancer Res2018-08-06T00:00:002018A Visually Apparent and Quantifiable CT Imaging Feature Identifies Biophysical Subtypes of Pancreatic Ductal Adenocarcinoma.30137376Fahrmann JF, Bantis LE, Capello M, Scelo G, Dennison JB, Patel N, Murage E, Vykoukal J, Kundnani DL, Foretova L, Fabianova E, Holcatova I, Janout V, Feng Z, Yip-Schneider M, Zhang J, Brand R, Taguchi A, Maitra A, Brennan P, Max Schmidt C, Hanash SJournal of the National Cancer InstituteA Plasma-Derived Protein-Metabolite Multiplexed Panel for Early-Stage Pancreatic Cancer. J Natl Cancer Inst. 2019 04 01; 111(4):372-379.J Natl Cancer Inst2019-04-01T00:00:002019A Plasma-Derived Protein-Metabolite Multiplexed Panel for Early-Stage Pancreatic Cancer.30142336Ideno N, Yamaguchi H, Ghosh B, Gupta S, Okumura T, Steffen DJ, Fisher CG, Wood LD, Singhi AD, Nakamura M, Gutkind JS, Maitra AGastroenterologyGNASR201C Induces Pancreatic Cystic Neoplasms in Mice That Express Activated KRAS by Inhibiting YAP1 Signaling. Gastroenterology. 2018 11; 155(5):1593-1607.e12.Gastroenterology2018-08-22T00:00:002018GNASR201C Induces Pancreatic Cystic Neoplasms in Mice That Express Activated KRAS by Inhibiting YAP1 Signaling.30274973Bannon SA, Montiel MF, Goldstein JB, Dong W, Mork ME, Borras E, Hasanov M, Varadhachary GR, Maitra A, Katz MH, Feng L, Futreal A, Fogelman DR, Vilar E, McAllister FCancer prevention research (Philadelphia, Pa.)High Prevalence of Hereditary Cancer Syndromes and Outcomes in Adults with Early-Onset Pancreatic Cancer. Cancer Prev Res (Phila). 2018 11; 11(11):679-686.Cancer Prev Res (Phila)2018-10-01T00:00:002018High Prevalence of Hereditary Cancer Syndromes and Outcomes in Adults with Early-Onset Pancreatic Cancer.30286471Feldmann G, Brossart P, Maitra AOncology research and treatment'Diseases Desperate Grown by Desperate Appliance Are Relieved, or Not at all' - Towards Finding a Cure for Pancreatic Cancer, Where Do We Stand Today? Oncol Res Treat. 2018; 41(10):588-589.Oncol Res Treat2018-09-28T00:00:002018'Diseases Desperate Grown by Desperate Appliance Are Relieved, or Not at all' - Towards Finding a Cure for Pancreatic Cancer, Where Do We Stand Today?30324485Gulhati P, Prakash L, Katz MHG, Wang X, Javle M, Shroff R, Fogelman D, Lee JE, Tzeng CD, Lee JH, Weston B, Tamm E, Bhosale P, Koay EJ, Maitra A, Wang H, Wolff RA, Varadhachary GRAnnals of surgical oncologyFirst-Line Gemcitabine and Nab-Paclitaxel Chemotherapy for Localized Pancreatic Ductal Adenocarcinoma. Ann Surg Oncol. 2019 Feb; 26(2):619-627.Ann Surg Oncol2018-10-15T00:00:002018First-Line Gemcitabine and Nab-Paclitaxel Chemotherapy for Localized Pancreatic Ductal Adenocarcinoma.30325853Goggins MG, Lippman SM, Constantinou PE, Jacks T, Petersen GM, Syngal S, Maitra APancreasIntercepting Pancreatic Cancer: Our Dream Team's Resolve to Stop Pancreatic Cancer. Pancreas. 2018 Nov/Dec; 47(10):1175-1176.Pancreas2018-11-01T00:00:002018Intercepting Pancreatic Cancer: Our Dream Team's Resolve to Stop Pancreatic Cancer.30325864Maitra A, Sharma A, Brand RE, Van Den Eeden SK, Fisher WE, Hart PA, Hughes SJ, Mather KJ, Pandol SJ, Park WG, Feng Z, Serrano J, Rinaudo JAS, Srivastava S, Chari ST, Consortium for the Study of Chronic Pancreatitis, Diabetes, and Pancreatic Cancer (CPDPC)PancreasA Prospective Study to Establish a New-Onset Diabetes Cohort: From the Consortium for the Study of Chronic Pancreatitis, Diabetes, and Pancreatic Cancer. Pancreas. 2018 Nov/Dec; 47(10):1244-1248.Pancreas2018-11-01T00:00:002018A Prospective Study to Establish a New-Onset Diabetes Cohort: From the Consortium for the Study of Chronic Pancreatitis, Diabetes, and Pancreatic Cancer.30170819Sharib JM, Fonseca AL, Swords DS, Jaradeh K, Bracci PM, Firpo MA, Hatcher S, Scaife CL, Wang H, Kim GE, Mulvihill SJ, Maitra A, Koay EJ, Kirkwood KSSurgerySurgical overtreatment of pancreatic intraductal papillary mucinous neoplasms: Do the 2017 International Consensus Guidelines improve clinical decision making? Surgery. 2018 12; 164(6):1178-1184.Surgery2018-08-28T00:00:002018Surgical overtreatment of pancreatic intraductal papillary mucinous neoplasms: Do the 2017 International Consensus Guidelines improve clinical decision making?30240661Bernard V, Kim DU, San Lucas FA, Castillo J, Allenson K, Mulu FC, Stephens BM, Huang J, Semaan A, Guerrero PA, Kamyabi N, Zhao J, Hurd MW, Koay EJ, Taniguchi CM, Herman JM, Javle M, Wolff R, Katz M, Varadhachary G, Maitra A, Alvarez HAGastroenterologyCirculating Nucleic Acids Are Associated With Outcomes of Patients With Pancreatic Cancer. Gastroenterology. 2019 01; 156(1):108-118.e4.Gastroenterology2018-09-19T00:00:002018Circulating Nucleic Acids Are Associated With Outcomes of Patients With Pancreatic Cancer.30355799Zhou L, Husted H, Moore T, Lu M, Deng D, Liu Y, Ramachandran V, Arumugam T, Niehrs C, Wang H, Chiao P, Ling J, Curran MA, Maitra A, Hung MC, Lee JE, Logsdon CD, Hwang RFScience translational medicineSuppression of stromal-derived Dickkopf-3 (DKK3) inhibits tumor progression and prolongs survival in pancreatic ductal adenocarcinoma. Sci Transl Med. 2018 10 24; 10(464).Sci Transl Med2018-10-24T00:00:002018Suppression of stromal-derived Dickkopf-3 (DKK3) inhibits tumor progression and prolongs survival in pancreatic ductal adenocarcinoma.30655325Penchev VR, Chang YT, Begum A, Ewachiw T, Gocke C, Li J, McMillan RH, Wang Q, Anders R, Marchionni L, Maitra A, Uren A, Rasheed Z, Matsui WMolecular cancer research : MCREzrin Promotes Stem Cell Properties in Pancreatic Ductal Adenocarcinoma. Mol Cancer Res. 2019 04; 17(4):929-936.Mol Cancer Res2019-01-17T00:00:002019Ezrin Promotes Stem Cell Properties in Pancreatic Ductal Adenocarcinoma.30747823Wang EM, Akasaka H, Zhao J, Varadhachary GR, Lee JE, Maitra A, Fleming JB, Hung MC, Wang H, Katz MHGPancreasExpression and Clinical Significance of Protein Kinase RNA-Like Endoplasmic Reticulum Kinase and Phosphorylated Eukaryotic Initiation Factor 2a in Pancreatic Ductal Adenocarcinoma. Pancreas. 2019 Mar; 48(3):323-328.Pancreas2019-03-01T00:00:002019Expression and Clinical Significance of Protein Kinase RNA-Like Endoplasmic Reticulum Kinase and Phosphorylated Eukaryotic Initiation Factor 2a in Pancreatic Ductal Adenocarcinoma.30747824Begum A, McMillan RH, Chang YT, Penchev VR, Rajeshkumar NV, Maitra A, Goggins MG, Eshelman JR, Wolfgang CL, Rasheed ZA, Matsui WPancreasDirect Interactions With Cancer-Associated Fibroblasts Lead to Enhanced Pancreatic Cancer Stem Cell Function. Pancreas. 2019 Mar; 48(3):329-334.Pancreas2019-03-01T00:00:002019Direct Interactions With Cancer-Associated Fibroblasts Lead to Enhanced Pancreatic Cancer Stem Cell Function.30753823Carugo A, Minelli R, Sapio L, Soeung M, Carbone F, Robinson FS, Tepper J, Chen Z, Lovisa S, Svelto M, Amin S, Srinivasan S, Del Poggetto E, Loponte S, Puca F, Dey P, Malouf GG, Su X, Li L, Lopez-Terrada D, Rakheja D, Lazar AJ, Netto GJ, Rao P, Sgambato A, Maitra A, Tripathi DN, Walker CL, Karam JA, Heffernan TP, Viale A, Roberts CWM, Msaouel P, Tannir NM, Draetta GF, Genovese GCancer cellp53 Is a Master Regulator of Proteostasis in SMARCB1-Deficient Malignant Rhabdoid Tumors. Cancer Cell. 2019 02 11; 35(2):204-220.e9.Cancer Cell2019-02-11T00:00:002019p53 Is a Master Regulator of Proteostasis in SMARCB1-Deficient Malignant Rhabdoid Tumors.30651550Capello M, Vykoukal JV, Katayama H, Bantis LE, Wang H, Kundnani DL, Aguilar-Bonavides C, Aguilar M, Tripathi SC, Dhillon DS, Momin AA, Peters H, Katz MH, Alvarez H, Bernard V, Ferri-Borgogno S, Brand R, Adler DG, Firpo MA, Mulvihill SJ, Molldrem JJ, Feng Z, Taguchi A, Maitra A, Hanash SMNature communicationsExosomes harbor B cell targets in pancreatic adenocarcinoma and exert decoy function against complement-mediated cytotoxicity. Nat Commun. 2019 01 16; 10(1):254.Nat Commun2019-01-16T00:00:002019Exosomes harbor B cell targets in pancreatic adenocarcinoma and exert decoy function against complement-mediated cytotoxicity.30721664Singhi AD, Koay EJ, Chari ST, Maitra AGastroenterologyEarly Detection of Pancreatic Cancer: Opportunities and Challenges. Gastroenterology. 2019 05; 156(7):2024-2040.Gastroenterology2019-02-02T00:00:002019Early Detection of Pancreatic Cancer: Opportunities and Challenges.30385653Bernard V, Semaan A, Huang J, San Lucas FA, Mulu FC, Stephens BM, Guerrero PA, Huang Y, Zhao J, Kamyabi N, Sen S, Scheet PA, Taniguchi CM, Kim MP, Tzeng CW, Katz MH, Singhi AD, Maitra A, Alvarez HAClinical cancer research : an official journal of the American Association for Cancer ResearchSingle-Cell Transcriptomics of Pancreatic Cancer Precursors Demonstrates Epithelial and Microenvironmental Heterogeneity as an Early Event in Neoplastic Progression. Clin Cancer Res. 2019 Apr 01; 25(7):2194-2205.Clin Cancer Res2018-11-01T00:00:002018Single-Cell Transcriptomics of Pancreatic Cancer Precursors Demonstrates Epithelial and Microenvironmental Heterogeneity as an Early Event in Neoplastic Progression.30530635Lippman SM, Abate-Shen C, Colbert Maresso KL, Colditz GA, Dannenberg AJ, Davidson NE, Disis ML, DuBois RN, Szabo E, Giuliano AR, Hait WN, Lee JJ, Kensler TW, Kramer BS, Limburg P, Maitra A, Martinez ME, Rebbeck TR, Schmitz KH, Vilar E, Hawk ETCancer prevention research (Philadelphia, Pa.)AACR White Paper: Shaping the Future of Cancer Prevention - A Roadmap for Advancing Science and Public Health. Cancer Prev Res (Phila). 2018 12; 11(12):735-778.Cancer Prev Res (Phila)2018-12-01T00:00:002018AACR White Paper: Shaping the Future of Cancer Prevention - A Roadmap for Advancing Science and Public Health.30612740Liu S, Hausmann S, Carlson SM, Fuentes ME, Francis JW, Pillai R, Lofgren SM, Hulea L, Tandoc K, Lu J, Li A, Nguyen ND, Caporicci M, Kim MP, Maitra A, Wang H, Wistuba II, Porco JA, Bassik MC, Elias JE, Song J, Topisirovic I, Van Rechem C, Mazur PK, Gozani OCellMETTL13 Methylation of eEF1A Increases Translational Output to Promote Tumorigenesis. Cell. 2019 01 24; 176(3):491-504.e21.Cell2019-01-03T00:00:002019METTL13 Methylation of eEF1A Increases Translational Output to Promote Tumorigenesis.30617132Staal B, Liu Y, Barnett D, Hsueh P, He Z, Gao C, Partyka K, Hurd MW, Singhi AD, Drake RR, Huang Y, Maitra A, Brand RE, Haab BBClinical cancer research : an official journal of the American Association for Cancer ResearchThe sTRA Plasma Biomarker: Blinded Validation of Improved Accuracy Over CA19-9 in Pancreatic Cancer Diagnosis. Clin Cancer Res. 2019 05 01; 25(9):2745-2754.Clin Cancer Res2019-01-07T00:00:002019The sTRA Plasma Biomarker: Blinded Validation of Improved Accuracy Over CA19-9 in Pancreatic Cancer Diagnosis.PathologyAuthorship 94066110Authorship 9412881Authorship 9424931Authorship 942712630850740Maitra ANatureMolecular envoys pave the way for pancreatic cancer to invade the liver. Nature. 2019 03; 567(7747):181-182.Nature2019-03-01T00:00:002019Molecular envoys pave the way for pancreatic cancer to invade the liver.30836094Singhi AD, George B, Greenbowe JR, Chung J, Suh J, Maitra A, Klempner SJ, Hendifar A, Milind JM, Golan T, Brand RE, Zureikat AH, Roy S, Schrock AB, Miller VA, Ross JS, Ali SM, Bahary NGastroenterologyReal-Time Targeted Genome Profile Analysis of Pancreatic Ductal Adenocarcinomas Identifies Genetic Alterations That Might Be Targeted With Existing Drugs or Used as Biomarkers. Gastroenterology. 2019 06; 156(8):2242-2253.e4.Gastroenterology2019-03-02T00:00:002019Real-Time Targeted Genome Profile Analysis of Pancreatic Ductal Adenocarcinomas Identifies Genetic Alterations That Might Be Targeted With Existing Drugs or Used as Biomarkers.29736695Maitra AIndian journal of pediatricsSevere Asthma: Challenges and Pitfalls in Management. Indian J Pediatr. 2018 Sep; 85(9):763-772.Indian J Pediatr2018-05-07T00:00:002018Severe Asthma: Challenges and Pitfalls in Management.30635425Blando J, Sharma A, Higa MG, Zhao H, Vence L, Yadav SS, Kim J, Sepulveda AM, Sharp M, Maitra A, Wargo J, Tetzlaff M, Broaddus R, Katz MHG, Varadhachary GR, Overman M, Wang H, Yee C, Bernatchez C, Iacobuzio-Donahue C, Basu S, Allison JP, Sharma PProceedings of the National Academy of Sciences of the United States of AmericaComparison of immune infiltrates in melanoma and pancreatic cancer highlights VISTA as a potential target in pancreatic cancer. Proc Natl Acad Sci U S A. 2019 01 29; 116(5):1692-1697.Proc Natl Acad Sci U S A2019-01-11T00:00:002019Comparison of immune infiltrates in melanoma and pancreatic cancer highlights VISTA as a potential target in pancreatic cancer.Authorship 9434923330918400Yao W, Rose JL, Wang W, Seth S, Jiang H, Taguchi A, Liu J, Yan L, Kapoor A, Hou P, Chen Z, Wang Q, Nezi L, Xu Z, Yao J, Hu B, Pettazzoni PF, Ho IL, Feng N, Ramamoorthy V, Jiang S, Deng P, Ma GJ, Den P, Tan Z, Zhang SX, Wang H, Wang YA, Deem AK, Fleming JB, Carugo A, Heffernan TP, Maitra A, Viale A, Ying H, Hanash S, DePinho RA, Draetta GFNatureSyndecan 1 is a critical mediator of macropinocytosis in pancreatic cancer. Nature. 2019 04; 568(7752):410-414.Nature2019-03-27T00:00:002019Syndecan 1 is a critical mediator of macropinocytosis in pancreatic cancer.Authorship 94408720Authorship 944248930726735Seth S, Li CY, Ho IL, Corti D, Loponte S, Sapio L, Del Poggetto E, Yen EY, Robinson FS, Peoples M, Karpinets T, Deem AK, Kumar T, Song X, Jiang S, Kang Y, Fleming J, Kim M, Zhang J, Maitra A, Heffernan TP, Giuliani V, Genovese G, Futreal A, Draetta GF, Carugo A, Viale ACell reportsPre-existing Functional Heterogeneity of Tumorigenic Compartment as the Origin of Chemoresistance in Pancreatic Tumors. Cell Rep. 2019 02 05; 26(6):1518-1532.e9.Cell Rep2019-02-05T00:00:002019Pre-existing Functional Heterogeneity of Tumorigenic Compartment as the Origin of Chemoresistance in Pancreatic Tumors.30728464Ideno N, Yamaguchi H, Okumura T, Huang J, Brun MJ, Ho ML, Suh J, Gupta S, Maitra A, Ghosh BLaboratory investigation; a journal of technical methods and pathologyA pipeline for rapidly generating genetically engineered mouse models of pancreatic cancer using in vivo CRISPR-Cas9-mediated somatic recombination. Lab Invest. 2019 Jul; 99(8):1233-1244.Lab Invest2019-02-06T00:00:002019A pipeline for rapidly generating genetically engineered mouse models of pancreatic cancer using in vivo CRISPR-Cas9-mediated somatic recombination.Authorship 944460230940522Saluja A, Maitra AGastroenterologyPancreatitis and Pancreatic Cancer. Gastroenterology. 2019 05; 156(7):1937-1940.Gastroenterology2019-03-30T00:00:002019Pancreatitis and Pancreatic Cancer.Authorship 9452932Authorship 945469230995147Shaw KRM, Maitra AAnnual review of genomics and human geneticsThe Status and Impact of Clinical Tumor Genome Sequencing. Annu Rev Genomics Hum Genet. 2019 08 31; 20:413-432.Annu Rev Genomics Hum Genet2019-04-17T00:00:002019The Status and Impact of Clinical Tumor Genome Sequencing.31002791Yao W, Maitra ACellHear Pancreatic Cancer Stem Cells ROR. Cell. 2019 04 18; 177(3):516-518.Cell2019-04-18T00:00:002019Hear Pancreatic Cancer Stem Cells ROR.Authorship 9463971731043430Fujimoto TN, Colbert LE, Huang Y, Molkentine JM, Deorukhkar A, Baseler L, Yu M, Lin D, Gupta S, Cabeceiras PK, Kingsley CV, Tailor RC, Sawakuchi GO, Koay EJ, Piwnica-Worms H, Maitra A, Taniguchi CMCancer researchSelective EGLN Inhibition Enables Ablative Radiotherapy and Improves Survival in Unresectable Pancreatic Cancer. Cancer Res. 2019 05 01; 79(9):2327-2338.Cancer Res2019-05-01T00:00:002019Selective EGLN Inhibition Enables Ablative Radiotherapy and Improves Survival in Unresectable Pancreatic Cancer.Authorship 94764014Authorship 948407931120258Dutta P, Perez MR, Lee J, Kang Y, Pratt M, Salzillo TC, Weygand J, Zacharias NM, Gammon ST, Koay EJ, Kim M, McAllister F, Sen S, Maitra A, Piwnica-Worms D, Fleming JB, Bhattacharya PKJournal of proteome researchCombining Hyperpolarized Real-Time Metabolic Imaging and NMR Spectroscopy To Identify Metabolic Biomarkers in Pancreatic Cancer. J Proteome Res. 2019 07 05; 18(7):2826-2834.J Proteome Res2019-06-04T00:00:002019Combining Hyperpolarized Real-Time Metabolic Imaging and NMR Spectroscopy To Identify Metabolic Biomarkers in Pancreatic Cancer.31170555Vicente D, Lee AJ, Hall CS, Lucci A, Lee JE, Kim MP, Katz MHG, Hurd MW, Maitra A, Rhim Md AD, Tzeng CDThe Journal of surgical researchCirculating Tumor Cells and Transforming Growth Factor Beta in Resected Pancreatic Adenocarcinoma. J Surg Res. 2019 11; 243:90-99.J Surg Res2019-06-03T00:00:002019Circulating Tumor Cells and Transforming Growth Factor Beta in Resected Pancreatic Adenocarcinoma.Authorship 948899531180816Khorana AA, McKernin SE, Berlin J, Hong TS, Maitra A, Moravek C, Mumber M, Schulick R, Zeh HJ, Katz MHGJournal of clinical oncology : official journal of the American Society of Clinical OncologyPotentially Curable Pancreatic Adenocarcinoma: ASCO Clinical Practice Guideline Update. J Clin Oncol. 2019 08 10; 37(23):2082-2088.J Clin Oncol2019-06-10T00:00:002019Potentially Curable Pancreatic Adenocarcinoma: ASCO Clinical Practice Guideline Update.Authorship 950226128476743Maitra AJournal of the National Comprehensive Cancer Network : JNCCNSlicing and Dicing Pancreatic Cancer Into Actionable Nuggets. J Natl Compr Canc Netw. 2017 05; 15(5):649-650.J Natl Compr Canc Netw2017-05-01T00:00:002017Slicing and Dicing Pancreatic Cancer Into Actionable Nuggets.Authorship 951309231253855Soragni A, Maitra ANature reviews. CancerOf scientists and tweets. Nat Rev Cancer. 2019 09; 19(9):479-480.Nat Rev Cancer2019-09-01T00:00:002019Of scientists and tweets.Authorship 9524482Authorship 952470731332344Pant S, Maitra A, Yap TANature reviews. Clinical oncologyPARP inhibition - opportunities in pancreatic cancer. Nat Rev Clin Oncol. 2019 10; 16(10):595-596.Nat Rev Clin Oncol2019-10-01T00:00:002019PARP inhibition - opportunities in pancreatic cancer.31335325Yu M, Nguyen ND, Huang Y, Lin D, Fujimoto TN, Molkentine JM, Deorukhkar A, Kang Y, San Lucas FA, Fernandes CJ, Koay EJ, Gupta S, Ying H, Koong AC, Herman JM, Fleming JB, Maitra A, Taniguchi CMJCI insightMitochondrial fusion exploits a therapeutic vulnerability of pancreatic cancer. JCI Insight. 2019 07 23; 5.JCI Insight2019-07-23T00:00:002019Mitochondrial fusion exploits a therapeutic vulnerability of pancreatic cancer.31335328Hosein AN, Huang H, Wang Z, Parmar K, Du W, Huang J, Maitra A, Olson E, Verma U, Brekken RAJCI insightCellular heterogeneity during mouse pancreatic ductal adenocarcinoma progression at single-cell resolution. JCI Insight. 2019 07 23; 5.JCI Insight2019-07-23T00:00:002019Cellular heterogeneity during mouse pancreatic ductal adenocarcinoma progression at single-cell resolution.Authorship 9529201731358539Vence L, Bucktrout SL, Fernandez Curbelo I, Blando J, Smith BM, Mahne AE, Lin JC, Park T, Pascua E, Sai T, Chaparro-Riggers J, Subudhi SK, Scutti JB, Higa MG, Zhao H, Yadav SS, Maitra A, Wistuba II, Allison JP, Sharma PClinical cancer research : an official journal of the American Association for Cancer ResearchCharacterization and Comparison of GITR Expression in Solid Tumors. Clin Cancer Res. 2019 11 01; 25(21):6501-6510.Clin Cancer Res2019-07-29T00:00:002019Characterization and Comparison of GITR Expression in Solid Tumors.Authorship 9535852531398337Riquelme E, Zhang Y, Zhang L, Montiel M, Zoltan M, Dong W, Quesada P, Sahin I, Chandra V, San Lucas A, Scheet P, Xu H, Hanash SM, Feng L, Burks JK, Do KA, Peterson CB, Nejman D, Tzeng CD, Kim MP, Sears CL, Ajami N, Petrosino J, Wood LD, Maitra A, Straussman R, Katz M, White JR, Jenq R, Wargo J, McAllister FCellTumor Microbiome Diversity and Composition Influence Pancreatic Cancer Outcomes. Cell. 2019 08 08; 178(4):795-806.e12.Cell2019-08-08T00:00:002019Tumor Microbiome Diversity and Composition Influence Pancreatic Cancer Outcomes.Authorship 95400017Authorship 955702331533487Kamyabi N, Bernard V, Maitra AExpert review of anticancer therapyLiquid biopsies in pancreatic cancer. Expert Rev Anticancer Ther. 2019 10; 19(10):869-878.Expert Rev Anticancer Ther2019-09-26T00:00:002019Liquid biopsies in pancreatic cancer.Authorship 95598713Authorship 9560692131552914Cazacu IM, Luzuriaga Chavez AA, Mendoza TR, Qiao W, Singh BS, Bokhari RH, Saftoiu A, Lee JH, Weston B, Stroehlein JR, Kim MP, G Katz MH, Maitra A, McAllister F, Bhutani MSEndoscopic ultrasoundQuality of life impact of EUS in patients at risk for developing pancreatic cancer. Endosc Ultrasound. 2020 Jan-Feb; 9(1):53-58.Endosc Ultrasound2020-01-01T00:00:002020Quality of life impact of EUS in patients at risk for developing pancreatic cancer.31557131Tu B, Yao J, Ferri-Borgogno S, Zhao J, Chen S, Wang Q, Yan L, Zhou X, Zhu C, Bang S, Chang Q, Bristow CA, Kang Y, Zheng H, Wang H, Fleming JB, Kim M, Heffernan TP, Draetta GF, Pan D, Maitra A, Yao W, Gupta S, Ying HJCI insightYAP1 oncogene is a context-specific driver for pancreatic ductal adenocarcinoma. JCI Insight. 2019 11 01; 4(21).JCI Insight2019-11-01T00:00:002019YAP1 oncogene is a context-specific driver for pancreatic ductal adenocarcinoma.Authorship 9580863231663852Bhagat TD, Von Ahrens D, Dawlaty M, Zou Y, Baddour J, Achreja A, Zhao H, Yang L, Patel B, Kwak C, Choudhary GS, Gordon-Mitchell S, Aluri S, Bhattacharyya S, Sahu S, Bhagat P, Yu Y, Bartenstein M, Giricz O, Suzuki M, Sohal D, Gupta S, Guerrero PA, Batra S, Goggins M, Steidl U, Greally J, Agarwal B, Pradhan K, Banerjee D, Nagrath D, Maitra A, Verma AeLifeLactate-mediated epigenetic reprogramming regulates formation of human pancreatic cancer-associated fibroblasts. Elife. 2019 11 01; 8.Elife2019-11-01T00:00:002019Lactate-mediated epigenetic reprogramming regulates formation of human pancreatic cancer-associated fibroblasts.Authorship 960559731688603Wang M, Estrella JS, Katz MH, Kim M, Rashid A, Lee JE, Maitra A, Wistuba II, Wolff RA, Varadhachary GR, Wang HPancreasExpression of Epithelial-Mesenchymal Transition Markers in Treated Pancreatic Ductal Adenocarcinoma. Pancreas. 2019 Nov/Dec; 48(10):1367-1372.Pancreas2019-11-01T00:00:002019Expression of Epithelial-Mesenchymal Transition Markers in Treated Pancreatic Ductal Adenocarcinoma.Authorship 9628961031857726De Jesus-Acosta A, Sugar EA, O'Dwyer PJ, Ramanathan RK, Von Hoff DD, Rasheed Z, Zheng L, Begum A, Anders R, Maitra A, McAllister F, Rajeshkumar NV, Yabuuchi S, de Wilde RF, Batukbhai B, Sahin I, Laheru DABritish journal of cancerPhase 2 study of vismodegib, a hedgehog inhibitor, combined with gemcitabine and nab-paclitaxel in patients with untreated metastatic pancreatic adenocarcinoma. Br J Cancer. 2020 02; 122(4):498-505.Br J Cancer2019-12-20T00:00:002019Phase 2 study of vismodegib, a hedgehog inhibitor, combined with gemcitabine and nab-paclitaxel in patients with untreated metastatic pancreatic adenocarcinoma.Authorship 976122931959629Song X, Akasaka H, Wang H, Abbasgholizadeh R, Shin JH, Zang F, Chen J, Logsdon CD, Maitra A, Bean AJ, Wang HThe Journal of biological chemistryHematopoietic progenitor kinase 1 down-regulates the oncogenic receptor tyrosine kinase AXL in pancreatic cancer. J Biol Chem. 2020 02 21; 295(8):2348-2358.J Biol Chem2020-01-20T00:00:002020Hematopoietic progenitor kinase 1 down-regulates the oncogenic receptor tyrosine kinase AXL in pancreatic cancer.Authorship 9778352532046984Dey P, Li J, Zhang J, Chaurasiya S, Strom A, Wang H, Liao WT, Cavallaro F, Denz P, Bernard V, Yen EY, Genovese G, Gulhati P, Liu J, Chakravarti D, Deng P, Zhang T, Carbone F, Chang Q, Ying H, Shang X, Spring DJ, Ghosh B, Putluri N, Maitra A, Wang YA, DePinho RACancer discoveryOncogenic KRAS-Driven Metabolic Reprogramming in Pancreatic Cancer Cells Utilizes Cytokines from the Tumor Microenvironment. Cancer Discov. 2020 04; 10(4):608-625.Cancer Discov2020-02-11T00:00:002020Oncogenic KRAS-Driven Metabolic Reprogramming in Pancreatic Cancer Cells Utilizes Cytokines from the Tumor Microenvironment.Authorship 978492732097445Horsley AR, Alrumuh A, Bianco B, Bayfield K, Tomlinson J, Jones A, Maitra A, Cunningham S, Smith J, Fullwood C, Pandyan A, Gilchrist FJPloS oneLung clearance index in healthy volunteers, measured using a novel portable system with a closed circuit wash-in. PLoS One. 2020; 15(2):e0229300.PLoS One2020-02-25T00:00:002020Lung clearance index in healthy volunteers, measured using a novel portable system with a closed circuit wash-in.Authorship 9790903Authorship 9792573Authorship 97926210Authorship 9794474Authorship 97957215Authorship 979842232139179Yao W, Maitra A, Ying HEBioMedicineRecent insights into the biology of pancreatic cancer. EBioMedicine. 2020 Mar; 53:102655.EBioMedicine2020-03-02T00:00:002020Recent insights into the biology of pancreatic cancer.32176886Chari ST, Sharma A, Maitra AAnnals of internal medicineEarly Detection of Sporadic Pancreatic Ductal Adenocarcinoma: Problems, Promise, and Prospects. Ann Intern Med. 2020 04 21; 172(8):558-559.Ann Intern Med2020-03-17T00:00:002020Early Detection of Sporadic Pancreatic Ductal Adenocarcinoma: Problems, Promise, and Prospects.32179091Ma Y, Li J, Wang H, Chiu Y, Kingsley CV, Fry D, Delaney SN, Wei SC, Zhang J, Maitra A, Yee CGastroenterologyCombination of PD-1 Inhibitor and OX40 Agonist Induces Tumor Rejection and Immune Memory in Mouse Models of Pancreatic Cancer. Gastroenterology. 2020 07; 159(1):306-319.e12.Gastroenterology2020-03-14T00:00:002020Combination of PD-1 Inhibitor and OX40 Agonist Induces Tumor Rejection and Immune Memory in Mouse Models of Pancreatic Cancer.32192904Bhutani MS, Cazacu IM, Roy-Chowdhuri S, Maitra A, Pishvaian MJPancreatology : official journal of the International Association of Pancreatology (IAP) ... [et al.]Upfront molecular profiling of pancreatic cancer patients - An idea whose time has come. Pancreatology. 2020 Apr; 20(3):391-393.Pancreatology2020-02-05T00:00:002020Upfront molecular profiling of pancreatic cancer patients - An idea whose time has come.32162067Kamyabi N, Abbasgholizadeh R, Maitra A, Ardekani A, Biswal SL, Grande-Allen KJBiomedical microdevicesIsolation and mutational assessment of pancreatic cancer extracellular vesicles using a microfluidic platform. Biomed Microdevices. 2020 03 11; 22(2):23.Biomed Microdevices2020-03-11T00:00:002020Isolation and mutational assessment of pancreatic cancer extracellular vesicles using a microfluidic platform.32114502Overman M, Javle M, Davis RE, Vats P, Kumar-Sinha C, Xiao L, Mettu NB, Parra ER, Benson AB, Lopez CD, Munugalavadla V, Patel P, Tao L, Neelapu S, Maitra AJournal for immunotherapy of cancerRandomized phase II study of the Bruton tyrosine kinase inhibitor acalabrutinib, alone or with pembrolizumab in patients with advanced pancreatic cancer. J Immunother Cancer. 2020 02; 8(1).J Immunother Cancer2020-02-01T00:00:002020Randomized phase II study of the Bruton tyrosine kinase inhibitor acalabrutinib, alone or with pembrolizumab in patients with advanced pancreatic cancer.Authorship 987873132322029Maitra ANaturePancreatic cancer hidden in plain sight. Nature. 2020 05; 581(7806):34-35.Nature2020-05-01T00:00:002020Pancreatic cancer hidden in plain sight.Authorship 988723932370304Fahrmann JF, Mao X, Irajizad E, Katayama H, Capello M, Tanaka I, Kato T, Wistuba II, Maitra A, Ostrin EJ, Hanash SM, Vykoukal JCancersPlasma-Derived Extracellular Vesicles Convey Protein Signatures that Reflect Pathophysiology in Lung and Pancreatic Adenocarcinomas. Cancers (Basel). 2020 May 02; 12(5).Cancers (Basel)2020-05-02T00:00:002020Plasma-Derived Extracellular Vesicles Convey Protein Signatures that Reflect Pathophysiology in Lung and Pancreatic Adenocarcinomas.Authorship 989279332393771Hosein AN, Brekken RA, Maitra ANature reviews. Gastroenterology & hepatologyPancreatic cancer stroma: an update on therapeutic targeting strategies. Nat Rev Gastroenterol Hepatol. 2020 08; 17(8):487-505.Nat Rev Gastroenterol Hepatol2020-05-11T00:00:002020Pancreatic cancer stroma: an update on therapeutic targeting strategies.Authorship 9899991632442403Wang Z, Hausmann S, Lyu R, Li TM, Lofgren SM, Flores NM, Fuentes ME, Caporicci M, Yang Z, Meiners MJ, Cheek MA, Howard SA, Zhang L, Elias JE, Kim MP, Maitra A, Wang H, Bassik MC, Keogh MC, Sage J, Gozani O, Mazur PKCancer cellSETD5-Coordinated Chromatin Reprogramming Regulates Adaptive Resistance to Targeted Pancreatic Cancer Therapy. Cancer Cell. 2020 06 08; 37(6):834-849.e13.Cancer Cell2020-05-21T00:00:002020SETD5-Coordinated Chromatin Reprogramming Regulates Adaptive Resistance to Targeted Pancreatic Cancer Therapy.Authorship 9904221132466260Dutta P, Pando SC, Mascaro M, Riquelme E, Zoltan M, Zacharias NM, Gammon ST, Piwnica-Worms D, Pagel MD, Sen S, Maitra A, Shams S, McAllister F, Bhattacharya PKInternational journal of molecular sciencesEarly Detection of Pancreatic Intraepithelial Neoplasias (PanINs) in Transgenic Mouse Model by Hyperpolarized 13C Metabolic Magnetic Resonance Spectroscopy. Int J Mol Sci. 2020 May 25; 21(10).Int J Mol Sci2020-05-25T00:00:002020Early Detection of Pancreatic Intraepithelial Neoplasias (PanINs) in Transgenic Mouse Model by Hyperpolarized 13C Metabolic Magnetic Resonance Spectroscopy.Authorship 9916531032532830Liu Y, Kaur S, Huang Y, Fahrmann JF, Rinaudo JA, Hanash SM, Batra SK, Singhi AD, Brand RE, Maitra A, Haab BBCancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive OncologyBiomarkers and Strategy to Detect Preinvasive and Early Pancreatic Cancer: State of the Field and the Impact of the EDRN. Cancer Epidemiol Biomarkers Prev. 2020 12; 29(12):2513-2523.Cancer Epidemiol Biomarkers Prev2020-06-12T00:00:002020Biomarkers and Strategy to Detect Preinvasive and Early Pancreatic Cancer: State of the Field and the Impact of the EDRN.Authorship 991996632545271Lee JJ, Kopetz S, Vilar E, Shen JP, Chen K, Maitra AGenesRelative Abundance of SARS-CoV-2 Entry Genes in the Enterocytes of the Lower Gastrointestinal Tract. Genes (Basel). 2020 06 11; 11(6).Genes (Basel)2020-06-11T00:00:002020Relative Abundance of SARS-CoV-2 Entry Genes in the Enterocytes of the Lower Gastrointestinal Tract.Authorship 9948706Authorship 99499715Authorship 9958511432683683Grossberg AJ, Chu LC, Deig CR, Fishman EK, Hwang WL, Maitra A, Marks DL, Mehta A, Nabavizadeh N, Simeone DM, Weekes CD, Thomas CRCA: a cancer journal for cliniciansMultidisciplinary standards of care and recent progress in pancreatic ductal adenocarcinoma. CA Cancer J Clin. 2020 09; 70(5):375-403.CA Cancer J Clin2020-07-19T00:00:002020Multidisciplinary standards of care and recent progress in pancreatic ductal adenocarcinoma.32694827Zhu Z, Achreja A, Meurs N, Animasahun O, Owen S, Mittal A, Parikh P, Lo TW, Franco-Barraza J, Shi J, Gunchick V, Sherman MH, Cukierman E, Pickering AM, Maitra A, Sahai V, Morgan MA, Nagrath S, Lawrence TS, Nagrath DNature metabolismTumour-reprogrammed stromal BCAT1 fuels branched-chain ketoacid dependency in stromal-rich PDAC tumours. Nat Metab. 2020 08; 2(8):775-792.Nat Metab2020-07-06T00:00:002020Tumour-reprogrammed stromal BCAT1 fuels branched-chain ketoacid dependency in stromal-rich PDAC tumours.32738099Murphy AG, Zahurak M, Shah M, Weekes CD, Hansen A, Siu LL, Spreafico A, LoConte N, Anders NM, Miles T, Rudek MA, Doyle LA, Nelkin B, Maitra A, Azad NS, ETCTN-9231 Study TeamClinical and translational scienceA Phase I Study of Dinaciclib in Combination With MK-2206 in Patients With Advanced Pancreatic Cancer. Clin Transl Sci. 2020 11; 13(6):1178-1188.Clin Transl Sci2020-08-01T00:00:002020A Phase I Study of Dinaciclib in Combination With MK-2206 in Patients With Advanced Pancreatic Cancer.Authorship 996336432739138Sharib J, Esserman L, Koay EJ, Maitra A, Shen Y, Kirkwood KS, Ozanne EMSurgeryCost-effectiveness of consensus guideline based management of pancreatic cysts: The sensitivity and specificity required for guidelines to be cost-effective. Surgery. 2020 10; 168(4):601-609.Surgery2020-07-29T00:00:002020Cost-effectiveness of consensus guideline based management of pancreatic cysts: The sensitivity and specificity required for guidelines to be cost-effective.Authorship 9983771632860704Zhang Y, Chandra V, Riquelme Sanchez E, Dutta P, Quesada PR, Rakoski A, Zoltan M, Arora N, Baydogan S, Horne W, Burks J, Xu H, Hussain P, Wang H, Gupta S, Maitra A, Bailey JM, Moghaddam SJ, Banerjee S, Sahin I, Bhattacharya P, McAllister FThe Journal of experimental medicineInterleukin-17-induced neutrophil extracellular traps mediate resistance to checkpoint blockade in pancreatic cancer. J Exp Med. 2020 12 07; 217(12).J Exp Med2020-12-07T00:00:002020Interleukin-17-induced neutrophil extracellular traps mediate resistance to checkpoint blockade in pancreatic cancer.Authorship 9993582232914036Koay EJ, Katz MHG, Wang H, Wang X, Prakash L, Javle M, Shroff R, Fogelman D, Avila S, Zaid M, Elganainy D, Lee Y, Crane CH, Krishnan S, Das P, Fleming JB, Lee JE, Tamm EP, Bhosale P, Lee JH, Weston B, Maitra A, Wolff RA, Varadhachary GRJCO precision oncologyComputed Tomography-Based Biomarker Outcomes in a Prospective Trial of Preoperative FOLFIRINOX and Chemoradiation for Borderline Resectable Pancreatic Cancer. JCO Precis Oncol. 2019; 3.JCO Precis Oncol2019-08-23T00:00:002019Computed Tomography-Based Biomarker Outcomes in a Prospective Trial of Preoperative FOLFIRINOX and Chemoradiation for Borderline Resectable Pancreatic Cancer.Authorship 9999931332967217Ferri-Borgogno S, Barui S, McGee AM, Griffiths T, Singh PK, Piett CG, Ghosh B, Bhattacharyya S, Singhi A, Pradhan K, Verma A, Nagel Z, Maitra A, Gupta SCancersParadoxical Role of AT-rich Interactive Domain 1A in Restraining Pancreatic Carcinogenesis. Cancers (Basel). 2020 Sep 21; 12(9).Cancers (Basel)2020-09-21T00:00:002020Paradoxical Role of AT-rich Interactive Domain 1A in Restraining Pancreatic Carcinogenesis.Authorship 10008108Authorship 1000857733006443Winnard PT, Bharti SK, Sharma RK, Krishnamachary B, Mironchik Y, Penet MF, Goggins MG, Maitra A, Kamel I, Horton KM, Jacobs MA, Bhujwalla ZMJournal of cachexia, sarcopenia and muscleBrain metabolites in cholinergic and glutamatergic pathways are altered by pancreatic cancer cachexia. J Cachexia Sarcopenia Muscle. 2020 12; 11(6):1487-1500.J Cachexia Sarcopenia Muscle2020-10-02T00:00:002020Brain metabolites in cholinergic and glutamatergic pathways are altered by pancreatic cancer cachexia.33009500Singh K, Pruski M, Bland R, Younes M, Guha S, Thosani N, Maitra A, Cash BD, McAllister F, Logsdon CD, Chang JT, Bailey-Lundberg JMLaboratory investigation; a journal of technical methods and pathologyKras mutation rate precisely orchestrates ductal derived pancreatic intraepithelial neoplasia and pancreatic cancer. Lab Invest. 2021 02; 101(2):177-192.Lab Invest2020-10-02T00:00:002020Kras mutation rate precisely orchestrates ductal derived pancreatic intraepithelial neoplasia and pancreatic cancer.Authorship 10028751433058885Cazacu IM, Semaan A, Stephens B, Swartzlander DB, Guerrero PA, Singh BS, Lungulescu CV, Danciulescu MM, Cherciu Harbiyeli IF, Streata I, Popescu C, Saftoiu A, Roy-Chowdhuri S, Maitra A, Bhutani MSGastrointestinal endoscopyDiagnostic value of digital droplet polymerase chain reaction and digital multiplexed detection of single-nucleotide variants in pancreatic cytology specimens collected by EUS-guided FNA. Gastrointest Endosc. 2021 05; 93(5):1142-1151.e2.Gastrointest Endosc2020-10-12T00:00:002020Diagnostic value of digital droplet polymerase chain reaction and digital multiplexed detection of single-nucleotide variants in pancreatic cytology specimens collected by EUS-guided FNA.Authorship 10032912933087697Bradley SD, Talukder AH, Lai I, Davis R, Alvarez H, Tiriac H, Zhang M, Chiu Y, Melendez B, Jackson KR, Katailiha A, Sonnemann HM, Li F, Kang Y, Qiao N, Pan BF, Lorenzi PL, Hurd M, Mittendorf EA, Peterson CB, Javle M, Bristow C, Kim M, Tuveson DA, Hawke D, Kopetz S, Wolff RA, Hwu P, Maitra A, Roszik J, Yee C, Liz?e GNature communicationsVestigial-like 1 is a shared targetable cancer-placenta antigen expressed by pancreatic and basal-like breast cancers. Nat Commun. 2020 10 21; 11(1):5332.Nat Commun2020-10-21T00:00:002020Vestigial-like 1 is a shared targetable cancer-placenta antigen expressed by pancreatic and basal-like breast cancers.Authorship 100464214Authorship 100503813Authorship 10054591533158812Tomihara H, Carbone F, Perelli L, Huang JK, Soeung M, Rose JL, Robinson FS, Lissanu Deribe Y, Feng N, Takeda M, Inoue A, Poggetto ED, Deem AK, Maitra A, Msaouel P, Tannir NM, Draetta GF, Viale A, Heffernan TP, Bristow CA, Carugo A, Genovese GCancer researchLoss of ARID1A Promotes Epithelial-Mesenchymal Transition and Sensitizes Pancreatic Tumors to Proteotoxic Stress. Cancer Res. 2021 01 15; 81(2):332-343.Cancer Res2020-11-06T00:00:002020Loss of ARID1A Promotes Epithelial-Mesenchymal Transition and Sensitizes Pancreatic Tumors to Proteotoxic Stress.33221151Wei D, Zaid MM, Katz MH, Prakash LR, Kim M, Tzeng CD, Lee JE, Agrawal A, Rashid A, Wang H, Varadhachary G, Wolff RA, Tamm EP, Bhosale PR, Maitra A, Koay EJ, Wang HPancreatology : official journal of the International Association of Pancreatology (IAP) ... [et al.]Clinicopathological correlation of radiologic measurement of post-therapy tumor size and tumor volume for pancreatic ductal adenocarcinoma. Pancreatology. 2021 Jan; 21(1):200-207.Pancreatology2020-11-14T00:00:002020Clinicopathological correlation of radiologic measurement of post-therapy tumor size and tumor volume for pancreatic ductal adenocarcinoma.33188144Semaan A, Bernard V, Lee JJ, Wong JW, Huang J, Swartzlander DB, Stephens BM, Monberg ME, Weston BR, Bhutani MS, Chang K, Scheet PA, Maitra A, Jakubek YA, Guerrero PAClinical cancer research : an official journal of the American Association for Cancer ResearchDefining the Comprehensive Genomic Landscapes of Pancreatic Ductal Adenocarcinoma Using Real-World Endoscopic Aspiration Samples. Clin Cancer Res. 2021 02 15; 27(4):1082-1093.Clin Cancer Res2020-11-13T00:00:002020Defining the Comprehensive Genomic Landscapes of Pancreatic Ductal Adenocarcinoma Using Real-World Endoscopic Aspiration Samples.Authorship 10065921033291471Zaid M, Widmann L, Dai A, Sun K, Zhang J, Zhao J, Hurd MW, Varadhachary GR, Wolff RA, Maitra A, Katz MHG, Herman JM, Wang H, Knopp MV, Williams TM, Bhosale P, Tamm EP, Koay EJCancersPredictive Modeling for Voxel-Based Quantification of Imaging-Based Subtypes of Pancreatic Ductal Adenocarcinoma (PDAC): A Multi-Institutional Study. Cancers (Basel). 2020 Dec 05; 12(12).Cancers (Basel)2020-12-05T00:00:002020Predictive Modeling for Voxel-Based Quantification of Imaging-Based Subtypes of Pancreatic Ductal Adenocarcinoma (PDAC): A Multi-Institutional Study.Authorship 10070772533333055Fahrmann JF, Schmidt CM, Mao X, Irajizad E, Loftus M, Zhang J, Patel N, Vykoukal J, Dennison JB, Long JP, Do KA, Zhang J, Chabot JA, Kluger MD, Kastrinos F, Brais L, Babic A, Jajoo K, Lee LS, Clancy TE, Ng K, Bullock A, Genkinger J, Yip-Schneider MT, Maitra A, Wolpin BM, Hanash SGastroenterologyLead-Time Trajectory of CA19-9 as an Anchor Marker for Pancreatic Cancer Early Detection. Gastroenterology. 2021 03; 160(4):1373-1383.e6.Gastroenterology2020-12-14T00:00:002020Lead-Time Trajectory of CA19-9 as an Anchor Marker for Pancreatic Cancer Early Detection.Authorship 10073942133344245Zaid M, Elganainy D, Dogra P, Dai A, Widmann L, Fernandes P, Wang Z, Pelaez MJ, Ramirez JR, Singhi AD, Dasyam AK, Brand RE, Park WG, Rahmanuddin S, Rosenthal MH, Wolpin BM, Khalaf N, Goel A, Von Hoff DD, Tamm EP, Maitra A, Cristini V, Koay EJFrontiers in oncologyImaging-Based Subtypes of Pancreatic Ductal Adenocarcinoma Exhibit Differential Growth and Metabolic Patterns in the Pre-Diagnostic Period: Implications for Early Detection. Front Oncol. 2020; 10:596931.Front Oncol2020-12-02T00:00:002020Imaging-Based Subtypes of Pancreatic Ductal Adenocarcinoma Exhibit Differential Growth and Metabolic Patterns in the Pre-Diagnostic Period: Implications for Early Detection.Authorship 1009533433468438Bray JK, Dawlaty MM, Verma A, Maitra ATrends in cancerRoles and Regulations of TET Enzymes in Solid Tumors. Trends Cancer. 2021 07; 7(7):635-646.Trends Cancer2021-01-16T00:00:002021Roles and Regulations of TET Enzymes in Solid Tumors.Authorship 10116051733589425Pitarresi JR, Norgard RJ, Chiarella AM, Suzuki K, Bakir B, Sahu V, Li J, Zhao J, Marchand B, Wengyn MD, Hsieh A, Kim IK, Zhang A, Sellin K, Lee V, Takano S, Miyahara Y, Ohtsuka M, Maitra A, Notta F, Kremer R, Stanger BZ, Rustgi AKCancer discoveryPTHrP Drives Pancreatic Cancer Growth and Metastasis and Reveals a New Therapeutic Vulnerability. Cancer Discov. 2021 07; 11(7):1774-1791.Cancer Discov2021-02-15T00:00:002021PTHrP Drives Pancreatic Cancer Growth and Metastasis and Reveals a New Therapeutic Vulnerability.Authorship 101523612Authorship 101528425Authorship 10155471533832821Zhao J, Soto LMS, Wang H, Katz MH, Prakash LR, Kim M, Tzeng CD, Lee JE, Wolff RA, Huang Y, Wistuba II, Maitra A, Wang HPancreatology : official journal of the International Association of Pancreatology (IAP) ... [et al.]Overexpression of CD73 in pancreatic ductal adenocarcinoma is associated with immunosuppressive tumor microenvironment and poor survival. Pancreatology. 2021 Aug; 21(5):942-949.Pancreatology2021-04-01T00:00:002021Overexpression of CD73 in pancreatic ductal adenocarcinoma is associated with immunosuppressive tumor microenvironment and poor survival.33835956Kenner B, Chari ST, Kelsen D, Klimstra DS, Pandol SJ, Rosenthal M, Rustgi AK, Taylor JA, Yala A, Abul-Husn N, Andersen DK, Bernstein D, Brunak S, Canto MI, Eldar YC, Fishman EK, Fleshman J, Go VLW, Holt JM, Field B, Goldberg A, Hoos W, Iacobuzio-Donahue C, Li D, Lidgard G, Maitra A, Matrisian LM, Poblete S, Rothschild L, Sander C, Schwartz LH, Shalit U, Srivastava S, Wolpin BPancreasArtificial Intelligence and Early Detection of Pancreatic Cancer: 2020 Summative Review. Pancreas. 2021 03 01; 50(3):251-279.Pancreas2021-03-01T00:00:002021Artificial Intelligence and Early Detection of Pancreatic Cancer: 2020 Summative Review.33785875Semaan A, Bernard V, Kim DU, Lee JJ, Huang J, Kamyabi N, Stephens BM, Qiao W, Varadhachary GR, Katz MH, Shen Y, San Lucas FA, Gascoyne P, Alvarez HA, Maitra A, Guerrero PABritish journal of cancerCharacterisation of circulating tumour cell phenotypes identifies a partial-EMT sub-population for clinical stratification of pancreatic cancer. Br J Cancer. 2021 06; 124(12):1970-1977.Br J Cancer2021-03-30T00:00:002021Characterisation of circulating tumour cell phenotypes identifies a partial-EMT sub-population for clinical stratification of pancreatic cancer.Authorship 10161281733839689Kim MP, Li X, Deng J, Zhang Y, Dai B, Allton KL, Hughes TG, Siangco C, Augustine JJ, Kang Y, McDaniel JM, Xiong S, Koay EJ, McAllister F, Bristow CA, Heffernan TP, Maitra A, Liu B, Barton MC, Wasylishen AR, Fleming JB, Lozano GCancer discoveryOncogenic KRAS Recruits an Expansive Transcriptional Network through Mutant p53 to Drive Pancreatic Cancer Metastasis. Cancer Discov. 2021 08; 11(8):2094-2111.Cancer Discov2021-04-10T00:00:002021Oncogenic KRAS Recruits an Expansive Transcriptional Network through Mutant p53 to Drive Pancreatic Cancer Metastasis.Authorship 10169331233893071Dittmar RL, Liu S, Tai MC, Rajapakshe K, Huang Y, Longton G, DeCapite C, Hurd MW, Paris PL, Kirkwood KS, Coarfa C, Maitra A, Brand RE, Killary AM, Sen SCancer prevention research (Philadelphia, Pa.)Plasma miRNA Biomarkers in Limited Volume Samples for Detection of Early-stage Pancreatic Cancer. Cancer Prev Res (Phila). 2021 07; 14(7):729-740.Cancer Prev Res (Phila)2021-04-23T00:00:002021Plasma miRNA Biomarkers in Limited Volume Samples for Detection of Early-stage Pancreatic Cancer.Authorship 1017859633958732Butler SS, Date K, Okumura T, Lueck C, Ghosh B, Maitra A, Suh JGene therapyMembrane-bound MMP-14 protease-activatable adeno-associated viral vectors for gene delivery to pancreatic tumors. Gene Ther. 2022 04; 29(3-4):138-146.Gene Ther2021-05-06T00:00:002021Membrane-bound MMP-14 protease-activatable adeno-associated viral vectors for gene delivery to pancreatic tumors.Authorship 1019430334040169Han J, DePinho RA, Maitra ANature reviews. Gastroenterology & hepatologySingle-cell RNA sequencing in pancreatic cancer. Nat Rev Gastroenterol Hepatol. 2021 07; 18(7):451-452.Nat Rev Gastroenterol Hepatol2021-07-01T00:00:002021Single-cell RNA sequencing in pancreatic cancer.Authorship 1020186734079044Singh K, Pruski M, Bland R, Younes M, Guha S, Thosani N, Maitra A, Cash BD, McAllister F, Logsdon CD, Chang JT, Bailey-Lundberg JMLaboratory investigation; a journal of technical methods and pathologyCorrection to: Kras mutation rate precisely orchestrates ductal derived pancreatic intraepithelial neoplasia and pancreatic cancer. Lab Invest. 2021 Sep; 101(9):1304.Lab Invest2021-09-01T00:00:002021Correction to: Kras mutation rate precisely orchestrates ductal derived pancreatic intraepithelial neoplasia and pancreatic cancer.Authorship 10213291034137725Enriquez JS, Chu Y, Pudakalakatti S, Hsieh KL, Salmon D, Dutta P, Millward NZ, Lurie E, Millward S, McAllister F, Maitra A, Sen S, Killary A, Zhang J, Jiang X, Bhattacharya PK, Shams SJMIR medical informaticsHyperpolarized Magnetic Resonance and Artificial Intelligence: Frontiers of Imaging in Pancreatic Cancer. JMIR Med Inform. 2021 Jun 17; 9(6):e26601.JMIR Med Inform2021-06-17T00:00:002021Hyperpolarized Magnetic Resonance and Artificial Intelligence: Frontiers of Imaging in Pancreatic Cancer.Authorship 1024266534197737Hambarde S, Tsai CL, Pandita RK, Bacolla A, Maitra A, Charaka V, Hunt CR, Kumar R, Limbo O, Le Meur R, Chazin WJ, Tsutakawa SE, Russell P, Schlacher K, Pandita TK, Tainer JAMolecular cellEXO5-DNA structure and BLM interactions direct DNA resection critical for ATR-dependent replication restart. Mol Cell. 2021 07 15; 81(14):2989-3006.e9.Mol Cell2021-06-30T00:00:002021EXO5-DNA structure and BLM interactions direct DNA resection critical for ATR-dependent replication restart.Authorship 10259461034301741Horsley AR, Belcher J, Bayfield K, Bianco B, Cunningham S, Fullwood C, Jones A, Shawcross A, Smith JA, Maitra A, Gilchrist FJThoraxLongitudinal assessment of lung clearance index to monitor disease progression in children and adults with cystic fibrosis. Thorax. 2022 04; 77(4):357-363.Thorax2021-07-22T00:00:002021Longitudinal assessment of lung clearance index to monitor disease progression in children and adults with cystic fibrosis.Authorship 10265803134330913Giuliani V, Miller MA, Liu CY, Hartono SR, Class CA, Bristow CA, Suzuki E, Sanz LA, Gao G, Gay JP, Feng N, Rose JL, Tomihara H, Daniele JR, Peoples MD, Bardenhagen JP, Geck Do MK, Chang QE, Vangamudi B, Vellano C, Ying H, Deem AK, Do KA, Genovese G, Marszalek JR, Kovacs JJ, Kim M, Fleming JB, Guccione E, Viale A, Maitra A, Emilia Di Francesco M, Yap TA, Jones P, Draetta G, Carugo A, Chedin F, Heffernan TPNature communicationsPRMT1-dependent regulation of RNA metabolism and DNA damage response sustains pancreatic ductal adenocarcinoma. Nat Commun. 2021 07 30; 12(1):4626.Nat Commun2021-07-30T00:00:002021PRMT1-dependent regulation of RNA metabolism and DNA damage response sustains pancreatic ductal adenocarcinoma.Authorship 1027631334387255Trikudanathan G, Lou E, Maitra A, Majumder SCurrent opinion in gastroenterologyEarly detection of pancreatic cancer: current state and future opportunities. Curr Opin Gastroenterol. 2021 09 01; 37(5):532-538.Curr Opin Gastroenterol2021-09-01T00:00:002021Early detection of pancreatic cancer: current state and future opportunities.Authorship 102825514Authorship 10282901134426439Lee JJ, Bernard V, Semaan A, Monberg ME, Huang J, Stephens BM, Lin D, Rajapakshe KI, Weston BR, Bhutani MS, Haymaker CL, Bernatchez C, Taniguchi CM, Maitra A, Guerrero PAClinical cancer research : an official journal of the American Association for Cancer ResearchElucidation of Tumor-Stromal Heterogeneity and the Ligand-Receptor Interactome by Single-Cell Transcriptomics in Real-world Pancreatic Cancer Biopsies. Clin Cancer Res. 2021 11 01; 27(21):5912-5921.Clin Cancer Res2021-08-23T00:00:002021Elucidation of Tumor-Stromal Heterogeneity and the Ligand-Receptor Interactome by Single-Cell Transcriptomics in Real-world Pancreatic Cancer Biopsies.34429247Tong YT, Wang H, Wei D, Prakash LR, Kim M, Tzeng CD, Lee JE, Rashid A, Koay EJ, Wolff RA, Maitra A, Katz MH, Wang HPancreatology : official journal of the International Association of Pancreatology (IAP) ... [et al.]GRP78 expression and prognostic significance in patients with pancreatic ductal adenocarcinoma treated with neoadjuvant therapy versus surgery first. Pancreatology. 2021 Oct; 21(7):1378-1385.Pancreatology2021-08-18T00:00:002021GRP78 expression and prognostic significance in patients with pancreatic ductal adenocarcinoma treated with neoadjuvant therapy versus surgery first.Authorship 10298892634529467Del Poggetto E, Ho IL, Balestrieri C, Yen EY, Zhang S, Citron F, Shah R, Corti D, Diaferia GR, Li CY, Loponte S, Carbone F, Hayakawa Y, Valenti G, Jiang S, Sapio L, Jiang H, Dey P, Gao S, Deem AK, Rose-John S, Yao W, Ying H, Rhim AD, Genovese G, Heffernan TP, Maitra A, Wang TC, Wang L, Draetta GF, Carugo A, Natoli G, Viale AScience (New York, N.Y.)Epithelial memory of inflammation limits tissue damage while promoting pancreatic tumorigenesis. Science. 2021 Sep 17; 373(6561):eabj0486.Science2021-09-17T00:00:002021Epithelial memory of inflammation limits tissue damage while promoting pancreatic tumorigenesis.Authorship 10312622734625409Furniss CS, Yurgelun MB, Ukaegbu C, Constantinou PE, Lafferty CC, Talcove-Berko ER, Schwartz AN, Stopfer JE, Underhill-Blazey M, Kenner B, Nelson SH, Okumura S, Law S, Zhou AY, Coffin TB, Rodriguez NJ, Uno H, Ocean AJ, McAllister F, Lowy AM, Lippman SM, Klein AP, Madlensky L, Petersen GM, Garber JE, Goggins MG, Maitra A, Syngal SCancer prevention research (Philadelphia, Pa.)Novel Models of Genetic Education and Testing for Pancreatic Cancer Interception: Preliminary Results from the GENERATE Study. Cancer Prev Res (Phila). 2021 11; 14(11):1021-1032.Cancer Prev Res (Phila)2021-10-08T00:00:002021Novel Models of Genetic Education and Testing for Pancreatic Cancer Interception: Preliminary Results from the GENERATE Study.Authorship 1033396934830866Marcus R, Ferri-Borgogno S, Hosein A, Foo WC, Ghosh B, Zhao J, Rajapakshe K, Brugarolas J, Maitra A, Gupta SCancersOncogenic KRAS Requires Complete Loss of BAP1 Function for Development of Murine Intrahepatic Cholangiocarcinoma. Cancers (Basel). 2021 Nov 15; 13(22).Cancers (Basel)2021-11-15T00:00:002021Oncogenic KRAS Requires Complete Loss of BAP1 Function for Development of Murine Intrahepatic Cholangiocarcinoma.Authorship 103492742789582Burdett-Smith P, Rowland K, Woodhouse KW, Maitra AKArchives of emergency medicineA comparative study of the injury profile of the elderly patients in an accident and emergency department. Arch Emerg Med. 1989 Sep; 6(3):189-92.Arch Emerg Med1989-09-01T00:00:001989A comparative study of the injury profile of the elderly patients in an accident and emergency department.Authorship 10354448Authorship 10355171134900719Garc?a Garc?a CJ, Acevedo Diaz AC, Kumari N, Govindaraju S, de la Cruz Bonilla M, San Lucas FA, Nguyen ND, Jim?nez Sacarello I, Piwnica-Worms H, Maitra A, Taniguchi CMFrontiers in oncologyHIF2 Regulates Intestinal Wnt5a Expression. Front Oncol. 2021; 11:769385.Front Oncol2021-11-25T00:00:002021HIF2 Regulates Intestinal Wnt5a Expression.34905283Gan Q, Roy-Chowdhuri S, Duose DY, Stewart JM, Coronel E, Bhutani MS, Lee JH, Weston B, Ge PS, Ross WA, Maitra ACancer cytopathologyAdequacy evaluation and use of pancreatic adenocarcinoma specimens for next-generation sequencing acquired by endoscopic ultrasound-guided FNA and FNB. Cancer Cytopathol. 2022 04; 130(4):275-283.Cancer Cytopathol2021-12-14T00:00:002021Adequacy evaluation and use of pancreatic adenocarcinoma specimens for next-generation sequencing acquired by endoscopic ultrasound-guided FNA and FNB.Authorship 10361212Authorship 103635716Authorship 103640816Authorship 1036491634971802Chen Y, Capello M, Rios Perez MV, Vykoukal JV, Roife D, Kang Y, Prakash LR, Katayama H, Irajizad E, Fleury A, Ferri-Borgogno S, Baluya DL, Dennison JB, Do KA, Fiehn O, Maitra A, Wang H, Chiao PJ, Katz MHG, Fleming JB, Hanash SM, Fahrmann JFMolecular metabolismCES2 sustains HNF4a expression to promote pancreatic adenocarcinoma progression through an epoxide hydrolase-dependent regulatory loop. Mol Metab. 2022 02; 56:101426.Mol Metab2021-12-28T00:00:002021CES2 sustains HNF4a expression to promote pancreatic adenocarcinoma progression through an epoxide hydrolase-dependent regulatory loop.34973294Hosein AN, Dangol G, Okumura T, Roszik J, Rajapakshe K, Siemann M, Zaid M, Ghosh B, Monberg M, Guerrero PA, Singhi A, Haymaker CL, Clevers H, Abou-Elkacem L, Woermann SM, Maitra AGastroenterologyLoss of Rnf43 Accelerates Kras-Mediated Neoplasia and Remodels the Tumor Immune Microenvironment in Pancreatic Adenocarcinoma. Gastroenterology. 2022 04; 162(4):1303-1318.e18.Gastroenterology2021-12-30T00:00:002021Loss of Rnf43 Accelerates Kras-Mediated Neoplasia and Remodels the Tumor Immune Microenvironment in Pancreatic Adenocarcinoma.34980020Douglas JE, Liu S, Ma J, Wolff RA, Pant S, Maitra A, Tamm EP, Bhosale P, Katz MHG, Varadhachary GR, Koay EJBMC cancerPIONEER-Panc: a platform trial for phase II randomized investigations of new and emerging therapies for localized pancreatic cancer. BMC Cancer. 2022 Jan 03; 22(1):14.BMC Cancer2022-01-03T00:00:002022PIONEER-Panc: a platform trial for phase II randomized investigations of new and emerging therapies for localized pancreatic cancer.34954100Chari ST, Maitra A, Matrisian LM, Shrader EE, Wu BU, Kambadakone A, Zhao YQ, Kenner B, Rinaudo JAS, Srivastava S, Huang Y, Feng Z, Early Detection Initiative ConsortiumContemporary clinical trialsEarly Detection Initiative: A randomized controlled trial of algorithm-based screening in patients with new onset hyperglycemia and diabetes for early detection of pancreatic ductal adenocarcinoma. Contemp Clin Trials. 2022 02; 113:106659.Contemp Clin Trials2021-12-23T00:00:002021Early Detection Initiative: A randomized controlled trial of algorithm-based screening in patients with new onset hyperglycemia and diabetes for early detection of pancreatic ductal adenocarcinoma.Authorship 1037278535022962Menter DG, Afshar-Kharghan V, Shen JP, Martch SL, Maitra A, Kopetz S, Honn KV, Sood AKCancer metastasis reviewsOf vascular defense, hemostasis, cancer, and platelet biology: an evolutionary perspective. Cancer Metastasis Rev. 2022 03; 41(1):147-172.Cancer Metastasis Rev2022-01-12T00:00:002022Of vascular defense, hemostasis, cancer, and platelet biology: an evolutionary perspective.Authorship 10389105Authorship 10391553Authorship 103928213Authorship 103937317Authorship 103940625Authorship 104020224Authorship 104113720Authorship 1041684435216965Garcia Garcia CJ, Huang Y, Fuentes NR, Turner MC, Monberg ME, Lin D, Nguyen ND, Fujimoto TN, Zhao J, Lee JJ, Bernard V, Yu M, Delahoussaye AM, Jimenez Sacarello I, Caggiano EG, Phan JL, Deorukhkar A, Molkentine JM, Saur D, Maitra A, Taniguchi CMGastroenterologyStromal HIF2 Regulates Immune Suppression in the Pancreatic Cancer Microenvironment. Gastroenterology. 2022 06; 162(7):2018-2031.Gastroenterology2022-02-22T00:00:002022Stromal HIF2 Regulates Immune Suppression in the Pancreatic Cancer Microenvironment.35110355Shah P, Forget MA, Frank ML, Jiang P, Sakellariou-Thompson D, Federico L, Khairullah R, Neutzler CA, Wistuba I, Chow CB, Long Y, Fujimoto J, Lin SY, Maitra A, Negrao MV, Mitchell KG, Weissferdt A, Vaporciyan AA, Cascone T, Roth JA, Zhang J, Sepesi B, Gibbons DL, Heymach JV, Haymaker CL, McGrail DJ, Reuben A, Bernatchez CJournal for immunotherapy of cancerCombined IL-2, agonistic CD3 and 4-1BB stimulation preserve clonotype hierarchy in propagated non-small cell lung cancer tumor-infiltrating lymphocytes. J Immunother Cancer. 2022 02; 10(2).J Immunother Cancer2022-02-01T00:00:002022Combined IL-2, agonistic CD3 and 4-1BB stimulation preserve clonotype hierarchy in propagated non-small cell lung cancer tumor-infiltrating lymphocytes.35120601Alam A, Levanduski E, Denz P, Villavicencio HS, Bhatta M, Alhorebi L, Zhang Y, Gomez EC, Morreale B, Senchanthisai S, Li J, Turowski SG, Sexton S, Sait SJ, Singh PK, Wang J, Maitra A, Kalinski P, DePinho RA, Wang H, Liao W, Abrams SI, Segal BH, Dey PCancer cellFungal mycobiome drives IL-33 secretion and type 2 immunity in pancreatic cancer. Cancer Cell. 2022 02 14; 40(2):153-167.e11.Cancer Cell2022-02-03T00:00:002022Fungal mycobiome drives IL-33 secretion and type 2 immunity in pancreatic cancer.35121902W?rmann SM, Zhang A, Thege FI, Cowan RW, Rupani DN, Wang R, Manning SL, Gates C, Wu W, Levin-Klein R, Rajapakshe KI, Yu M, Multani AS, Kang Y, Taniguchi CM, Schlacher K, Bellin MD, Katz MHG, Kim MP, Fleming JB, Gallinger S, Maddipati R, Harris RS, Notta F, Ross SR, Maitra A, Rhim ADNature cancerAPOBEC3A drives deaminase domain-independent chromosomal instability to promote pancreatic cancer metastasis. Nat Cancer. 2021 12; 2(12):1338-1356.Nat Cancer2021-11-18T00:00:002021APOBEC3A drives deaminase domain-independent chromosomal instability to promote pancreatic cancer metastasis.35097226Bagley AF, Ludmir EB, Maitra A, Minsky BD, Li Smith G, Das P, Koong AC, Holliday EB, Taniguchi CM, Katz MHG, Tamm EP, Wolff RA, Overman MJ, Patel S, Kim MP, Tzeng CD, Ikoma N, Bhutani MS, Koay EJClinical and translational radiation oncologyNBTXR3, a first-in-class radioenhancer for pancreatic ductal adenocarcinoma: Report of first patient experience. Clin Transl Radiat Oncol. 2022 Mar; 33:66-69.Clin Transl Radiat Oncol2022-01-11T00:00:002022NBTXR3, a first-in-class radioenhancer for pancreatic ductal adenocarcinoma: Report of first patient experience.35339459Kasliwal S, Baydogan S, Harrison D, Mork M, Maitra A, Mcallister FGastroenterologyImplementation of a Video-based Remote Germline Testing for Individuals With Pancreatic Ductal Adenocarcinoma. Gastroenterology. 2022 07; 163(1):316-318.e1.Gastroenterology2022-03-23T00:00:002022Implementation of a Video-based Remote Germline Testing for Individuals With Pancreatic Ductal Adenocarcinoma.35352061Hosein AN, Dougan SK, Aguirre AJ, Maitra ANature cancerTranslational advances in pancreatic ductal adenocarcinoma therapy. Nat Cancer. 2022 03; 3(3):272-286.Nat Cancer2022-03-29T00:00:002022Translational advances in pancreatic ductal adenocarcinoma therapy.35050739Capello M, Fahrmann JF, Rios Perez MV, Vykoukal JV, Irajizad E, Tripathi SC, Roife D, Bantis LE, Kang Y, Kundnani DL, Xu H, Prakash LR, Long JP, Katayama H, Fleury A, Ferri-Borgogno S, Baluya DL, Dennison JB, Aguilar-Bonavides C, Casabar JP, Celiktas M, Do KA, Fiehn O, Maitra A, Wang H, Feng Z, Chiao PJ, Katz MH, Fleming JB, Hanash SMJCO precision oncologyCES2 Expression in Pancreatic Adenocarcinoma Is Predictive of Response to Irinotecan and Is Associated With Type 2 Diabetes. JCO Precis Oncol. 2020 Nov; 4:426-436.JCO Precis Oncol2020-11-01T00:00:002020CES2 Expression in Pancreatic Adenocarcinoma Is Predictive of Response to Irinotecan and Is Associated With Type 2 Diabetes.Authorship 1044472535470312Chen W, Butler RK, Lustigova E, Chari ST, Maitra A, Rinaudo JA, Wu BUJournal of clinical gastroenterologyRisk Prediction of Pancreatic Cancer in Patients With Recent-onset Hyperglycemia: A Machine-learning Approach. J Clin Gastroenterol. 2023 01 01; 57(1):103-110.J Clin Gastroenterol2023-01-01T00:00:002023Risk Prediction of Pancreatic Cancer in Patients With Recent-onset Hyperglycemia: A Machine-learning Approach.Authorship 10448652235491652Hernandez S, Parra ER, Uraoka N, Tang X, Shen Y, Qiao W, Jiang M, Zhang S, Mino B, Lu W, Pandurengan R, Haymaker C, Affolter K, Scaife CL, Yip-Schneider M, Schmidt CM, Firpo MA, Mulvihill SJ, Koay EJ, Wang H, Wistuba II, Maitra A, Solis LM, Sen SClinical cancer research : an official journal of the American Association for Cancer ResearchDiminished Immune Surveillance during Histologic Progression of Intraductal Papillary Mucinous Neoplasms Offers a Therapeutic Opportunity for Cancer Interception. Clin Cancer Res. 2022 05 02; 28(9):1938-1947.Clin Cancer Res2022-05-02T00:00:002022Diminished Immune Surveillance during Histologic Progression of Intraductal Papillary Mucinous Neoplasms Offers a Therapeutic Opportunity for Cancer Interception.23232026Venkannagari S, Fiskus W, Peth K, Atadja P, Hidalgo M, Maitra A, Bhalla KNOncotargetSuperior efficacy of co-treatment with dual PI3K/mTOR inhibitor NVP-BEZ235 and pan-histone deacetylase inhibitor against human pancreatic cancer. Oncotarget. 2012 Nov; 3(11):1416-27.Oncotarget2012-11-01T00:00:002012Superior efficacy of co-treatment with dual PI3K/mTOR inhibitor NVP-BEZ235 and pan-histone deacetylase inhibitor against human pancreatic cancer.Authorship 10464911835606824Zhang Y, Chen X, Wang H, Gordon-Mitchell S, Sahu S, Bhagat TD, Choudhary G, Aluri S, Pradhan K, Sahu P, Carbajal M, Zhang H, Agarwal B, Shastri A, Martell R, Starczynowski D, Steidl U, Maitra A, Verma AJournal of hematology & oncologyInnate immune mediator, Interleukin-1 receptor accessory protein (IL1RAP), is expressed and pro-tumorigenic in pancreatic cancer. J Hematol Oncol. 2022 05 23; 15(1):70.J Hematol Oncol2022-05-23T00:00:002022Innate immune mediator, Interleukin-1 receptor accessory protein (IL1RAP), is expressed and pro-tumorigenic in pancreatic cancer.Authorship 10469481435643254Wang CX, Elganainy D, Zaid MM, Butner JD, Agrawal A, Nizzero S, Minsky BD, Holliday EB, Taniguchi CM, Smith GL, Koong AC, Herman JM, Das P, Maitra A, Wang H, Wolff RA, Katz MHG, Crane CH, Cristini V, Koay EJInternational journal of radiation oncology, biology, physicsMass Transport Model of Radiation Response: Calibration and Application to Chemoradiation for Pancreatic Cancer. Int J Radiat Oncol Biol Phys. 2022 09 01; 114(1):163-172.Int J Radiat Oncol Biol Phys2022-05-26T00:00:002022Mass Transport Model of Radiation Response: Calibration and Application to Chemoradiation for Pancreatic Cancer.Authorship 1047694535666804Thege FI, Rupani DN, Barathi BB, Manning SL, Maitra A, Rhim AD, W?rmann SMCancer researchA Programmable In Vivo CRISPR Activation Model Elucidates the Oncogenic and Immunosuppressive Functions of MYC in Lung Adenocarcinoma. Cancer Res. 2022 08 03; 82(15):2761-2776.Cancer Res2022-08-03T00:00:002022A Programmable In Vivo CRISPR Activation Model Elucidates the Oncogenic and Immunosuppressive Functions of MYC in Lung Adenocarcinoma.Authorship 10479883135697807Cao S, Wang JR, Ji S, Yang P, Dai Y, Guo S, Montierth MD, Shen JP, Zhao X, Chen J, Lee JJ, Guerrero PA, Spetsieris N, Engedal N, Taavitsainen S, Yu K, Livingstone J, Bhandari V, Hubert SM, Daw NC, Futreal PA, Efstathiou E, Lim B, Viale A, Zhang J, Nykter M, Czerniak BA, Brown PH, Swanton C, Msaouel P, Maitra A, Kopetz S, Campbell P, Speed TP, Boutros PC, Zhu H, Urbanucci A, Demeulemeester J, Van Loo P, Wang WNature biotechnologyEstimation of tumor cell total mRNA expression in 15 cancer types predicts disease progression. Nat Biotechnol. 2022 11; 40(11):1624-1633.Nat Biotechnol2022-06-13T00:00:002022Estimation of tumor cell total mRNA expression in 15 cancer types predicts disease progression.Authorship 104911716Authorship 1049201535752636Monberg ME, Geiger H, Lee JJ, Sharma R, Semaan A, Bernard V, Wong J, Wang F, Liang S, Swartzlander DB, Stephens BM, Katz MHG, Chen K, Robine N, Guerrero PA, Maitra ANature communicationsOccult polyclonality of preclinical pancreatic cancer models drives in vitro evolution. Nat Commun. 2022 06 25; 13(1):3652.Nat Commun2022-06-25T00:00:002022Occult polyclonality of preclinical pancreatic cancer models drives in vitro evolution.35333778Wu BU, Lustigova E, Chen Q, Dong EY, Maitra A, Chari ST, Feng Z, Rinaudo JA, Matrisian LM, Parker RA, Consortium for the Study of Chronic Pancreatitis, Diabetes, and Pancreatic Cancer (CPDPC), Consortium for the Study of Chronic Pancreatitis, Diabetes, and Pancreatic Cancer (CPDPC)Clinical and translational gastroenterologyImaging of the Pancreas in New-Onset Diabetes: A Prospective Pilot Study. Clin Transl Gastroenterol. 2022 06 01; 13(6):e00478.Clin Transl Gastroenterol2022-06-01T00:00:002022Imaging of the Pancreas in New-Onset Diabetes: A Prospective Pilot Study.Authorship 10508911535849783Schalck A, Sakellariou-Thompson D, Forget MA, Sei E, Hughes TG, Reuben A, Bai S, Hu M, Kumar T, Hurd MW, Katz MHG, Tzeng CD, Pant S, Javle M, Fogelman DR, Maitra A, Haymaker CL, Kim MP, Navin NE, Bernatchez CCancer discoverySingle-Cell Sequencing Reveals Trajectory of Tumor-Infiltrating Lymphocyte States in Pancreatic Cancer. Cancer Discov. 2022 10 05; 12(10):2330-2349.Cancer Discov2022-10-05T00:00:002022Single-Cell Sequencing Reveals Trajectory of Tumor-Infiltrating Lymphocyte States in Pancreatic Cancer.Authorship 10514531835883108Zhang Y, Chen X, Wang H, Gordon-Mitchell S, Sahu S, Bhagat TD, Choudhary G, Aluri S, Pradhan K, Sahu P, Carbajal M, Zhang H, Agarwal B, Shastri A, Martell R, Starczynowski D, Steidl U, Maitra A, Verma AJournal of hematology & oncologyCorrection: Innate immune mediator, Interleukin-1 receptor accessory protein (IL1RAP), is expressed and pro-tumorigenic in pancreatic cancer. J Hematol Oncol. 2022 Jul 26; 15(1):100.J Hematol Oncol2022-07-26T00:00:002022Correction: Innate immune mediator, Interleukin-1 receptor accessory protein (IL1RAP), is expressed and pro-tumorigenic in pancreatic cancer.Authorship 10562784Authorship 10570032Authorship 105574421Authorship 106017914Authorship 1057959336008214Li CY, Rajapakshe KI, Maitra APancreatology : official journal of the International Association of Pancreatology (IAP) ... [et al.]Integrative transcriptomic analysis identifies a novel gene signature to predict prognosis of pancreatic cancer in different subtypes. Pancreatology. 2022 Nov; 22(7):965-972.Pancreatology2022-08-13T00:00:002022Integrative transcriptomic analysis identifies a novel gene signature to predict prognosis of pancreatic cancer in different subtypes.36196575Amit M, Maitra ACancer discoveryThe Boring Schwann Cells: Tumor Me-TAST-asis along Nerves. Cancer Discov. 2022 10 05; 12(10):2240-2243.Cancer Discov2022-10-05T00:00:002022The Boring Schwann Cells: Tumor Me-TAST-asis along Nerves.36282600Kang Y, Deng J, Ling J, Li X, Chiang YJ, Koay EJ, Wang H, Burks JK, Chiao PJ, Hurd MW, Bhutani MS, Lee JH, Weston BR, Maitra A, Ikoma N, Tzeng CD, Lee JE, DePinho RA, Wolff RA, Pant S, McAllister F, Katz MH, Fleming JB, Kim MPThe Journal of clinical investigation3D imaging analysis on an organoid-based platform guides personalized treatment in pancreatic ductal adenocarcinoma. J Clin Invest. 2022 12 15; 132(24).J Clin Invest2022-12-15T00:00:0020223D imaging analysis on an organoid-based platform guides personalized treatment in pancreatic ductal adenocarcinoma.36585453Gulhati P, Schalck A, Jiang S, Shang X, Wu CJ, Hou P, Ruiz SH, Soto LS, Parra E, Ying H, Han J, Dey P, Li J, Deng P, Sei E, Maeda DY, Zebala JA, Spring DJ, Kim M, Wang H, Maitra A, Moore D, Clise-Dwyer K, Wang YA, Navin NE, DePinho RANature cancerTargeting T cell checkpoints 41BB and LAG3 and myeloid cell CXCR1/CXCR2 results in antitumor immunity and durable response in pancreatic cancer. Nat Cancer. 2023 01; 4(1):62-80.Nat Cancer2022-12-30T00:00:002022Targeting T cell checkpoints 41BB and LAG3 and myeloid cell CXCR1/CXCR2 results in antitumor immunity and durable response in pancreatic cancer.36049831Mohindroo C, De Jesus-Acosta A, Yurgelun MB, Maitra A, Mork M, McAllister FSurgical pathology clinicsThe Evolving Paradigm of Germline Testing in Pancreatic Ductal Adenocarcinoma and Implications for Clinical Practice. Surg Pathol Clin. 2022 Sep; 15(3):491-502.Surg Pathol Clin2022-08-02T00:00:002022The Evolving Paradigm of Germline Testing in Pancreatic Ductal Adenocarcinoma and Implications for Clinical Practice.Authorship 10636791636746143Sohn AJ, Taherian M, Katz MHG, Prakash LR, Chatterjee D, Wang H, Kim M, Tzeng CD, Lee JE, Ikoma N, Rashid A, Wolff RA, Zhao D, Koay EJ, Sun R, Maitra A, Wang HThe American journal of surgical pathologyIntegrated Pathologic Score Effectively Stratifies Patients With Pancreatic Ductal Adenocarcinoma Who Received Neoadjuvant Therapy and Pancreaticoduodenectomy. Am J Surg Pathol. 2023 04 01; 47(4):421-430.Am J Surg Pathol2023-02-06T00:00:002023Integrated Pathologic Score Effectively Stratifies Patients With Pancreatic Ductal Adenocarcinoma Who Received Neoadjuvant Therapy and Pancreaticoduodenectomy.Authorship 10644352036824971Mahadevan KK, McAndrews KM, LeBleu VS, Yang S, Lyu H, Li B, Sockwell AM, Kirtley ML, Morse SJ, Moreno Diaz BA, Kim MP, Feng N, Lopez AM, Guerrero PA, Sugimoto H, Arian KA, Ying H, Barekatain Y, Kelly PJ, Maitra A, Heffernan TP, Kalluri RbioRxiv : the preprint server for biologyOncogenic Kras G12D specific non-covalent inhibitor reprograms tumor microenvironment to prevent and reverse early pre-neoplastic pancreatic lesions and in combination with immunotherapy regresses advanced PDAC in a CD8 + T cells dependent manner. bioRxiv. 2023 Feb 18.bioRxiv2023-02-18T00:00:002023Oncogenic Kras G12D specific non-covalent inhibitor reprograms tumor microenvironment to prevent and reverse early pre-neoplastic pancreatic lesions and in combination with immunotherapy regresses advanced PDAC in a CD8 + T cells dependent manner.Authorship 1064964736862364Kolbinger FR, Bernard V, Lee JJ, Stephens BM, Branchi V, Raghav KPS, Maitra A, Guerrero PA, Semaan AJournal of gastrointestinal cancerSignificance of Distinct Liquid Biopsy Compartments in Evaluating Somatic Mutations for Targeted Therapy Selection in Cancer of Unknown Primary. J Gastrointest Cancer. 2023 Dec; 54(4):1276-1285.J Gastrointest Cancer2023-03-02T00:00:002023Significance of Distinct Liquid Biopsy Compartments in Evaluating Somatic Mutations for Targeted Therapy Selection in Cancer of Unknown Primary.Authorship 10675293Authorship 1067279336997301Cephas AT, Hwang WL, Maitra A, Parnas O, DelGiorno KEGutIt is better to light a candle than to curse the darkness: single-cell transcriptomics sheds new light on pancreas biology and disease. Gut. 2023 06; 72(6):1211-1219.Gut2023-03-30T00:00:002023It is better to light a candle than to curse the darkness: single-cell transcriptomics sheds new light on pancreas biology and disease.37001882Haldar SD, Vilar E, Maitra A, Zaidi NCancer prevention research (Philadelphia, Pa.)Worth a Pound of Cure? Emerging Strategies and Challenges in Cancer Immunoprevention. Cancer Prev Res (Phila). 2023 09 01; 16(9):483-495.Cancer Prev Res (Phila)2023-09-01T00:00:002023Worth a Pound of Cure? Emerging Strategies and Challenges in Cancer Immunoprevention.Authorship 10683003Authorship 1068915437059070Halbrook CJ, Lyssiotis CA, Pasca di Magliano M, Maitra ACellPancreatic cancer: Advances and challenges. Cell. 2023 04 13; 186(8):1729-1754.Cell2023-04-13T00:00:002023Pancreatic cancer: Advances and challenges.37124705Tovar DR, Rosenthal MH, Maitra A, Koay EJArtificial intelligence surgeryPotential of artificial intelligence in the risk stratification for and early detection of pancreatic cancer. Artif Intell Surg. 2023; 3(1):14-26.Artif Intell Surg2023-03-20T00:00:002023Potential of artificial intelligence in the risk stratification for and early detection of pancreatic cancer.Authorship 106975015Authorship 10693811537174073Tong YT, Lai Z, Katz MHG, Prakash LR, Wang H, Chatterjee D, Kim M, Tzeng CD, Lee JE, Ikoma N, Rashid A, Wolff RA, Zhao D, Koay EJ, Maitra A, Wang HCancersPrognosticators for Patients with Pancreatic Ductal Adenocarcinoma Who Received Neoadjuvant FOLFIRINOX or Gemcitabine/Nab-Paclitaxel Therapy and Pancreatectomy. Cancers (Basel). 2023 May 04; 15(9).Cancers (Basel)2023-05-04T00:00:002023Prognosticators for Patients with Pancreatic Ductal Adenocarcinoma Who Received Neoadjuvant FOLFIRINOX or Gemcitabine/Nab-Paclitaxel Therapy and Pancreatectomy.37140994Wang H, Moniruzzaman R, Li L, Ji B, Liu Y, Zuo X, Abbasgholizadeh R, Zhao J, Liu G, Wang R, Tang H, Sun R, Su X, Tan TH, Maitra A, Wang HThe Journal of clinical investigationHematopoietic progenitor kinase 1 inhibits the development and progression of pancreatic intraepithelial neoplasia. J Clin Invest. 2023 06 15; 133(12).J Clin Invest2023-06-15T00:00:002023Hematopoietic progenitor kinase 1 inhibits the development and progression of pancreatic intraepithelial neoplasia.Authorship 10745522Authorship 107209015Authorship 107342532Authorship 10730671237285225Sans M, Makino Y, Min J, Rajapakshe KI, Yip-Schneider M, Schmidt CM, Hurd MW, Burks JK, Gomez JA, Thege FI, Fahrmann JF, Wolff RA, Kim MP, Guerrero PA, Maitra ACancer discoverySpatial Transcriptomics of Intraductal Papillary Mucinous Neoplasms of the Pancreas Identifies NKX6-2 as a Driver of Gastric Differentiation and Indolent Biological Potential. Cancer Discov. 2023 08 04; 13(8):1844-1861.Cancer Discov2023-08-04T00:00:002023Spatial Transcriptomics of Intraductal Papillary Mucinous Neoplasms of the Pancreas Identifies NKX6-2 as a Driver of Gastric Differentiation and Indolent Biological Potential.37370842Liang TZ, Katz MHG, Prakash LR, Chatterjee D, Wang H, Kim M, Tzeng CD, Ikoma N, Wolff RA, Zhao D, Koay EJ, Maitra A, Kundu S, Wang HCancersComparative Analyses of the Clinicopathologic Features of Short-Term and Long-Term Survivors of Patients with Pancreatic Ductal Adenocarcinoma Who Received Neoadjuvant Therapy and Pancreatoduodenectomy. Cancers (Basel). 2023 Jun 18; 15(12).Cancers (Basel)2023-06-18T00:00:002023Comparative Analyses of the Clinicopathologic Features of Short-Term and Long-Term Survivors of Patients with Pancreatic Ductal Adenocarcinoma Who Received Neoadjuvant Therapy and Pancreatoduodenectomy.37248301Chu Y, Dai E, Li Y, Han G, Pei G, Ingram DR, Thakkar K, Qin JJ, Dang M, Le X, Hu C, Deng Q, Sinjab A, Gupta P, Wang R, Hao D, Peng F, Yan X, Liu Y, Song S, Zhang S, Heymach JV, Reuben A, Elamin YY, Pizzi MP, Lu Y, Lazcano R, Hu J, Li M, Curran M, Futreal A, Maitra A, Jazaeri AA, Ajani JA, Swanton C, Cheng XD, Abbas HA, Gillison M, Bhat K, Lazar AJ, Green M, Litchfield K, Kadara H, Yee C, Wang LNature medicinePan-cancer T cell atlas links a cellular stress response state to immunotherapy resistance. Nat Med. 2023 Jun; 29(6):1550-1562.Nat Med2023-05-29T00:00:002023Pan-cancer T cell atlas links a cellular stress response state to immunotherapy resistance.37403656Colbert Maresso K, Maitra A, Hawk ET, Vilar ECancer prevention research (Philadelphia, Pa.)From Premalignant Biology to Precision Interception: Connecting the Dots with a Curated Collection of Invited Articles. Cancer Prev Res (Phila). 2023 07 05; 16(7):365-367.Cancer Prev Res (Phila)2023-07-05T00:00:002023From Premalignant Biology to Precision Interception: Connecting the Dots with a Curated Collection of Invited Articles.Authorship 107826421Authorship 107788622Authorship 107778922Authorship 107936422Authorship 107854719Authorship 10789061537625403Mahadevan KK, LeBleu VS, Ramirez EV, Chen Y, Li B, Sockwell AM, Gagea M, Sugimoto H, Sthanam LK, Tampe D, Zeisberg M, Ying H, Jain AK, DePinho RA, Maitra A, McAndrews KM, Kalluri RDevelopmental cellElimination of oncogenic KRAS in genetic mouse models eradicates pancreatic cancer by inducing FAS-dependent apoptosis by CD8+ T?cells. Dev Cell. 2023 09 11; 58(17):1562-1577.e8.Dev Cell2023-08-24T00:00:002023Elimination of oncogenic KRAS in genetic mouse models eradicates pancreatic cancer by inducing FAS-dependent apoptosis by CD8+ T?cells.37729870Irajizad E, Kenney A, Tang T, Vykoukal J, Wu R, Murage E, Dennison JB, Sans M, Long JP, Loftus M, Chabot JA, Kluger MD, Kastrinos F, Brais L, Babic A, Jajoo K, Lee LS, Clancy TE, Ng K, Bullock A, Genkinger JM, Maitra A, Do KA, Yu B, Wolpin BM, Hanash S, Fahrmann JFCell reports. MedicineA blood-based metabolomic signature predictive of risk for pancreatic cancer. Cell Rep Med. 2023 09 19; 4(9):101194.Cell Rep Med2023-09-19T00:00:002023A blood-based metabolomic signature predictive of risk for pancreatic cancer.37645752Sans M, Chen Y, Thege FI, Dou R, Min J, Yip-Schneider M, Zhang J, Wu R, Irajizad E, Makino Y, Rajapakshe KI, Hurd MW, Le?n-Letelier RA, Vykoukal J, Dennison JB, Do KA, Wolff RA, Guerrero PA, Kim MP, Schmidt CM, Maitra A, Hanash S, Fahrmann JFbioRxiv : the preprint server for biologyIntegrated spatial transcriptomics and lipidomics of precursor lesions of pancreatic cancer identifies enrichment of long chain sulfatide biosynthesis as an early metabolic alteration. bioRxiv. 2023 Aug 15.bioRxiv2023-08-15T00:00:002023Integrated spatial transcriptomics and lipidomics of precursor lesions of pancreatic cancer identifies enrichment of long chain sulfatide biosynthesis as an early metabolic alteration.37625401Mahadevan KK, McAndrews KM, LeBleu VS, Yang S, Lyu H, Li B, Sockwell AM, Kirtley ML, Morse SJ, Moreno Diaz BA, Kim MP, Feng N, Lopez AM, Guerrero PA, Paradiso F, Sugimoto H, Arian KA, Ying H, Barekatain Y, Sthanam LK, Kelly PJ, Maitra A, Heffernan TP, Kalluri RCancer cellKRASG12D inhibition reprograms the microenvironment of early and advanced pancreatic cancer to promote FAS-mediated killing by CD8+ T?cells. Cancer Cell. 2023 09 11; 41(9):1606-1620.e8.Cancer Cell2023-08-24T00:00:002023KRASG12D inhibition reprograms the microenvironment of early and advanced pancreatic cancer to promote FAS-mediated killing by CD8+ T?cells.37721516Semaan A, Bernard V, Wong J, Makino Y, Swartzlander DB, Rajapakshe KI, Lee JJ, Officer A, Schmidt CM, Wu HH, Scaife CL, Affolter KE, Nachmanson D, Firpo MA, Yip-Schneider M, Lowy AM, Harismendy O, Sen S, Maitra A, Jakubek YA, Guerrero PACancer research communicationsIntegrated Molecular Characterization of Intraductal Papillary Mucinous Neoplasms: An NCI Cancer Moonshot Precancer Atlas Pilot Project. Cancer Res Commun. 2023 10 10; 3(10):2062-2073.Cancer Res Commun2023-10-10T00:00:002023Integrated Molecular Characterization of Intraductal Papillary Mucinous Neoplasms: An NCI Cancer Moonshot Precancer Atlas Pilot Project.37609177Yousef A, Yousef M, Chowdhury S, Abdilleh K, Knafl M, Edelkamp P, Alfaro-Munoz K, Chacko R, Peterson J, Smaglo BG, Wolff RA, Pant S, Lee MS, Willis J, Overman M, Doss S, Matrisian L, Hurd MW, Snyder R, Katz MHG, Wang H, Maitra A, Shen JP, Zhao DResearch squareImpact of KRAS Mutations and Co-mutations on Clinical Outcomes in Pancreatic Ductal Adenocarcinoma. Res Sq. 2023 Aug 10.Res Sq2023-08-10T00:00:002023Impact of KRAS Mutations and Co-mutations on Clinical Outcomes in Pancreatic Ductal Adenocarcinoma.Authorship 1079901737774897Balasenthil S, Liu S, Dai J, Bamlet WR, Petersen G, Chari ST, Maitra A, Chen N, Sen S, McNeill Killary AClinica chimica acta; international journal of clinical chemistryBlood-based Migration Signature Biomarker Panel Discriminates Early Stage New Onset Diabetes related Pancreatic Ductal Adenocarcinoma from Type 2 Diabetes. Clin Chim Acta. 2023 Nov 01; 551:117567.Clin Chim Acta2023-09-27T00:00:002023Blood-based Migration Signature Biomarker Panel Discriminates Early Stage New Onset Diabetes related Pancreatic Ductal Adenocarcinoma from Type 2 Diabetes.Authorship 1080379237778962Chen Y, Maitra ATrends in cancerAnxiolytics cause anxiety in pancreatic cancer. Trends Cancer. 2023 11; 9(11):874-875.Trends Cancer2023-09-29T00:00:002023Anxiolytics cause anxiety in pancreatic cancer.Authorship 10810934Authorship 1081108737831007Wei D, Wang L, Zuo X, Maitra A, Bresalier RSClinical cancer research : an official journal of the American Association for Cancer ResearchA Small Molecule with Big Impact: MRTX1133 Targets the KRASG12D Mutation in Pancreatic Cancer. Clin Cancer Res. 2024 02 16; 30(4):655-662.Clin Cancer Res2024-02-16T00:00:002024A Small Molecule with Big Impact: MRTX1133 Targets the KRASG12D Mutation in Pancreatic Cancer.37834100Purushothaman A, Oliva-Ram?rez J, Treekitkarnmongkol W, Sankaran D, Hurd MW, Putluri N, Maitra A, Haymaker C, Sen SInternational journal of molecular sciencesDifferential Effects of Pancreatic Cancer-Derived Extracellular Vesicles Driving a Suppressive Environment. Int J Mol Sci. 2023 Sep 27; 24(19).Int J Mol Sci2023-09-27T00:00:002023Differential Effects of Pancreatic Cancer-Derived Extracellular Vesicles Driving a Suppressive Environment.Authorship 108428213207570Maitra AK, Reece VA, Richardson DThe British journal of clinical practiceAirgun injuries on Tyneside. Br J Clin Pract. 1988 Mar; 42(3):106-9.Br J Clin Pract1988-03-01T00:00:001988Airgun injuries on Tyneside.Authorship 10852593738123998Ben-Ami R, Wang QL, Zhang J, Supplee JG, Fahrmann JF, Lehmann-Werman R, Brais LK, Nowak J, Yuan C, Loftus M, Babic A, Irajizad E, Davidi T, Zick A, Hubert A, Neiman D, Piyanzin S, Gal-Rosenberg O, Horn A, Shemer R, Glaser B, Boos N, Jajoo K, Lee L, Clancy TE, Rubinson DA, Ng K, Chabot JA, Kastrinos F, Kluger M, Aguirre AJ, J?nne PA, Bardeesy N, Stanger B, O'Hara MH, Till J, Maitra A, Carpenter EL, Bullock AJ, Genkinger J, Hanash SM, Paweletz CP, Dor Y, Wolpin BMGutProtein biomarkers and alternatively methylated cell-free DNA detect early stage pancreatic cancer. Gut. 2024 Mar 07; 73(4):639-648.Gut2024-03-07T00:00:002024Protein biomarkers and alternatively methylated cell-free DNA detect early stage pancreatic cancer.Authorship 10862155Authorship 10861561Authorship 10861071538175578Le?n-Letelier RA, Dou R, Vykoukal J, Yip-Schneider MT, Maitra A, Irajizad E, Wu R, Dennison JB, Do KA, Zhang J, Schmidt CM, Hanash S, Fahrmann JFClinical chemistryContributions of the Microbiome-Derived Metabolome for Risk Assessment and Prognostication of Pancreatic Cancer. Clin Chem. 2024 Jan 04; 70(1):102-115.Clin Chem2024-01-04T00:00:002024Contributions of the Microbiome-Derived Metabolome for Risk Assessment and Prognostication of Pancreatic Cancer.38166233Abdilleh K, Khalid O, Ladnier D, Wan W, Seepo S, Rupp G, Corelj V, Worman ZF, Sain D, DiGiovanna J, Press B, Chandrashekhar S, Collisson E, Cui KY, Maitra A, Rejto PA, White KP, Matrisian L, Doss SJCO clinical cancer informaticsPancreatic Cancer Action Network's SPARK: A Cloud-Based Patient Health Data and Analytics Platform for Pancreatic Cancer. JCO Clin Cancer Inform. 2024 Jan; 8:e2300119.JCO Clin Cancer Inform2024-01-01T00:00:002024Pancreatic Cancer Action Network's SPARK: A Cloud-Based Patient Health Data and Analytics Platform for Pancreatic Cancer.38172340Maitra ANature cancerReaching your destination can require a diversion. Nat Cancer. 2024 Jan; 5(1):1.Nat Cancer2024-01-01T00:00:002024Reaching your destination can require a diversion.Authorship 10883202238310130Yousef A, Yousef M, Chowdhury S, Abdilleh K, Knafl M, Edelkamp P, Alfaro-Munoz K, Chacko R, Peterson J, Smaglo BG, Wolff RA, Pant S, Lee MS, Willis J, Overman M, Doss S, Matrisian L, Hurd MW, Snyder R, Katz MHG, Wang H, Maitra A, Shen JP, Zhao DNPJ precision oncologyImpact of KRAS mutations and co-mutations on clinical outcomes in pancreatic ductal adenocarcinoma. NPJ Precis Oncol. 2024 Feb 03; 8(1):27.NPJ Precis Oncol2024-02-03T00:00:002024Impact of KRAS mutations and co-mutations on clinical outcomes in pancreatic ductal adenocarcinoma.Authorship 10890712738320723Rodriguez NJ, Furniss CS, Yurgelun MB, Ukaegbu C, Constantinou PE, Fortes I, Caruso A, Schwartz AN, Stopfer JE, Underhill-Blazey M, Kenner B, Nelson SH, Okumura S, Zhou AY, Coffin TB, Uno H, Horiguchi M, Ocean AJ, McAllister F, Lowy AM, Klein AP, Madlensky L, Petersen GM, Garber JE, Lippman SM, Goggins MG, Maitra A, Syngal SGastroenterologyA Randomized Trial of Two Remote Health Care Delivery Models on the Uptake of Genetic Testing and Impact on Patient-Reported Psychological Outcomes in Families With Pancreatic Cancer: The Genetic Education, Risk Assessment, and Testing (GENERATE) Study. Gastroenterology. 2024 Feb 05.Gastroenterology2024-02-05T00:00:002024A Randomized Trial of Two Remote Health Care Delivery Models on the Uptake of Genetic Testing and Impact on Patient-Reported Psychological Outcomes in Families With Pancreatic Cancer: The Genetic Education, Risk Assessment, and Testing (GENERATE) Study.Authorship 10900951738451249Bahrambeigi V, Lee JJ, Branchi V, Rajapakshe KI, Xu Z, Kui N, Henry JT, Wang K, Stephens BM, Dhebat S, Hurd MW, Sun R, Yang P, Ruppin E, Wang W, Kopetz S, Maitra A, Guerrero PACancer researchTranscriptomic Profiling of Plasma Extracellular Vesicles Enables Reliable Annotation of the Cancer-specific Transcriptome and Molecular Subtype. Cancer Res. 2024 Mar 07.Cancer Res2024-03-07T00:00:002024Transcriptomic Profiling of Plasma Extracellular Vesicles Enables Reliable Annotation of the Cancer-specific Transcriptome and Molecular Subtype.Authorship 109050233Authorship 109055717Authorship 1090612938478609Ho IL, Li CY, Wang F, Zhao L, Liu J, Yen EY, Dyke CA, Shah R, Liu Z, ?etin AO, Chu Y, Citron F, Attanasio S, Corti D, Darbaniyan F, Del Poggetto E, Loponte S, Liu J, Soeung M, Chen Z, Jiang S, Jiang H, Inoue A, Gao S, Deem A, Feng N, Ying H, Kim M, Giuliani V, Genovese G, Zhang J, Futreal A, Maitra A, Heffernan T, Wang L, Do KA, Gargiulo G, Draetta G, Carugo A, Lin R, Viale AScience advancesClonal dominance defines metastatic dissemination in pancreatic cancer. Sci Adv. 2024 Mar 15; 10(11):eadd9342.Sci Adv2024-03-13T00:00:002024Clonal dominance defines metastatic dissemination in pancreatic cancer.38467382Yang D, Sun X, Moniruzzaman R, Wang H, Citu C, Zhao Z, Wistuba II, Wang H, Maitra A, Chen YGastroenterologyGenetic Deletion of Galectin-3 Inhibits Pancreatic Cancer Progression and Enhances the Efficacy of Immunotherapy. Gastroenterology. 2024 Mar 09.Gastroenterology2024-03-09T00:00:002024Genetic Deletion of Galectin-3 Inhibits Pancreatic Cancer Progression and Enhances the Efficacy of Immunotherapy.38464029Trinh VQ, Ankenbauer KE, Liu J, Batardiere M, Maurer HC, Copeland C, Wong J, Ben-Levy O, Torbit SM, Jarvis B, Revetta F, Ivanov S, Jyotsana N, Makino Y, Ruelas AM, Means AL, Maitra A, Tan MCB, DelGiorno KEbioRxiv : the preprint server for biologyOncogenic GNAS drives a gastric pylorus program in intraductal papillary mucinous neoplasms of the pancreas. bioRxiv. 2024 Feb 28.bioRxiv2024-02-28T00:00:002024Oncogenic GNAS drives a gastric pylorus program in intraductal papillary mucinous neoplasms of the pancreas.true1ProfessorProfessortrue1ProfessorProfessortrue1Assistant ProfessorAssistant Professortrue1Assistant ProfessorAssistant Professortrue1ProfessorProfessortrue1Associate ProfessorAssociate Professortrue1Assistant ProfessorAssistant Professortrue1ProfessorProfessortrue1Assistant ProfessorAssistant Professor24219822Canto MI, Anandasabapathy S, Brugge W, Falk GW, Dunbar KB, Zhang Z, Woods K, Almario JA, Schell U, Goldblum J, Maitra A, Montgomery E, Kiesslich R, Confocal Endomicroscopy for Barrett's Esophagus or Confocal Endomicroscopy for Barrett's Esophagus (Gastrointestinal endoscopyIn vivo endomicroscopy improves detection of Barrett's esophagus-related neoplasia: a multicenter international randomized controlled trial (with video). Gastrointest Endosc. 2014 Feb; 79(2):211-21.Gastrointest Endosc2013-11-09T00:00:002013In vivo endomicroscopy improves detection of Barrett's esophagus-related neoplasia: a multicenter international randomized controlled trial (with video).24962922Devaraj S, Maitra ADiabetesPancreatic safety of newer incretin-based therapies: are the "-tides" finally turning? Diabetes. 2014 Jul; 63(7):2219-21.Diabetes2014-07-01T00:00:002014Pancreatic safety of newer incretin-based therapies: are the "-tides" finally turning?24856586?zdemir BC, Pentcheva-Hoang T, Carstens JL, Zheng X, Wu CC, Simpson TR, Laklai H, Sugimoto H, Kahlert C, Novitskiy SV, De Jesus-Acosta A, Sharma P, Heidari P, Mahmood U, Chin L, Moses HL, Weaver VM, Maitra A, Allison JP, LeBleu VS, Kalluri RCancer cellDepletion of carcinoma-associated fibroblasts and fibrosis induces immunosuppression and accelerates pancreas cancer with reduced survival. Cancer Cell. 2014 Jun 16; 25(6):719-34.Cancer Cell2014-05-22T00:00:002014Depletion of carcinoma-associated fibroblasts and fibrosis induces immunosuppression and accelerates pancreas cancer with reduced survival.